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Preface
The title of this thesis reveals the interdisciplinary nature of my investigation,
where different mathematical methods were used to handle the questions of mod-
elling, analyzing and controlling thrombin formation in blood coagulation systems.
Different scientific disciplines have different languages and different ways to build
structures and processes, so that the flow between knowledge and new findings is
usually restricted to one particular field. As a consequence, disciplines of exact,
empirical or experimental nature can hardly communicate with each other. On
the other hand, systems like the blood coagulation system, cannot be explained or
understood only by using the laws or axioms of a single science. Thus, one of the
aims of this thesis was to create a science to science interface and a common plat-
form of knowledge based in different mathematical approaches. Everything started
therefore by collecting the necessary information from Mathematics, Medicine and
Biochemistry. So, there must be a proper way of stating the right questions and
getting the right answers. Thereby, one of the essential points was to pick up a
simple but by no means simplistic form to communicate contents.
The process of collecting relevant information from scientists with different back-
grounds is not a simple matter. However, the process of filtering and synthesizing
information from foreign disciplines is in general more demanding. In this phase,
the first task is to select information by rhetoric asking: what is really important?
what do I really need from the foreign disciplines? shall I go deeper into some of
these subjects? is there some piece missing? where do I get it? The second task
is to translate the information and state the problem in mathematical terms. The
later here, one has to decide which mathematical branch or branches are more
suitable to built the model and make further analysis. Thereby, it is crucial to
investigate whether there are known approaches in the literature and to keep in
mind that there are some natural relevant parameters with a very specific meaning
that cannot be changed. So, the model has to reflect at least some of the most
important characteristics of the system. Whenever possible, it should provide new
insights about the mechanism that is the object of study. Last but not least, the
results of the investigation should be made intelligible to all potential different
readers with variable scientific backgrounds. This is of major importance for the
different scientists to use the information gained and to progress in their own area.
In particular, mathematicians experience whether the approach can be fully based
on classical results or whether there is still the need of new results.
Thrombin is the essential enzyme product of the blood coagulation process. Since
the early investigations on this field, the blood coagulation process has been repre-
sented as a cascade of enzymatic reactions. Nowadays it is known to respond in a
threshold manner, involving numerous intermeshed controls including feedforward
and feedbackward loops. The regulation of the production of thrombin is vital
to the maintenance of the hemostatic balance in humans. However, uncontrolled
generation of this enzyme can lead to physiological disaster. From the medical
literature it is known that foreign surface contact, e. g. during application of arti-
ficial organs, is a strong activator of whole of the system. Thus, intelligibility of the
roles of the system components in this regulation is important for a therapeutic
control of thrombotic and bleeding disorders. Chapter 1 contains the physiolog-
ical background, where the principal procoagulatory and anticoagulatory factors
and the two pathways leading to the formation of a fibrin clot are introduced.
Furthermore, some aspects concerning the kinetics of coagulation are discussed
together with a brief description of the contribution of mathematical modelling to
the understanding of the dynamics inherent to this physiological system.
On the one hand, it is important for instance to know how biochemists deduce
from a reaction scheme the differential equations they work with. On the other
hand, it is also important to present contents in a terminology and formalism more
standard in control and in dynamical systems theories. Thus, we put together the
forthcoming information from the different literature sources in such a way that
references in subsequent chapters are easily made. Terms like stoichiometry or de-
ficiency of a network arise and help to gain insights into the structure of a chemical
network and to understand how they influence its dynamics. All this is done in
the first part of Chapter 2. Furthermore, since the blood coagulation system in-
volves a series of enzymatic reactions, the second part of this chapter explains
kinetic aspects of enzyme-catalyzed reactions. In particular, concepts like quasi-
steady assumption, Michaelis-Menten equation or enzyme inhibition are briefly
introduced.
Several attempts of modelling a part of the blood coagulation system include a
stiff system of nonlinear differential equations with unknown parameters. These
parameters are the reaction constants and the initial concentration of the coag-
ulation factors, which are normally estimated by fitting experimental data. The
number of parameters and equations is however considerably large, what might
result in low parameter sensitivity. Moreover, the reaction mechanism is also not
precisely known. In fact, there might be reactions that have been shown to ex-
ist in principle but do not occur in reality [SHH97]. Although kinetic analysis of
the individual reactions have been reported in the literature, an analysis of the
complete reaction network has been given less attention. Altogether, another aim
for this thesis was to make a careful mathematical analysis of two of the most
cited models among the scientific community investigating the mechanisms of the
blood coagulation cascade. One model is due to Stortelder, Hemker and Hemker
[SHH97] and the other one is due to Jones and Mann [JoMa94].
These models are presented in Chapter 3. With the tools provided in Chapter
2, an analysis of the stoichiometry of both models is made and the numerical
solution provided. Besides stoichiometry, we interpreted the reaction scheme of
Jones and Mann in terms of homologies of graphs. Due to inconsistent information
contained in the original model, the equations of the system are traced back by
using the law of mass action and concluded that there is a term that has been
introduced a posteriori to provoke a decay. The authors did not carefully analyze
the consequences of this ansatz, though. This is done in the following chapter of
this thesis.
An important characteristic of biochemical models is that variables representing
chemical concentrations take only nonnegative values. So, positive invariance of
both systems was checked. It turned out that the original system from Mann
and Jones is not positively invariant. Stability is another natural mathematical
requirement with clear biological significance. After checking that for any choice
of initial nonnegative values the system converges to an equilibrium, one may ask
furthermore about the structure of that equilibrium. This is done after identifying
first integrals and therewith conserved quantities. The number of equations of both
models could like this be reduced by the same amount of previously identified first
integrals. The stability of the corrected version of the model from Mann and Jones
was characterized in the sense of Lyapunov. Since zero is a simple eigenvalue of
the Jacobian matrix of the function defined by the right-hand side of the system
at a nonisolated equilibrium, local stability of Stortelder’s model was concluded
with a result given in Bibikov’s lecture notes. This is accomplished in Chapter 4. A
survey of known results of the qualitative theory of ordinary differential equations
is given in Appendix A.
The equilibria depend in particular on the value of the constants that represent
total concentrations. The questions to pose before proceeding are: if we are al-
lowed to manipulate some of the variables, can the equilibria be changed at will
and preserve stability? How many variables need to be manipulated? This kind
of questions may impact approaches to therapy and rational drug design. The
answer to some of these questions are given in Chapter 5 for Stortelder’s model
by using results from mathematical control theory. Since the linearized system is
not completely controllable, we checked the flatness of the nonlinear system in the
sense of M. Fließ and we identified a flat output. The results from control theory
used are presented in Appendix B.
In Chapter 6, the governing equations of the reaction scheme published in [JoMa94]
by using Michaelis and Menten relation are deduced followed by a qualitative anal-
ysis and model reduction of the new system. This system is responsive to changes
in the concentration of the factors associated to hemophilic disorders. Moreover,
based on this model for the extrinsic pathway we propose a new approach to model
and simulating thrombin formation by the intrinsic pathway and do, as before, a
qualitative analysis and a model reduction. To motivate the construction of a
model only comprising a part of the intrinsic haemostasis, we give the example
of a patient subject to heart valve replacement. This valves are normally artifi-
cial and therefore foreign substances may trigger the blood coagulation system.
As a consequence, such patients have to take anti-coagulant drugs all their life
time. So we wished to steer the system by using anti-coagulant drugs in order to
prevent the formation of a thrombus. However, these two models do not account
for the role of physiological inhibitory substances like anti-thrombin in the course
of thrombin concentration with time. On the other hand, drugs like heparin only
act in the presence of anti-thrombin. So, before studying the controllability of the
systems presented in this chapter, one should extend them by including the action
of inhibitors.
In Chapter 7 we propose a first approach to model the action of platelets on
the common pathway by slightly modifying the model from Stortelder et al and
extend the truncated model to a model by substituting RV V by the plasmatic
factors leading to thrombin formation by the extrinsic pathway. As usual, this
is accomplished together with a qualitative analysis of both systems and model
reduction.
The last chapter is a summary of the main results and contains also some final
remarks.
Unfortunately, due to the absence of experimental data, the models presented in
this thesis could not be validated nor be rejected. But, one has to keep in mind
that a mathematical model is useful to gain some understanding of the underlying
dynamics and mechanisms governing the phenomena. So, we hope that this thesis
will provide new insights into the process of thrombin formation towards a more
systematical way to gain information from these and other models concerning the
blood coagulation system.
Aachen, January 2007 Sandra O´rfa˜o
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Chapter 1
The Blood Coagulation System
One of the most peculiar and remarkable properties of blood is its ability to solid-
ify or clot [Davie05]. The blood coagulation system maintains the integrity of the
mammalian circulatory system and the balance of blood fluidity in response to
vascular injury. The hemostatic response involves a complex series of events that
require the interaction of blood and vascular cellular elements and blood plasma1
proteins [JoMa94] [B-ZVBMR05]. It has been characterized as a series of prote-
olytic reactions in each of which an inactive percursor (zymogen) of a proteolytic
enzyme is converted to the active enzyme (protease) in a cascade or waterfall pat-
tern. The origin of this concept can be traced back to the early studies of the
blood coagulation system [Davie05]. Nowadays, it is characterized as a network of
feedback controlled reactions. The physiological response to vascular injury cul-
minates in the rapid generation of thrombin, at the site of injury, which cleaves
the plasma protein fibrinogen into insoluble fibrin monomers via limited proteol-
ysis [Jesty05] [FoKu98] [JoMa94]. Thus, the response of the coagulation process
is generally limited to the site of injury and is proportional in magnitude to the
extent of vascular damage [MNCHK90]. Moreover, because each step in the se-
ries is enzyme catalyzed, and one enzyme molecule can theoretically catalyze the
formation of a very large number of molecules of product, the cascade has the ca-
pacity of enormous amplification [Jesty05]. Qualitative or quantitative alterations
in this hemostatic balance determines one of three possible outcomes: hemorrhage,
controlled hemosthasis or thrombosis. Thus, comprehensibility of the roles of the
system components in this regulation is important for a therapeutic control of
thrombotic and bleeding disorders.
Over the past 25 years, reasonably comprehensive insights of the stock of proteins
and the associated biophysical and enzymatic processes involved in blood clotting
1Fluid of the blood with its clotting mechanisms intact and ready to go
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has been developed through the efforts of numerous investigators. A large amount
of rigorously obtained data describes association states, membrane binding ther-
modynamics, enzyme complex assembly kinetics, and reaction kinetics for the role
of processes [HJEM02]. However, the understanding of the dynamics is still poor
[FoKu98].
This chapter is dedicated to the description of the blood coagulation cascade and
its components. Aspects regarding the regulation of thrombin levels, clinical signif-
icance of the clotting cascade and pharmacological intervention are also discussed.
Finally, an overview of how mathematical modelling has been contributing and
can still contribute for the understanding of biological processes and in particular
of the blood coagulation system is given.
1.1 Coagulation factors. Coagulation cascade
When a blood vessel is injured, a number of physiological mechanisms are acti-
vated that promote hemostasis, or the cessation of bleeding (hemo=blood; sta-
sis=steady-state). Breakage of the endothelial lining of a vessel exposes collagen
proteins from the subendothelial connective tissue to the blood.
The mechanisms for initiating and regulating blood coagulation in humans include
the following three general processes [Davie05]:
• the immediate contraction of blood vessels at the site of injury, which limits
the flow to the area of injury;
• formation of the platelet2 plug;
• generation of a fibrin mesh or clot to stabilize the platelet plug. If the plug
contains only platelets we speak about a white thrombus ; if red blood cells
are present, we call it a red thrombus.
Phospholipids that are exposed on the platelet membrane participate in the action
of clotting factors.
1.1.1 Coagulation factors and related coagulation disorders
Most of the clotting proteins, or clotting factors, are precursors of proteolytic
enzymes and are also known as zymogens. The second major group is the cofactor
proteins, which accelerate reactions. Although it is known that some of the clotting
2Platelets or thrombocytes are cell fragments circulating in the blood that are involved in the
mechanisms of primary hemostasis (see Figure 1.1)
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proteins are synthesized in other tissues, the liver is the major site of synthesis for
probably all the plasma proteins [Jesty05].
The nomenclature of the proteins involved in clotting is complicated and almost
arbitrary. Actually, in many cases, there are at least two designations for the
same protein. However, it is general practice to represent the inactive form of the
coagulation factors by Roman numerals. A lower case ”a” appearing as a subscript
means ”activated”. For example, the activation of the zymogen factor X produces
the protease factor Xa.
There are several ways to introduce the coagulation factors and related diseases.
The choice of the most adequate among them depends actually on the reader. This
thesis is written for audiences with different scientific backgrounds that include
specialists on blood coagulation, like physiologists, and non-specialists, like mathe-
maticians and engineers. So, we had to find a compromise. As coagulation factors
were identified through patients with different coagulation disorders, historical
aspects are added to help a non-specialist to understand better the relationship
between the factor’s nomenclature and the diseases to which they are related. For
more historical aspects exploring these and other events and presenting the people
involved in unraveling the basic mechanisms leading to the clotting of blood from
it beginning on see [Davie05] and [Lin95].
John Hageman was a patient of Prof. Rattnoff, a professor of medicine at the
Western Reserve University that lead a project on blood coagulation. Hageman
had a rather strange clotting abnormality in that his blood did not clot when in
contact to a glass test tube. However, this could be corrected by the addition of a
small amount of plasma or serum3 from normal individuals or from patients with
other known coagulation disorders such as hemophilia. The most interesting was
that Hageman did not experience any bleeding tendency. From these studies it
was concluded that in normal plasma there must be a protein in an inactive form
that is activated in a test tube when bound to a glass surface or crushed glass or
kaolin. This was consistent with the idea that this plasma protein could trigger
fibrin formation in blood collected in a glass container in the absence of tissue
extracts. This assumption was proved after several purification steps. The protein
was not present in Hageman’s blood and received the name Hageman factor, now
called factor XII [Davie05].
In 1936, Patek and Stetson found that patients with hemophilia were lacking a
factor present in normal plasma. They called it anti-hemophilic factor (AHF) or
anti-hemophilic globulin (AHG). This deficiency is now called hemophilia A or
factor VIII deficiency[Davie05].
Factor XIII was first called Laki-Lorand or fibrin-stabilizing factor. In the pres-
ence of this plasma protein and calcium fibrin became rather insoluble. Years later,
3Clotted plasma
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it was found that activated factor XIII cross-links fibrin monomers [Davie05].
A rare disorder resulting in bruising and bleeding after minor lacerations or dental
extraction has at its origin on the lack of a plasma protein factor V, also called
proaccelerin or Labile factor. The disease was referred to as parahemophilia. Fac-
tor V is furthermore where we find the most common hereditary risk factor for
thrombosis. Here, factor V, while it is normally converted to active factor V, is
defective in its ability to be inactivated by protein C yielding abnormally high
levels of thrombin generation [Davie05][Jesty05].
Thrombin is the essential enzyme product of the blood coagulation enzymatic cas-
cade. The regulation of the production of this enzyme is vital for the maintenance
of the hemostatic balance in humans. As a matter of fact, genetic and acquired
deficiencies that cause reduction in, or the absence of, thrombin generation lead
to hemorrhagic syndromes. Defects in the regulatory and dynamic processes that
down-regulate thrombin generation are associated with thrombotic risk [BvVM99].
Alexander and co-workers described another factor in serum that accelerated the
conversion of prothrombin to thrombin. This factor was called serum prothrombin
conversion accelerator (SPCA) and the defect factor VII deficiency[Davie05].
Another clotting disorder called hemophilia B was described in 1952 among others
by Biggs and co-workers. The protein lacking was known as plasma thromboplastin
component (PTC), Christmas factor or factor IX [Davie05].
In 1953, Rosenthal and co-workers described a clotting disease that they called
plasma thromboplastin antecedent (PTA) deficiency or factor XI deficiency. Pa-
tients with PTA deficiency present mild or moderate bleeding symptoms that often
became evident only after surgery or injury [Davie05].
Stuart factor deficiency of factor X deficiency was first described by Hougie and
co-workers. In patients suffering from this bleeding disorder, factor X fails to
readily convert prothrombin to thrombin, resulting consequently in the formation
of an abnormal or delayed fibrin clot [Davie05].
Tissue factor is an integral membrane glycoprotein and functions as a receptor for
factor V II or V IIa (circulating in the blood). It is normally expressed at only very
low levels in the endothelial cells, which line the blood vessel [Davie05] [Jesty05].
While it is a fact that much of the existing knowledge of how coagulation works
in vivo comes from clinical data on bleeding disorders of patients with hereditary
deficiencies of clotting factors, it must be emphasized that such diseases are very
rare. In fact, for each single person with hemophilia (A or B) - the most common
hereditary bleeding defect- about 4 to 5000 other people will suffer a thrombotic
3Endothelial cells play a number of roles in the hemostatic process in addition to binding
coagulation factors
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episode during their lifetime [Jesty05]. Furthermore, it has been recently found
that hereditary abnormalities are in fact much more common in thrombotic than
in bleeding disorders.
As already mentioned, most clotting proteases require cofactor proteins to make
the reactions that they catalyze go fast enough. A cofactor is a protein that has
no catalytic site, but regulates the activity of an accompanying protease [Jesty05].
More specifically: factor V IIa requires tissue factor; factor IXa requires factor
V IIIa; factor Xa (acting on prothrombin) requires factor Va; and thrombin acti-
vation of protein C action on factor V and factor V III requires protein S.
Table 1.1 summarizes some of the most important aspects related to the coagula-
tion factors, like their physiological concentration and their function. Note that the
concentrations of the different factors are not exact. In the literature, the values
vary rather widely. The values given in this table are the most common. The last
column makes the correspondence between the coagulation factors and the clotting
pathway within which they are activated. In the next section we describe the blood
coagulation cascade and therewith explain the meaning of both the intrinsic and
the extrinsic pathways.
1.1.2 Coagulation cascade
Already at the early times of investigation, the blood coagulation system was
represented as a cascade of enzymatic reactions, first by Ratnoff and Davie and
then by MacFarlane in 1964. These two models helped to clarify the sequence in
which clotting factors interacted and provided concepts that were readily tested
in laboratory environments [Davie05].
Historical reasons also justify the existence of two pathways (see Table 1.1) lead-
ing to the formation of a fibrin clot. One is called the intrinsic pathway or the
contact pathway and the other the extrinsic pathway or the tissue factor pathway
[Davie05]. Although initiated through different mechanisms, it is believed that the
two pathways merge at the level of activated factor X to a final common pathway
that results in the formation of insoluble fibrin polymers via the prothrombinase
complex. The intrinsic pathway is initiated either by exposure of plasma to a neg-
atively charged surface, such as that provided by collagen at the side of injury
or by the glass of a test tube. The extrinsic pathway is initiated upon contact
of circulating factor V IIa with the transmembrane protein tissue factor, which
becomes available after vascular injury.
Furthermore, the coagulation process is now known to also involve numerous in-
termeshed controls including feedforward and feedback loops, in which an enzyme
produced in one step promotes or inhibits earlier or later reactions [Jesty05]. Thus,
the system is said to respond in a threshold manner [FoKu98], where an activation
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Table 1.1: Coagulation factors and functional classification
Name Concentration Place Properties Pathway
[µmol/l] Source Function
Factor I 8.8 Liver Soluble protein; Both
Fibrinogen Platelets Cofactor; Precursor of fibrin
Factor II 1.4 Liver(vit. K) Precursor of thrombin; Both
Prothrombin Plasma zymogen of serine protease; enzyme
Factor III – Tissue cells Lipoprotein; Extrinsic
Tissue Factor (TF) cofactor; enzyme
Factor IV 2500 – Necessary for the activation Both
Calcium (Ca2+) of the most coagulation factors
Factor V 0.03 Liver Binds to platelet’s membrane; Both
Proaccelerin Plasma/Platelets cofactor
Factor V I – – Part of the prothrombinase Both
Act. factor V complex
Factor V II 0.03 Liver (vit. K) Zymogen of serine protease; Extrinsic
Proconvertin Plasma proenzyme
Factor V III < 0.0004 Plasma Cofactor in the activation Intrinsic
Antihaemophilic factor of factor X
Factor IX 0.09 Liver (vit. K) Zymogen of serine protease; Intrinsic
Christmas factor, PTC∗ Plasma proenzyme
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Factor X 0.2 Liver (vit. K) Zymogen of serine protease; Intrinsic
Stuarts factor Plasma proenzyme
Factor XI 0.034 Plasma Zymogen of serine protease; Intrinsic
PTA∗∗ proenzyme
Factor XII 0.45 Plasma Zymogen of serine protease Intrinsic
Hageman factor activated by kallikerein; proenzyme
Factor XIII 0.1 Platelets Transglutaminase; produces Both
Fibrin stab. factor Plasma fibrin cross-linking
∗PTC - plasma thromboplastin component; ∗∗PTA - plasma thromboplastin antecedent;
prothrombinase-enzyme complex that converts prothrombin into thrombin.
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8 Chapter 1. The Blood Coagulation System
significant activators of TF.V II, the complex TF.V IIa itself and the factor Xa.
The factor TF.V IIa enzyme complex, also known as extrinsic tenase, results out
of the binding of small amounts of pre-existing circulating factor V IIa and besides
factor TF.V II and factor Xa, it activates as well factor IX by limited proteolysis
[BvVM99] [Davie05], linking the two pathways at this stage. However, activated
factor Xa is a potent activator of factor V II and this constitutes an example of
surface-dependent positive feed-back loop [FoKu98]. Nevertheless, the ability of
factor Xa to activate factor V II creates another link between the intrinsic and
the extrinsic pathways.
Current literature supports the notion that the physiologic hemostatic response
is initiated by the extrinsic pathway [LKSM94] - see for instance [Lin95] for two
models supporting this theory. However, this would make the activation of factor
X by the complex V IIIaIXa superfluous, what happens to be a paradox because
this complex is thought to be one of the most strongest activators of factor X.
At this point, the key observation is that people who lack factor XII are clini-
cally normal. Thus, if the intrinsic pathway functions normally, its contribution
to haemostasis is small. In contrast, a deficiency in TF has never been observed
in humans, and is probably lethal [Jesty05].
The common pathway. Activation of prothrombin to thrombin
As referred before, the two pathways merge. From the current literature, it is
generally accepted that they merge at the activation of factor X. The common
pathway can therefore be divided in three segments:
• activation of factor X;
• thrombin formation from prothrombin;
• fibrinogen to fibrin.
After activation of factor X, the next step is to activate prothrombin to form
thrombin, and then convert fibrinogen to fibrin and cross-link it, completing the
basic clotting pathways.
From the limited amount of factor Xa produced by the complex TF.V IIa, pico-
molar concentrations of thrombin are produced, during an initiation phase, which
partially activates platelets and cleaves factors V and V III, generating their ac-
tive forms Va and V IIIa by positive feedback [BvVM99]. It is furthermore defined
as the time needed to generate approximately 2nM of thrombin [HJEM02].
Subsequently, during a propagation phase, factor Xa forms the so called prothrom-
binase complex with cofactor Va, in the presence of calcium and phospholipids,
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which is the primary activator of prothrombin. This yields the bulk of throm-
bin generation, (about 96 % of the total amount during the propagation phase
[B-ZVBMR05]). Moreover, prothrombin activation by the complex XaVa is iden-
tical in form with the activation of factor X by the complex IXaV IIIa. And,
furthermore, it is generally accepted that the interaction of factor Xa with factor
Va enhances the turnover number of factor Xa about 2800 to 3000- fold [BWHL95]
[NeTrMa84].
The thrombin further amplifies its own generation by activating factor XI and
completing activation of platelets, factors V and V III. Additionally, thrombin also
cleaves fibrinogen and factor XIII to form the insoluble cross-linked fibrin-clot
[BuMa02].
The formation of thrombin may occur more rapidly as result of the release of tissue
thromboplastin4 from damaged tissue cells.
As the concentration of thrombin increases, factor V IIIa is cleaved by thrombin
and inactivated [Davie05].
Figure 1.1 summarizes the most important reactions occurring. For completeness
see for instance [Lin95], [Pru00].
Thrombocytes and procoagulatory activity
Fibrin formation is just one part of the hemostatic system. The other compo-
nents are the platelets, and the system by which damaged vessels contract under
sympathetic nervous control.
Platelet or thrombocyte function and coagulation are often separated for didactic
reasons, but the two systems are closely interconnected, each requiring the other for
its function. Nevertheless, a normal clot consists of a nested structure of aggregated
platelets and fibrin [Jesty05].
In the absence of injury, platelets are repelled from each other and from the en-
dothelial lining of vessels. In contrast, damage of the endothelium of vessels makes
platelets stick to exposed collagen proteins starting the so called primary hemosta-
sis (see Figure 1.1).
To some extent the platelets can function without the clotting system and vice-
versa, but the platelets require products of the clotting system to aggregate prop-
erly, and the clotting system requires platelets to form fibrin properly. In other
words, the primary platelet clot is relatively unstable. Therefore, an efficient
hemostasis asks for the consolidation of the platelet rich thrombus. This starts
with the activation of the blood coagulation cascade and with the building of
4Protein in the surface of endothelial cells
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Figure 1.1: Blood coagulation cascade
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thrombin and fibrin next to the area occupied by the aggregated platelets. So, we
speak about the secondary hemostasis (see Figure 1.1).
Decisive for the procoagulatory effect of the thrombocytes are the activated blood
platelets. In fact, during activation, negatively charged phospholipids on the throm-
bocytes surface are exposed, increasing the binding activity for plasmatic coagu-
lation factors like factors V, V IIIa, IXa and Xa while catalyzing both the tenase
and prothrombinase complexes.
Additionally, platelets are also storage components of proteins involved in blood
coagulation and its regulation. A deficiency in functional platelets, i. e., thrombo-
cytopenia, is associated with bleeding complications. In ”synthetic plasma” and in
whole blood, thrombin generation profiles observed at platelet concentration be-
low 0.1× 108/ml ( < 5% of mean plasma value), the thrombin generation profile
is similar to that observed in severe hemophilia blood [Jesty05].
More detailed description about thrombocytes, their morphology and function can
be found in [Gaw99], [Lin95] and [Pru00].
1.2 Regulation of thrombin levels
1.2.1 The role of anticoagulants
There are two principal mechanisms by which thrombin activity is regulated.
The predominant form of thrombin in circulation is the inactive prothrombin,
whose activation requires the pathways of proenzyme activity described above.
So, the balance between active and inactive enzymes is assured by feedback mech-
anisms occurring at each step in the cascade. On the other hand, the initiation and
propagation phases of the coagulation system are differentially regulated by sub-
stances called inhibitors or anti-coagulants as well, the principal being antithrom-
bin III (ATIII), activated proteins C and S, and tissue factor pathway inhibitor
(TFPI) [BvVM99]. Besides these, we still may point out α2−macroglobulin and
heparin cofactor II as thrombin inhibitors. Altogether, the major task is to prevent
blood from clotting.
From the studies done about the process of the blood coagulation system, it be-
haves such that the interaction between procoagulants and inhibitors produces
threshold responses with respect to stimuli, and the whole process functions alto-
gether in a ”yes / no” configuration in which the procoagulant initiating stimulus
must be at a certain level [BvVM99].
ATIII is perhaps the most important coagulation inhibitor. It controls the ac-
tivities of thrombin, and of factors IXa, Xa, XIa and XIIa. Moreover, it is in
12 Chapter 1. The Blood Coagulation System
significant molar excess to its target enzymes and is said to damp the propagation
phase [BvVM99].
A number of epidemiological studies have shown that concentration variations
of blood coagulation proteins, respectively prothrombin, ATIII, protein C and
S, factors V II, V III and IX within the 50 % to 150 % of their mean value
concentration are associated with thrombotic risk [BvVM99].
TFPI inhibits the extrinsic pathway very quickly. In fact, this protein is a factor
Xa dependent inhibitor of the complex TF.V IIa, blocking additional thrombin
generation. The inability of TFPI to bind factor V IIa in the absence of factor Xa
probably explains why factor V IIa is able to circulate for a relatively long period
of time [Lin95].
It is also known from the literature (see for instance [BvVM99]) that if all pro-
coagulants factors and stoichiometric inhibitors are at their mean plasma concen-
trations, thrombin generation occurs and after an initiation it reaches a maximum
concentration of approximately 300nmol/L or 0.3µmol/L and it can vary between
100 and 400nmol/L depending upon the experimental circumstances. The forma-
tion and inhibition rates are equal at 2,5 minutes after the process has started.
Subsequently, thrombin is completely inhibited in about 10 minutes. Two more
scenarios were considered and analyzed: the first where ATIII and TFPI were
present at 150 % and procoagulants reduced to 50 % of their mean values con-
centration and the second where the concenration of the anticoagulants by 50 %
combined with an increase of the concentration of all procoagulants to 150 %.
In the first case, the total thrombin concentration was reduced approximately 25
% of the normal profile; in the second case an 700 % increase in total throm-
bin generation was observed, the maximum concentration being not larger than
1µmol/L.
Thrombin also plays an important regulatory role in coagulation as its activ-
ity initiates numerous positive and negative feedback loops [AtPa05]. It binds to
thrombomodulin, another endothelial transmembrane protein, to activate protein
C. The activated form of protein C degrades factors V IIIa and Va, limiting the
activity of these two factors. Thereby, protein S acts as a cofactor of protein C.
Table 1.2 summarizes inhibitors and some properties.
1.2.2 Pharmacological intervention in bleeding and in thrombosis
One of the objectives of this thesis is to study the possibility of steering the
system by means of an external control modelling the action of a drug on thrombin
formation. So, as a motivation, we refer briefly some of the most common clotting
disorders and their treatment.
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Name Concentration Place Properties
[µmol/l] Source Function
ATIII 3.4 Plasma Mediated inactivation
Antithrombin III of factors IIa,
V IIa, IXa, Xa
Protein S 0.3 vit. K Cofactor for
Plasma act. protein C in
factors Va and V IIIa
inactivation
Protein C 0.06 vit. K Zymogen of serine
Plasma protease
TFPI 0.0025 Platelets; Mediated inactivation
Tissue factor plasma; of complex TF : V IIa
pathway inhibitor tissue cells and its product
complexesA
n
ti
-c
o
ag
u
la
n
t
fa
ct
o
rs
Table 1.2: Inhibitors and some of their properties
The hemophilia resulting from a deficiency in factor V III can be treated by in-
fusion of factor V III concentrates prepared from either human plasma or by
recombinant DNA technology.
The activity of antithrombin III can become more effective by the use of heparin.
Heparin can be given intravenously during certain medical procedures. What hap-
pens is that heparin binds to a specific site of antithrombin III, producing an
altered form of the protein with higher affinity to thrombin and to the other fac-
tors also inhibited by antithrombin. Heparin is the most used anticoagulant drug
for the immediate treatment of thrombosis (heart attack, thromboembolic stroke,
pulmonary embolism, etc) and it is also used for anticoagulation in surgical pro-
cedures involving a significant risk of postoperative thrombosis. However, heparin
only prevents clotting in the presence of ATIII. Thus, patients lacking this pro-
tein have a greater risk of suffering a thrombotic episode during their life time
[Jesty05].
Other kind of drugs with anticoagulatory effect are coumarin based drugs. They
inhibit the vitamin K dependent reactions, but it takes several days for their
maximum effect to be realized.
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1.3 Kinetic aspects and mathematical modelling
1.3.1 Kinetic aspects
Kinetic analysis of the individual reactions in the extrinsic pathway have been
reported, but a mathematical analysis of the complete reaction network has been
given less attention.
Although there is some controversy regarding the existence of some reaction or
factor, we can enumerate the following information about kinetic aspects of the
blood coagulation cascade:
(i) Factor Xa is an enzyme with different catalytic properties in the presence or
absence of its active cofactor factor Va [LKSM94] [NTM79].
(ii) According to [NeMa79], factor Xa in the presence of phospholipids and
thrombin can activate factor V and factor V III. But, in [MoTr90] it is shown
that this reaction does not seem to play a role in clotting plasma, although
it happens to be important under certain experimental circumstances.
(iii) Once formed, factor V IIIa is subject to spontaneous inactivation [LoPa91].
(iv) Factor IXa is virtually inactive without factor V IIIa [vDTRH81].
(v) Factors IX and X serve as competitive substrates for TF.V IIa complex
[LaMa91].
(vi) In the presence of phospholipids, factor Xa catalyzes the formation of factor
IXα [LaMa91].
All these aspects make the interpretation of the kinetics of coagulation less than ob-
vious. Other difficulties arise if we consider that there is an absence of steady state
conditions; that concentration of all substrates, cofactors, and enzymes change
throughout the reaction; that enzyme/activator concentrations exceed substrate
concentrations and that the natural concentrations of the coagulation proteins
in blood vary over an extremely wide range [JoMa94]. In other words, it is not
known whether the reaction scheme deduced from experiments is indeed the one
operative in plasma. In fact, there might exist unknown factors or reactions and
reactions that have been shown to be possible in principle may not occur in reality
[SHH97].
1.3.2 Mathematical modelling of the blood coagulation system
Although the cascade model of sequential reactions has provided enormous insights
into the general process of hemostatic reactions in vitro, it has not explained in a
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satisfactory way the dynamic regulation of blood coagulation reactions occurring
in vivo [JoMa94].
A number of research groups have recognized the usefulness of mathematical mod-
elling in trying to understand the coagulation process. Mathematical modelling is
a valuable tool because it provides a rapid and a less expensive way to simulate
planned experiments.
Nesheim et. al in [NeTrMa84] explore a steady-state model of prothrombin activity
involving two phases. One phase corresponding to the bulk solution and other
the thin atells surrounding phospholipid membranes. Without including explicit
spatial dependencies, the steady state of thrombin production in both phases is
examined as a function of phospholipid concentration.
Another more recent model from the same laboratory, see [JoMa94], considers dy-
namic interactions between a number of the coagulation enzymes and zymogens
from the extrinsic pathway. Although inhibition is ignored and the possible regu-
latory role played by phospholipid surfaces in controlling the coagulation reactions
is not addressed, this paper is one of the most cited in the blood coagulation litera-
ture and because of that it will deserve in this thesis a special treatment regarding
mathematical aspects. In 2002, this model was extended and the results are pub-
lished in [HJEM02]. This extension includes among others the TFPI-mediated
inactivation of the complex TF.V IIa, the inactivation of factors IIa, V IIa, IXa
and Xa by ATIII, the initial activation of cofactors V and V III by thrombin
generated by factor Xa membrane, factor V III dissociation, the bind compe-
tition and kinetic activation steps that exist between TF and factors V II and
V IIa and the activation of factor V II by thrombin, factor Xa and factor IXa.
However, although the reaction scheme was published, the set of differential equa-
tions governing the system was omitted. In fact, a software package was written
to enable rapid transformation of the chemical reaction schemes to the necessary
time-dependent partial differential equations required for this model and their
solution. The software package is said to use an internet based interface with a
generally applicable Runge-Kutta5 solver that provides solutions to a family of
time-dependent differential equations. Unfortunately, the information published is
not enough to make a mathematical analysis.
Beltrami, Jesty and Willems take a different tack in analyzing a system made up of
multiple interacting feedback loops [JeBeWi93] for solution-phase reactions. The
main result is that the system responds in a threshold manner. However, they do
not match any part of the coagulation pathway and no account is taken of surface
binding reactions or transport of reactants. Fogelson et al. made an extension
of this model including both solution-phase and membrane-phase reactions (see
5Belongs to the so called one step methods, where the basic principle is to collect information
around the last approximation to define the next iteration step
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[FoKu98]). In this approach, the concentrations of the membrane-binding site are
limited and they were treated as control variables. The results were obtained
by linearized stability analysis for the numerical solution with methods for stiff
ordinary differential equations implemented in a software package. Still, the model
system does not match any part of the coagulation system exactly. So, the reported
results need to be tested and refined in more realistic models.
Stortelder, Hemker and Hemker presented in [SHH97] a truncated model com-
prising a system of non-linear differential equations with unknown parameters,
namely the reaction constants and the initial concentration of the factors. Pa-
rameter estimation was used in order to determine these in such a way that the
experimental data were well fitted by the theoretical model. This model concerns
the common pathway; factor X was activated by a purified enzyme RV V, factor
V and prothrombin activation in the presence of phospholipids is considered and
it also includes the inactivation of thrombin by ATIII and α2−macroglobulin.
Furthermore, according to Leipold in [LBRD95], the main limitations of some
published models are:
• consideration of only a small part of the coagulation cascade;
• empirical description of interactions for which molecular mechanisms were
known;
• determination of some or all of the parameters from experimental data by
curve fitting without comparing the model predictions to experimental data.
Even if what is written in the first item is somehow desirable from the physiolog-
ical point of view, one must keep in mind that there is not a single mathematical
model describing all the possible mechanisms that occur in the blood coagulation
system. In fact, any attempt in doing this will result in a very complex model from
which it will be almost impossible either to gain some new insights or to under-
stand and interpret unexpected experimental observations. Therefore, to reduce
the dimension of the models without losing qualitative information seems to be a
good approach. This is also one of the goals of this thesis.
For a review on the development of theoretical research in hemostasis and throm-
bosis using mathematical modelling and computer simulation see [AtPa05].
As a final remark, one may say that although activation of the clotting cascade
is crucial, uncontrolled generation of thrombin can lead to disaster. Foreign sur-
face contact, e.g. during the implant of artificial organs, is a strong activator of
whole of the system and therefore anticoagulatory measures are unavoidable. The
interaction of all these parameters is still the subject of numerous investigations,
however they are mainly of experimental nature. In spite of great progress in this
direction, it seems still to be justified to introduce mathematical models which
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enable predicting e.g. the sequential enzymatic reaction leading to the formation
of thrombin. Besides non-linearity, these systems also have the property of stiff-
ness, including fast and slow modes, and therefore they should be also carefully
analyzed.
In this work we deal with the models published in [SHH97] and in [JoMa94] and
analyze them mathematically in order to be able to reduce the dimension in a
rational way. As a result of the analysis performed, both models are extendend
and new aspects are introduced and studied. Moreover, mathematical approaches
for modelling thrombin formation in both pathways are given. Because of the im-
portance of pharmacological intervention in different clinical scenarios we analyze
the system from [SHH97] regarding mathematical controllability aspects. Since the
model from [JoMa94] does not include the action of inhibitors we do not study the
controllability of this system, because there are drugs like heparin which efficiency
depends on the presence of a physiological inhibitor.
Although the identification of some parameters from experimental data would be
desirable, no experimental data is available that allows us to accomplish this task.
Chapter 2
Chemical Reaction Networks
This chapter is a self-contained exposition of some fundamental concepts of chem-
ical reaction networks theory. It provides among others the necessary information
for a non-specialist to understand how chemists and biochemical engineers derive
the differential equations they work with and to explain how these differential
equations are tied to a reaction network structure. Moreover, it is important for
what follows in the next chapters to present things in a terminology and formalism
more standard in control and in dynamical systems theories, for it is not a simple
matter to put together and to refer the forthcoming information from the different
literature sources. In the first part of the chapter we start with the definition of
a chemical reaction network and end by giving some definitions and properties
relating the reaction network structure and the nature of composition trajectories
based on the papers [Aris65a] and [Aris65b] written by Rutherford Aris, on the lec-
ture notes [Fein79] from Martin Feinberg and on the paper [Son01] from Eduardo
Sontag. Thereby we motivate the formalism by working through some examples.
We will see that for the classes of deficiency zero and deficiency one chemical re-
action networks the existence and uniqueness of equilibria, and local asymptotic
stability are well characterized. But, for other kind of classes there are still lot of
questions open regarding these and other dynamical properties. Since the blood
coagulation system is a biochemical network where inactive proenzymes are con-
verted to active enzymes, in the second part we turn our attention to enzyme
catalyzed reactions. Regarding this subject, we refer in particular to [KeSn98],
[SeSl89], [BriHal25], [Seg88], [Son05b] and [Mur93].
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2.1 Definition of a reaction network
In [Aris65a] and [Aris65b] Aris examines the foundations of a rational analysis of
chemical systems and their reactions whereas Feinberg in [Fein79] makes a first
attempt to develop a more general theory about chemical reaction networks by
providing theorems which tie qualitative aspects directly to the reaction network
structure.
2.1.1 Notation and terminology
The algebra of finite dimensional vector spaces lies at the basis of formal reaction
kinetics of the simplest representation of chemical species [Aris65a].
Elementary atomic species or chemical elements are the basic unit of structure
available when we consider a reaction system. Atomic species can combine to
form molecular species. We have the following definition:
Definition 2.1.1. A molecular species Ss is an entity of the form
Ss = β
1
sB1 + β
2
sB2 + . . .+ β
T
s BT , s = 1, . . . , S
where βts, s = 1, . . . , S are integers. The Bt, t = 1, . . . , T are symbols for the
chemical elements.
Besides the set of molecular species or chemical species S, we can associate to each
reaction network two more sets. The first is the set of objects appearing before and
after the reaction arrows. These objects are called complexes1 of the network and
the set of complexes is designated by C. The second set is the set R of reactions.
1The word complex is also used for instance while describing enzyme catalyzed reactions (see
Section 2.3). So, be aware of the context to avoid confusion
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As a preliminary motivation and to illustrate these we consider the following ex-
ample taken from [Fein79]:
Example 2.1.2. Suppose that A,B,C,D and E are chemical species and that
the chemical reactions occurring among them are well reflected in the following
diagram
A 2B
A+ C D
B + E
Figure 2.1: Example of a reaction scheme.
Then S = {A,B,C,D,E}, C = {A, 2B,A+ C,D,B + E}, and
R = {A→ 2B, 2B → A,A+ C → D,D → A+ C,D → B + E,B +E → A+C}.
In the sequel, the idea is to associate to each of these sets a finite-dimensional
vector space, so that we may speak about the vector of species concentrations or
about the vector of reaction rate constants.
Before proceeding, we need to introduce some notation and give some more defi-
nitions.
R≥0 (resp. R+) represent the set of nonnegative (resp. positive) real numbers.
Let I be a finite set. Then, RI represents the vector space of real valued functions
with domain I, where the addition of functions and the multiplication of a function
by a real number are defined in the usual way. Likewise, by RI≥0 (resp. R
I
+) it is
meant the set of RI , which elements are functions that take non-negative (resp.
exclusively positive) values.
For x ∈ RI the subset of I defined by
suppx = {i ∈ I : xi 6= 0}
is called support of x.
If J is a subset of I, the symbol ωJ is used to indicate the characteristic function
on J. That is, ωJ is the vector of R
I such that
(ωJ )i =
{
1 if i ∈ J
0 if i 6∈ J.
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In particular, if J = {j} then we shall write only ωj and
(ωj)i =
{
1 if i = j
0 if i 6= j.
The standard basis of RI is given by
{ωj ∈ R
I : j ∈ I},
and we have that the dimension of RI is equal to the number of elements of the
finite set I.
Hence, each x ∈ RI has the representation
x =
∑
j∈I
xjωj .
R
I is taken to be endowed with the standard scalar product as follows: if x and z
are vectors of RI then
< x, z >=
∑
i∈I
xizi.
Let us now interpret the latter considerations in terms of reaction network termi-
nology.
With each species s ∈ S there is associated a (non-negative) molar concentration
cs. That is to say that there is a function c : S → R≥0 assigning to each species
its molar concentration. Note that, c ∈ RS≥0 ⊂ R
S is the composition state vector.
If our reactor is in composition state c, then
supp c = {s ∈ S : cs 6= 0}.
Hence, the support of c is the set of species present in the reactor.
Suppose that the network is endowed with mass action kinetics (see Section 2.2.1
for more details) so that with each reaction in R there is associated a (positive)
rate constant. Then, there exists a function k : R → R+ and k ∈ R
R
+ ⊂ R
R is a
vector of rate constants.
Remark 2.1.3. Let us suppose that the species ωA ∈ R
S combines with the species
ωB ∈ R
S . Then we write ωA + ωB ∈ R
S . By convention one could write instead
A + B ∈ RS . So, the complexes of a network are regarded as vectors in RS or,
in particular, as vectors in RS≥0. Thus, it makes sense to add two complexes, to
multiply a complex by a number and to calculate the scalar product of a complex
with any other vector of RS . Altogether, C ∈ RS≥0.
Remark 2.1.4. If m species and r reactions constitute the reaction system then
dimRS≥0 = m and dimR
R
+ = r.
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2.1.2 Defining reaction networks
We supply the formal definition of a chemical reaction network presented in
[Fein79].
Definition 2.1.5. A chemical reaction network consists of three sets:
(i) a finite set S, which elements are called species of the network.
(ii) a finite set C of distinct vectors in NS≥0 such that
⋃
p∈C
suppp = S.
The elements of C are called the complexes of the network.
(iii) a relation R ⊂ C × C such that
(a) (p,p) 6∈ R, for all p ∈ C (i. e. no complex reacts to itself).
(b) For each p ∈ C there exists p′ ∈ C such that (p′,p) ∈ R or such that
(p,p′) ∈ R (i. e. no complex is isolated).
The elements of R are called the reactions of the network. For each pair
(p,p′) ∈ R we say that the complex p reacts to the complex p′. We can use
instead a more suggestive notation p → p′ to say that p reacts to p′. Then,
the vector p is called the reactant complex and p′ is called product complex
of the reaction p → p′.
Remark 2.1.6. A chemical reaction on the set of species {si}, i = 1, . . . , n can be
written as
R ≡ ν1s1 + . . .+ νnsn. (2.1.1)
The multipliers νi ∈ R are called stoichiometric
2coefficients and they represent
the relative molar proportions of each molecular species in the reaction. If all the
stochiometric coefficients are zero then the reaction is said to be trivial.
The condition for a reaction to be proper is known in chemistry as balancing the
equation and it implies that
ν1s1 + . . .+ νnsn = 0.
2From the Greek, ”stoicheion”= element. The word Stoichiometry is part of the common
vocabulary of chemists and chemical engineers. According to [Aris65b] ”Stoichiometry literally
means measurement of the elements but the word is commonly used to refer to all manner of
calculations regarding the components of a chemical system...Stoichiometry is essentially the
bookkeeping of material components of the chemical system.”
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Conventionally, molecular species regarded as product complexes have a positive
stoichiometric coefficient. Reactant complexes are the molecular species with neg-
ative coefficient [Aris65a].
Remark 2.1.7. If we have a set of r chemical reactions on {si} then each reaction
can be written as
Rj ≡
n∑
i=1
νijsi, j = 1, . . . , r,
where ν = (νij) is the so called matrix of stoichiometric coefficients of the set {si}
or simply stoichiometric matrix.
The number of linearly independent reactions is equal to the rank of ν.
The next section is dedicated to the highlight of important aspects concerning the
kinetics for a reaction network.
2.2 Kinetics
One of the major aims of studying the kinetics of chemical networks is to analyze
systems of differential equations which describe the time evolution of the concen-
tration of the n chemical species involved. Let us start by defining the kinetics for
a reaction network.
Definition 2.2.1. A kinetics for a reaction network {S, C,R} is an assignment to
each reaction p → p′ ∈ R of a continuous rate function Kp→p′ : R
S
≥0 → R≥0 such
that
Kp→p′(c) > 0 if and only if suppp ⊂ supp c.
Definition 2.2.2. A reaction system {S, C,R,K} is the reaction network {S, C,R}
endowed with a kinetics K.
2.2.1 The law of mass action
The law of mass action describes the rate at which chemicals, whether large macro-
molecules or simple ions, collide and interact to form different chemical combina-
tions3. Thus, the number of collisions per unit of time is taken to be proportional
to the product of the concentrations of the chemicals involved and the factor
of proportionality depends on the geometrical shapes and sizes of the reactant
molecules, and on the temperature of the mixture [KeSn98]. This law describes
3Collision model
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well-stirred reactions with no special inhomogeneities and is not generally valid at
high concentrations.
Formally we have the following definition:
Definition 2.2.3. A kinetics K for a reaction network {S, C,R} is of mass action
type if, for each p → p′ ∈ R, there exists a positive number kp→p′ such that
Kp→p′(c) ≡ kp→p′
∏
s∈S
cνss , (2.2.1)
where νs is the stoichiometric coefficient of species s in the reactant complex p of
the reaction p → p′. The number kp→p′ is called the rate constant of the reaction
p → p′.
Example 2.2.4. Let us consider the reactions A + C → D and 2B → A of the
diagram in Example 2.1.2. For the reaction A + C → D, the higher the concen-
tration of A, the more occurrences of the reactions will be (similarly for C). That
is, it is presumed that the occurrence rate of the reaction A + C → D is propor-
tional to the probability of A and C to meet, which in turn, it is proportional,
at low concentrations, to the value of cAcB. For the reaction 2B → A one says
that 2 molecules of B are needed to form A, but we still have the same chemical
interpretation as before. We respectively write:
KA+C→D(c) ≡ kA+C→D(cA)
1(cB)
0(cC)
1(cD)
0(cE)
0 = kA+C→DcAcC
and
K2B→A(c) ≡ k2B→A(cA)
0(cB)
2(cC)
0(cD)
0(cE)
0 = k2B→A(cB)
2.
Remark 2.2.5. For c and p in RS≥0 let us define c
p as follows:
cp :=
∏
s∈S
cνss .
Then, mass action rate functions take the form
Kp→p′(c) ≡ kp→p′c
p.
The behavior of a homogeneous chemical system can be described by a system
of differential equations obtained from the reaction mechanism by applying the
law of mass action. Therefore, these equations are also known as mass balance
equations. In the next section we describe how to achieve this.
2.2.2 The differential equations for a reaction system
Definition 2.2.6. Let {S, C,R} be a reaction network. The reaction vector corre-
sponding to the reaction p → p′ ∈ R is the vector p′ − p ∈ RS .
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Remark 2.2.7. Note that the component of p′−p relative to the standard basis of
R
S corresponding to species s ∈ S is just ν′p − νp, i. e. the difference between the
stoichiometric coefficient of s in the product component p′ and its stoichiometric
coefficient in the reactant complex p.
Definition 2.2.8. For a reaction system {S, C,R,K} the species formation rate
function f : RS≥0 → R
S is defined by
f(c) ≡
∑
R
Kp→p′(c)(p
′ − p).
That is, f(·) is obtained by summing the reaction vectors for the network, each
multiplied by the corresponding reaction rate function. Moreover it fulfills the
following positivity requirement:
Lemma 2.2.9. Let {S, C,R,K} be a reaction system with species formation rate
function f(·). Then, for every s ∈ S and every c ∈ RS≥0, cs = 0 implies that
fs(c) ≥ 0.
Remark 2.2.10. The species formation for a mass action system {S, C,R, k} takes
the form:
f(c) ≡
∑
R
kp→p′ c
p(p′ − p).
By the differential equation of a reaction system {S, C,R,K} we mean
c˙ = f(c) =
∑
R
Kp→p′(c)(p
′ − p). (2.2.2)
Equation (2.2.2) is a vector differential equation which encodes the system of scalar
functions
c˙s =
∑
R
Kp→p′(c)(p
′ − p), for all s ∈ S.
In particular, for a mass action system {S, C,R, k} the corresponding vector dif-
ferential equation is given by
c˙ = f(c) =
∑
R
kp→p′ c
p(p′ − p).
2.2. Kinetics 27
Example 2.2.11. Consider the reaction: with k+ and k− denoting the forward and
A+B D
k+
k−
Figure 2.2: Second order reaction scheme.
the reverse rate constants of the reaction, respectively. The quantities A and B are
consumed by the forward reaction and produced by the reverse reaction, therefore
the rate of change of [A] and of [B] for the bidirectional reaction is respectively
given by:
d[A]
dt
= k−[D]− k+[A][B];
d[B]
dt
= k−[D]− k+[A][B].
For [D] we have,
d[D]
dt
= −k−[D] + k+[A][B].
Remark 2.2.12. If there exists an equilibrium, concentrations are not changing so
that
[D]eq =
k+
k−
[A]eq[B]eq.
If there are no other reactions involving A and D then [A] + [D] = A0 is constant
and
[D] = A0
[B]
Keq + [B]
. (2.2.3)
The number Keq =
k−
k+
is called the equilibrium constant, and relates to the rela-
tive preference for the chemicals to be in the combined state D compared to the
dissociated state. The equilibrium constant has units of concentration. If Keq is
small, then there is a high affinity between A and B [KeSn98].
In the next section, some considerations are given that help to gain some geometric
insight into the way phase portraits of the differential equations governing the
reaction scheme are structured.
2.2.3 Reaction network structure and nature of composition tra-
jectories
Regardless of the kinetics, reaction network structure imposes restrictions on the
shape and behavior of the composition trajectories. In particular, a trajectory
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that passes through a composition c ∈ RS≥0 can eventually reach a composition
c′ ∈ RS≥0 only if the pair (c
′, c) is compatible with certain ”stoichiometrical” con-
ditions the reaction network imposes [Fein79]. Roughly speaking, due to existence
of conservation laws, composition trajectories are not completely free to wander in
an arbitrary fashion through RS≥0 since there are only certain directions in which
the species formation rate vector can point. In other words, the species formation
rate f(c) must point along the cone generated by the reaction vectors and belongs
to the linear subspace of RS generated by them.
Definition 2.2.13. The stoichiometric subspace for a reaction network {S, C,R} is
the linear subspace S ⊂ RS defined by
S = span{y′ − y ∈ RS : y → y′ ∈ R}.
The dimension of the stoichiometric subspace for a reaction network is equal to
the rank of the network.
The following lemma is proved in [Fein79] states that there are conservation laws,
respectively first integrals4, arising from the stoichiometry.
Lemma 2.2.14. Let {S, C,R,K} be a reaction system and let c : I → RS≥0 be a
solution of
c˙ =
∑
R
Ky→y′(c)(y
′ − y), (2.2.4)
where I ⊂ R. Then, for arbitrary t1, t2 ∈ I such that t2 > t1 the solution c satisfies
c(t2)− c(t1) =
∑
R
∫ t2
t1
Ky→y′(c(τ))(y
′ − y)dτ, for all y → y′ ∈ R. (2.2.5)
Remark 2.2.15. A composition c1 ∈ R
S
≥0 can follow a composition c2 ∈ R
S
≥0 along
a solution of (2.2.4). Thus, if a solution c(t) of (2.2.4) passes through a composition
c0 then
c(t) ∈ (c0 + S) ∩ R
S
≥0,
where S is the stoichiometric subspace and
c0 + S = {c0 + γ; γ ∈ S} ⊂ R
S
is the parallel translate of S that passes through c0 and (c0 +S)∩R
S
≥0 referred to
as stoichiometric compatibility class [Son01].
Now we are able to define the stoichiometric compatibility of two vectors.
Definition 2.2.16. Let {S, C,R} be a reaction network, and let S ⊂ RS be its
stoichiometric subspace. Two vectors c1 ∈ R
S
≥0 and c2 ∈ R
S
≥0 are stoichiometrically
compatible if c1 − c2 lies in S.
4See Definition A.1.4
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Remark 2.2.17. Stoichiometric compatibility is an equivalence relation that in-
duces a partition of R≥0, respectively of R
S
+ into equivalence classes, the already
mentioned stoichiometric compatibility classes for the network. Moreover, since
c˙ ∈ S, trajectories remain in classes, that is, classes are positive invariant mani-
folds for the dynamical system [Son01]. For the definition of positively invariant
subsets see Appendix A.
Following Horn and Jackson, one says that a network {S, C,R} is conservative
if there exists a positive vector5 m ∈ S⊥, the orthogonal complement of the
stoichiometric subspace for the network. Moreover, it can be proved that a network
is conservative if and only if all its stoichiometric compatibility classes are compact.
For other concepts and examples of application, we refer to [Fein79].
2.2.4 Linkage classes. Weak reversibility. Deficiency
Reaction network structure may be discussed in terms of concepts like linkage
classes, weak reversibility and deficiency of a network. While the first two depend
essentially on a network’s character as a graph and not on the precise nature of
the complexes, the last one is influenced by the algebraic nature of the complexes,
what is the same as to say that the stoichiometry of the network plays no role.
The basic ideas behind these concepts are easy to understand in an intuitive way.
Therefore, we introduce them in an informal way following [Fein79].
5I.e. with all entries greater than zero
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Linkage classes
Consider the following reaction diagram:
A+ B C
D
2E
A+ E F G
G+ F H
Figure 2.3: Network with 3 linkage classes.
We observe that it is composed by three disjoint pieces. One containing the com-
plexes {A+ B,C,D, 2E}, other containing the complexes {A+ E,F,G} and the
third one contains the complexes {G+ F,H}.
These sets are called linkage classes.
Weak reversibility
A reversible network is one in which each reaction is accompanied by its ”anti-
reaction”. I. e., if the reaction y → y′ is considered in a reversible network, so it
is y → y′.
Example 2.2.18. The diagram of Figure 2.4 is reversible and that of Figure 2.5
not.
If a network is not reversible then it may be weakly reversible. This is an important
case to consider because both networks have almost the same properties. More-
over, every reversible network is also weakly reversible. A network is then weakly
reversible if, whenever there is a directed arrow path leading from complex y to
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A 2B
A+ C D
B + E
Figure 2.4: Reversible network.
A 2B
A+ C D
B + E
Figure 2.5: Not reversible but weakly
reversible network.
complex y′, there is also a directed arrow path leading from y′ back to y. Both
networks of Example 2.2.18 are weakly reversible.
In the following figure, we give two examples of networks which are not weakly
reversible.
A 2B
A+ C D
B + E
Figure 2.6: Not weakly reversible net-
work.
A 2B
A+ C D
B + E
Figure 2.7: Not weakly reversible net-
work.
Deficiency of a network
Since stoichiometry influences the rank of a network it plays a role by discussing
the deficiency of a network.
The deficiency amounts to a non-negative integer index, which helps to classify
networks. Let n be the number of complexes, l the number of linkage classes and
s the rank of the network. Denoting the deficiency by δ we have the following
relation:
δ := n− l − s.
Example 2.2.19. The network of Figure 2.5 has 5 complexes, 2 linkage classes and
rank 3. Thus, δ = 0. The same for the networks in Figures 2.4, 2.6 and 2.7.
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2.2.5 Two theorems
The following theorems are proved in [Fein79] and state the existence and unique-
ness of equilibria6, and local asymptotic stability for deficiency zero and deficiency
one networks. For the definitions of an equilibrium point and of asymptotic sta-
bility see Appendix A.
Theorem 2.2.20 (Deficiency Zero Theorem). Let {S, C,R} be any reaction network
of deficiency zero.
(i) If the network is not weakly reversible then, for arbitrary kinetics K, the
differential equations for the reaction system {S, C,R,K} cannot admit a
strictly positive equilibrium.
(ii) If the network is not weakly reversible then, for arbitrary kinetics K, the
differential equations for the reaction system {S, C,R,K} cannot admit a
periodic composition trajectory containing a positive composition.
(iii) If the network is weakly reversible then, for any mass action kinetics k ∈ RR+ ,
the differential equations for the mass action system {S, C,R, k} have the fol-
lowing properties: There exists within each positive stoichiometric compatibil-
ity class precisely one equilibrium; that equilibrium is asymptotically stable;
and there cannot exist a nontrivial cyclic composition trajectory in RR+ .
Theorem 2.2.21 (Deficiency One Theorem). Let {S, C,R} be a reaction network
with l linkage classes. Let δ denote the deficiency of the network, δθ the deficiency
of the θ−th linkage class, θ = 1, 2, . . . , l. Suppose furthermore that:
(i) δθ ≤ 1, θ = 1, 2, . . . , l
(ii) δ =
l∑
θ=1
δθ.
If the network is weakly reversible then, for any mass action kinetics k ∈ RR+ , the
differential equations for the mass action system {S, C,R, k} admit precisely one
equilibrium in each positive stoichiometric compatibility class.
Remark 2.2.22. The absence of weak reversibility condition might exclude the ex-
istence of positive equilibria or affect the uniqueness of equilibria within a positive
stoichiometric compatibility class.
6It is noteworthy to point out that when communicating with biologists and physicists the
words equilibrium and steady state do not have the same meaning. A steady state is one in which
the concentration is constant in the macroscopic sense, but this does not mean that chemical
reactions are not taking place. An equilibrium means something much stronger. So, never use
the word equilibrium while talking about steady states [Son05a]
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2.3 Enzyme kinetics
Reactions that do not follow mass action kinetics are usually proceeded by a com-
plex mechanism consisting of two or more elementary reaction steps. Complicated
reaction schemes may arise for instance if we are in the presence of a reaction
catalyzed by an enzyme. Typically, one obtains systems of highly nonlinear differ-
ential equations with many kinetic and stoichiometric parameters. These systems
are stiff, have multiple timescales and are computationally demanding to solve nu-
merically, making data fitting difficult as well. Since the blood coagulation system
comprises biochemical reactions involving enzyme activation we discuss briefly this
topic.
Enzymes are catalysts (generally proteins) that help convert other molecules called
substrates into products, but they themselves are not changed by the reaction.
Three of the most important features of enzymes are catalytic power, specificity
and regulation. In fact, enzymes accelerate the conversion of substrate into product
by given increases in speed of up to 10 million times; they are specific as they
catalyze the reaction of only a particular substrate or closely related substrates
and complicated positive and negative feedback systems allow precise control over
the set of reactions [KeSn98].
In the nineteenth century, the first scientists studying enzyme kinetics of the single
enzyme-substrate reaction experienced a number of difficulties. The experimental
practice was to follow the reaction over an extended period of time and to explain
observations in terms of the solutions of second-order rate equations. Brown and
other workers found that enzyme reactions do not follow directly the law of mass
action [SchMai03]. For, as the concentration of the substrate S is increased, the
rate of the reaction increases only to a certain extent, reaching a maximal reaction
velocity at high substrate concentrations. In 1903, V. Henri proposed the following
reaction scheme:
S + E C E + P
k1
k−1
k2
Figure 2.8: Reaction scheme for an enzymatic reaction proposed by Henri.
Using the formalism given above, we have:
S = {S,E,C, P}; C = {S +E,C,E + P} and R = {S +E → C,C → S +E,C →
E + P}.
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Here, the enzyme E converts the substrate S into the product P through a two
step process. First, E combines reversibly with S to form a complex C, which
then breaks down irreversibly with a certain probability per unit time k2 into the
product, P, releasing E in the process. The reverse reaction between E and P to
reform the complex is often slow enough to be neglected [Seg91].
According to the theory of enzymatic reactions of Leonor Michaelis and Maud
Leonora Menten in 1913, enzymes can be studied by measuring initial rate of
product formation under certain conditions. The established mathematical model
helps to understand the deviation from the law of mass action. In 1925, Briggs
and Haldane made another extension of Henri’s formulation [Son05b].
Let s = [S], c = [S], e = [E] and p = [P ]. Applying the law of mass action and
what has been said in Section 2.2 to the reaction mechanism in Figure 2.8 yields
four differential equations for the rate of change of s, c, e and p as
ds
dt
= k−1c− k1se
de
dt
= (k−1 + k2)c− k1se
dc
dt
= k1se− (k−1 + k2)c
dp
dt
= k2c.
(2.3.1)
These equations are also known as Briggs-Haldane equations. They were derived
in [BriHal25], which constitutes the first mathematical discussion of the so-called
quasi-steady state assumption.
Notice that p can be found by direct integration and there is a conserved quantity
since
de
dt
+
dc
dt
= 0, (2.3.2)
so that e+c = e0, where e0 6= 0 is the total amount of available enzyme. Moreover,
at time t = 0 we have s = s0, c = 0 and p = 0.
System (2.3.1) reduces to
ds
dt
= −k1(e0 − c)s+ k−1c
dc
dt
= k1(e0 − c)s− (k−1 + k2)c.
(2.3.3)
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2.3.1 The quasi-steady state assumption
Following [SeSl89], the hypothesis for the quasi-steady state approximation are:
(i) experimental measurements of the reaction rate should be performed after a
short initial phase, called the pre-steady state period but before the concen-
tration of the substrate decays considerably;
(ii) if the rate of product formation is approximately constant over the time
interval of observation then c is also approximately constant (see the 4th
equation of (2.3.1));
(iii) while s is high enough, the free enzyme E combines immediately with another
molecule of the substrate S. Then a quasi-steady-state is achieved in which
the enzyme is always saturated with its substrate.
(iv) from items (ii) and (iii) we have
dc
dt
≃ 0 for an appreciable period of time.
Applying the quasi-steady state assumption reduces the order of the system of
differential equations by an amount equal to the number of chemical species to
which the assumption was applied [ChaRu94].
Let us rewrite the system (2.3.3) as
ds
dt
= −k1(e0 − c)s+ k−1c
dc
dt
= k1(e0 − c)s− (k−1 + k2)c = k1 [se0 − (Km + s)c] ,
(2.3.4)
where Km =
k−1 + k2
k1
.
If c is approximately constant then we can solve the second equation for c, yielding:
c =
e0s
Km + s
.
Quoting [BdBS96], a differential equation for s, valid after the transient, can be
easily derived by realizing that if
dc
dt
is effectively zero then the two equations of
(2.3.4) can be added and
ds
dt
= −k2c,
i.e,
ds
dt
= −k2
e0s
Km + s
. (2.3.5)
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By convention, the substrate level changes negligibly during the fast transient so
that s(0) = s0. This initial condition and the differential equation (2.3.5) constitute
the quasi-steady state assumption. The constant Km is also known as Michaelis
constant.
By the method of separation of variables, we have:
s+Km ln
s
s0
= s0 − k2e0t. (2.3.6)
One then hopes that these quasi-steady state approximations will provide a good
approximation for calculating the post-transient development of the system under
consideration.
Despite of being a useful approximation, the Michaelis-Menten law is not univer-
sally applicable. One of the problems is to derive analytical approximations by
using the quasi-steady state assumption and identifying parameter regimens in
which they hold.
The original Michaelis-Menten condition requires
e0
s0
small, which was also the
basic assumption in [BriHal25].
The validity of the quasi-steady state was then first discussed by Laidler (1955).
He suggested that an excess of substrate concentration is the main prerequisite
and found out that the initial concentration of substrate must greatly exceed that
of the enzyme such that
e0
s0
≪ 1.
This condition can be derived mathematically after nondimensionalize7 the system
of differential equations by taking:
x =
s
s0
; y =
c
e0
and τ = k1e0t.
A proof can be found in [SeSl89].
Stayton and Fromm found the quasi-steady state assumption to generally hold for
s0
e0
> 100
by means of simulation modelling on a digital computer [StFr79].
More recently, Segel and Slemrod showed in [SeSl89] that a more general condition
is
e0
Km + s0
≪ 1.
7The aim is to identify independent parameters and to determine their relative magnitude.
An overview about scaling and nondimensionlization can be found in [LinSe88] or in [Seg88]
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They estimated two different timescales, the duration of the pre-steady-state pe-
riod (i. e. the fast time scale) and the duration of the period during which the
substrate is converted to product according to the quasi-steady state assump-
tion (i.e. the slow time scale). Knowledge of these scales is prerequisite to choose
suitable dimensionless independent variables. This approach is also described in
[Mur93].
This assumption guarantees that there is not a significant fraction of the substrate
bound to the enzyme during the assay [Seg88] [SeSl89]. Moreover, the final confir-
mation that smallness of the appropriate parameter is necessary and sufficient for
the quasi-steady state assumption to be valid have been given only recently (see
[NoeWa05]).
The quasi-steady state approximation can provide a good approximation even if
s0 ≈ e0 as long as e0 is small compared to Km [Seg88][SeSl89]. In [SchMai00] and
in [SchMen97] the case of high enzyme concentration is treated.
Another important aspect of enzyme kinetics in complex biochemical pathways
and, in particular, of the blood coagulation mechanism, is the effect of inhibitors
and activators of the enzyme. This topic is handled in the next section.
2.3.2 Enzyme inhibition
An enzyme inhibitor is a substance that inhibits the catalytic action of the enzyme.
Studies of reactions involving enzyme inhibition contribute to the understanding
of enzyme mechanisms, including control processes in the cell and the mode of
action of various drugs.
Loss of activity may be either reversible, where the activity of the enzyme may be
restored by removing the inhibitor, or irreversible, where the loss of activity is time
dependent and cannot be recovered during the timescale of interest. Furthermore,
if the inhibited enzyme is totally inactive, irreversible inhibition behaves as a time-
dependent loss of enzyme concentration. Irreversible inhibitors are also known as
catalytic poisons.
In the class of reversible inhibitors we may distinguish between competitive and
allosteric inhibitors. To understand the distinction keep in mind that an enzyme
is usually a large protein, considerably larger than the substrate molecule whose
reaction is catalyzed. Embedded in the large enzyme protein are one or more
active sites, to which the substrate can bind in a ”lock-and-key” fashion to form
the complex [KeSn98]. If another molecule has a shape similar enough to that of
the substrate molecule, it may also bind to the active site, preventing the binding
of a substrate molecule, thus inhibiting the reaction. The inhibition is then called
competitive because the inhibitor competes with the substrate molecule for the
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active site. In most cases, drugs act by competitive inhibition [Son05b].
Enzymes also have other binding sites different from the active site, the binding
of which regulates the activity of the enzyme at the active site. This binding sites
are structurally different from the catalytic active sites and are called allosteric or
regulatory sites [KeSn98]. The inhibition is also said to be noncompetitive. If the
formation of the complex Enyme − Substrate − Inhibitor is excluded then the
inhibition is competitive.
We illustrate the competitive inhibition by presenting an example given in [Son05b].
The chemical model is given by:
S + E C1 E + P I + E C2
k1
k−1
k2
k3
k−3
Figure 2.9: Example of a reaction scheme for competitive inhibition.
Using the same notation as above and letting [I] = i; [C1] = c1 and [C2] = c2. In
terms of ODE’s, we have:
ds
dt
= k−1c1 − k1se
de
dt
= (k−1 + k2)c1 + k−3c2 − k1se− k3ie
dc1
dt
= k1se− (k−1 + k2)c1
dc2
dt
= k3ie− k−3c2
di
dt
= k−3c2 − k3ie
dp
dt
= k2c1.
(2.3.7)
Note that c1 + c2 + e = e0. Moreover, i+ c2 = i0, where i(0) = i0. This allows us
to eliminate e and i from the equations. Discarding at first the equation for p, we
are left:
ds
dt
= k−1c1 − k1s(e0 − c1 − c2)
dc1
dt
= k1s(e0 − c1 − c2)− (k−1 + k2)c1
dc2
dt
= k3(i0 − c2)(e0 − c1 − c2)− k−3c2.
(2.3.8)
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Assuming that the enzyme concentrations are small relative to substrate, one may
furthermore perform a quasi-steady state approximation followed by a singular
perturbation analysis.
Setting
dci
dt
= 0, i = 1, 2 without eliminating i, we obtain
c1 =
Kie0s
Kmi+Kis+KmKi
and c2 =
Kme0i
Kmi+Kis+KmKi
,
where Km is the Michaelis constant and Ki =
k−3
k3
.
The product formation rate is
dp
dt
= k2c1. Therefore, with Vmax = k2e0,
dp
dt
=
Vmaxs
s+Km(1 + i/Ki)
.
If i = 0 then this formula reduces to the case where there is no inhibition.
Observe that the rate of product formation is smaller, at least for i ≫ 1, k3 ≫ 1
and k3 ≪ 1.
An example of allosteric inhibition can also be found in [Son05b]. More detailed
information is provided in [Mur93]. For a more general theory about equilibrium
binding of macromolecules with ligands see [Seg91].
2.3.3 Cooperativity
For many enzymes, the reaction velocity is not a simple hyperbolic curve, as pre-
dicted by the Michaelis-Menten model, but it has often a sigmoid like form. This
can result from cooperative effects, in which the enzyme can bind more than one
substrate molecule, but the binding of one substrate molecule affects the binding of
subsequent ones [KeSn98]. Hill (1910) was one of the first to appreciate a sigmoid
like behavior of protein while studying the binding of oxygen to hemoglobin.
In [Mur93], the case in which an enzyme can bind two substrate molecules was
treated. There are three possibilities for the state of the enzyme. Namely, as free
molecule, E, as a complex with an occupied center, C1, and as a complex with
two occupied centers, C2. The reaction mechanism is given by
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S + E C1 E + P
S + C1 C2 C1 + P
k1
k−1
k2
k3
k−3
k4
Figure 2.10: Reaction scheme in which an enzyme binds to two
substrate molecules.
With lower case letters denoting concentrations, the mass action law gives
ds
dt
= −k1se+ k−1c1 − k3sc1 + k−3c2
dc1
dt
= k1se− (k−1 + k2)c1 − k3sc1 + (k4 + k−3)c2
dc2
dt
= k3sc1 − (k4 + k−3)c2
de
dt
= −k1se+ (k−1 + k2)c1
dp
dt
= k2c1 + k4c2.
(2.3.9)
Appropriate initial conditions are s(0) = s0; e(0) = e0; c1(0) = c2(0) = p(0) = 0.
Moreover, e+ c1 + c2 = e0. Since, p can be obtained by quadrature and the total
amount of enzyme is conserved, the number of equations needed reduces to three.
ds
dt
= −k1e0s+ (k−1 + k1s− k3s)c1 + (k1s+ k−3)c2
dc1
dt
= −k1e0s+ (k−1 + k2 + k1s+ k3s)c1 + (k4 − k1s+ k−3)c2
dc2
dt
= k3sc1 − (k4 + k−3)c2,
(2.3.10)
A singular perturbation approach is used in [Mur93] to get
dp
dt
= −
ds
dt
= k2c1 + k2c2 =
(k2K
′
m + k4s)e0s
KmK
′
m + k2s+ s
2
,
where Km =
k−1 + k2
k1
and K
′
m =
k4 + k−3
k3
are the Michaelis constants for the
reaction scheme of Figure 2.10.
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When a cooperative phenomenon is suspected in an enzymatic reaction, a Hill plot
is often made. The underlying assumption is that
dp
dt
=
Vmaxs
n
Km + sn
,
where n > 0 is not usually an integer. This is called the Hill equation and n is
called Hill coefficient.
Remark 2.3.1. An integer Hill coefficient may in some cases have a mechanistic
explanation and be interpreted as the number of substrate molecules that can bind
simultaneously to the enzyme.
Remark 2.3.2. Although the Hill equation may be a reasonable quantitative form
to describe a reaction’s velocity in a Michaelis-Menten sense the detailed reactions
which give rise to it are not too realistic [Son05b] [Mur93]. However, empirical rate
forms like the Hill equation are extremely useful in modelling.
2.3.4 Biological systems and feedback controls
In this section, we go through some of the most important aspects regarding
feedback controls and biological systems by giving some examples. The information
provided here is essentially taken from [Mur93].
Many biological systems, as is the case of the blood coagulation system, have
feedback controls built into them and it is fundamental to know how to model
them. In rough terms, feedback is when the product of one step in a reaction
sequence has an effect on other reaction steps. Three specific examples are those
of autocatalysis, activation and inhibition. Autocatalysis is the process whereby
a chemical is involved in its own production. For an example and subsequent
discussion of the model equations see [Mur93]. For the particular case of the blood
coagulation system, we are more interested in the processes of activation and
inhibition.
Feedback inhibition
Suppose we have a system of differential equations that has been reduced to two
key elements yielding the dimensionless mechanism:
du
dt
=
k1
k2 + v
− k3u
dv
dt
= k4u− k5v,
(2.3.11)
where k1, k2, k3, k4 and k5 are positive constants. The biological interpretation is
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that u activates v, through the term k4u, and both u and v are degraded linearly
proportional to their concentrations; these are the k3u and k4v, respectively. This
linear degradation is referred to as first order kinetics removal. The term
k1
k2 + v
shows a negative feedback by v on the production of u, since an increase in v
decreases the production of u.
In [Mur93] it is shown that there is a stable positive stationary point. For the
concepts of stability and stationary point see Appendix A.
Two further examples one exhibiting substrate inhibition and the other considering
an activator-inhibitor system are also briefly discussed. The competitive inhibition
described above with some detail could also have been taken here as an example.
For a generalization of a system of differential equations to describe the kinetics
of enzyme amplifier systems based on the presence of a negative feedback loop see
[MaMo74].
Remark 2.3.3 (Final comment). We will see in the next chapter that the formalism
presented in this chapter cannot be applied 100 % to the models considered in this
thesis, in particular for the analysis of stoichiometry. The reason is essentially that
the formalism by Aris, Feinberg and others do not include the situation in which
one substance is activated by another in a network. This would require a much
more general theory. Nevertheless, the information summarized in this chapter
helps for instance to understand some of the principal concepts related to the
modelling and analysis of complex networks in a simple way. In the next chapter
we make an interpretation of our problem using this language and try to get some
structural information about the networks we are dealing with.
Chapter 3
Two Mathematical Models for
Thrombin Formation
As already mentioned in Chapter 1, the plasma coagulation system is a biochem-
ical chain reaction where inactive proenzymes are converted to active enzymes
involving several positive and negative feedbacks. Although the cascade model
has provided enormous insights into the general process, it does not satisfacto-
rily explain the dynamic regulation of blood coagulation reaction. In fact, one
of the problems encountered in the study of complicated biochemical processes
like thrombin generation in plasma is that neither the reaction mechanism nor
the reaction constants and initial concentrations are precisely known. Therefore,
these quantities are usually taken as unknown parameters in the theoretical model
and are estimated by fitting experimental data. In the literature there are several
mathematical models for approaching a part of the blood coagulation mechanism.
The models normally comprise stiff systems of non-linear differential equations
with unknown parameters, namely the reaction constants and/or the initial con-
centration of the factors.
In this work, we restrict ourselves to the analysis of two of the most cited models
among the scientific community investigating the mechanisms of the blood co-
agulation system. One of the models is due to Stortelder, Hemker and Hemker
[SHH97] and the other is due to Jones and Mann [JoMa94]. In this chapter we are
mainly concerned with the description of the models and the analysis comprises at
the first stoichiometric aspects of the networks and secondly the numerical inte-
gration. Noteworthy is that, the model from [JoMa94] had to be corrected before
because the set of differential equations does not match the reaction scheme given.
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The qualitative mathematical analysis including kinetic and dynamical aspects is
performed in Chapter 4.
3.1 The model by Stortelder, Hemker and Hemker
The model proposed in [SHH97] concerns the common pathway; factor X was
activated by a purified enzyme RV V, factor V and prothrombin activation in
the presence of phospholipids is considered and also includes the inactivation of
thrombin by ATIII and α2−macroglobulin.
The reaction scheme for thrombin formation postulated by Stortelder et al. is
represented in Figure 3.1:
Figure 3.1: Reaction scheme for thrombin formation by Stortelder et. al.
The coagulation factors are denoted by Roman numerals, the subscript a denoting
their activated form. The chain of reactions starts with the activation of factor X
by the purified enzyme from Russel’s Viper Venom (RV V ), kept constant in each
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experiment performed, followed by the activation of factor V, the production of
prothrombinase in the presence of phospholipids and the activation of prothrom-
bin. The inactivation of factor Xa by ATIII and of thrombin by ATIII and
α2−macroglobolin (α2M) are also taken into account.
Based on the existing biochemical knowledge, in particular using the Michaelis and
Menten equation, the reaction scheme was transformed into a set of 9 non-linear
differential equations with unknown parameters, namely the reaction constants
and the initial concentrations of the reactants.
d[X ]
dt
= −
kcatX [X ][RV V ]
kmX + [X ]
d[Xa]
dt
=
kcatX [X ][RV V ]
kmX + [X ]
− kiXa [Xa]− kPT [Va][Xa][PL] + kPL[PT ]
d[V ]
dt
= −
kcatV [V ][IIa]
kmV + [V ]
d[Va]
dt
=
kcatV [V ][IIa]
kmV + [V ]
− kPT [Va][Xa][PL] + kPL[PT ]
d[PL]
dt
= −kPT [Va][Xa][PL] + kPL[PT ]
d[PT ]
dt
= kPT [Va][Xa][PL]− kPL[PT ]
d[II]
dt
= −
kcatII [II][PT ]
kmII + [II]
−
kcat2[II][Xa]
km2 + [II]
d[IIa]
dt
=
kcatII [II][PT ]
kmII + [II]
+
kcat2[II][Xa]
km2 + [II]
− kiIIaα2M [IIa]− kiIIaATIII [IIa]
d[IIaα2M ]
dt
= kiIIaα2M [IIa].
(3.1.1)
The noncatalytic reactions were modelled by using the law of mass action and
inhibition was characterized as being of first order kinetics. Notice that the total
mass is not constant and that the system is not balanced.
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Although the reaction scheme was not explicitly published in the usual way, we
infer from (3.1.1) that following reactions occur:
X +RV V X.RV V Xa +RV V
k+
k−
kcatX
II +Xa II.Xa IIa +Xa
c1
c−1
kcat2
V + IIa V.IIa Va + IIa
c2
c−2
kcatV
Xa + PL+ Va PT
kPT
kPL
II + PT II.PT IIa + PT
c3
c−3
kcatII
IIa IIaATIII
kiIIaATIII
IIa IIaα2M
kiIIaα2M
Xa XaATIII
kiXa
Figure 3.2: Reaction scheme corresponding to (3.1.1).
In addition, the course of the concentration of the amidolytic activity of the throm-
bin was also modelled and the corresponding equation was:
AmAct = [IIa] + 0.556[IIaα2M ]. (3.1.2)
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Estimates for the 13 reaction constants were obtained by fitting the model to
experimental data:
kcatX kmX kiXa kPT kPL kcatV
239.1 23.65 4.531 122.9 801.4 7.844
kmV kcatII kmII kcat2 km2 kiIIaα2M kiIIaATIII
149.7 43.87 62.25 12.4 0.06148 0.1762 0.7859
Table 3.1: Dimensionless constants estimated by Stortelder et al. after fitting the
model to experimental data.
3.1.1 Stoichiometric analysis
Although this analysis should proceed that of the kinetics, the model proposed by
Stortelder et al. does not satisfy the law of mass action and the concepts introduced
in Chapter 2 do not apply. Furthermore, the system includes first order reactions
and it is neither reversible nor weakly reversible. Consequently, a stoichiometric
analysis like the one made by Sontag in [Son01] is also not possible.
3.1.2 Numerical integration results and remarks
Since the last equation of (3.1.1) is a simple integration, it was at first not consid-
ered. The remaining stiff system of eight equations was then solved numerically for
t ∈ [0, 30] minutes using the ODE solver from SCILAB (see Appendix C for some
technical details), allowing implicit integration of the system. We set RVV=0.03
and considered the following set of initial values:
X(0) = 0.2, Xa(0) = 0, V (0) = 0.03, Va(0) = 0, PL(0) = 0.05, PT (0) = 0,
II(0) = 1.4, IIa(0) = 0.
These values correspond to the physiological concentrations of the different factors
in blood in µmol/L and the substances to be activated have initial concentration
equal to zero.
The algorithm converged without major problems. We present the graphic corre-
sponding to the course of thrombin concentration versus the course of prothrombin
concentration with time in Figure 3.3 and the one corresponding to the course of
the concentration of the amidolytic activity of the thrombin modelled by (3.1.2)
in Figure 3.4.
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Figure 3.3: Thrombin versus prothrombin concentration.
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Figure 3.4: Course of the amidolytic activity of thrombin.
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The SCILAB code and the remaining graphics can be found in Appendix D1.
From the graphics, we are finally able to draw some conclusions and make some
remarks.
Factor X is not completely activated, but the amount of factor Xa is enough to
start the production of thrombin. This influence is modelled in the reaction term
r7 =
kcat2[II][Xa]
km2 + [II]
,
present in equations 7 and 8 of (3.1.1). Therefore, as Stortelder et al. stated, this
reaction cannot be neglected specially at the beginning, where a small percentage
of prothrombin is transformed into thrombin. This little amount of thrombin is
enough to activate factor V to built the prothrombinase complex, which is expected
by the physiologists to be the major activator of prothrombin making the influence
of factor Xa insignificant after an initial period of time. As this fact is not reflected
in the model, Stortelder and Hemker [SHH97] pointed out that both factor Xa
and PT complex contribute similarly in percentage for thrombin generation, not
excluding however that this might only be the case where RV V is taken as factor
X activator.
Prothrombinase is a Ca2+−dependent, 1:1, enzymatic complex of factor Xa and
factor Va that assemble in a reversible association on the surface of negatively
charged phospholipid vesicles or platelets and the course of prothrombinase con-
centration with time was modelled by using a third order term also appearing in
equations 2, 4 and 5 of (3.1.1). This term seems to be responsible for the concen-
tration of PT to be almost constant except perhaps at the beginning. Apparently,
it varies much more rapidly than the concentrations of the remaining factors yield-
ing some numerical uncertainties also reflected in the graphical representation, see
Figures D.5 and D.6. In Section 7.1 we analyze this term more carefully and make
an analogy with the work done by Nesheim and co-workers in [NeTrMa84].
In fact, only about 35 % of the whole amount of prothrombin is used to form
thrombin, which is simultaneously inactivated by the action of ATIII and of
α2−macroglobolin, keeping the whole amount of thrombin at a concentration level
less or equal to 0.1µmol/L. If the system is controllable, one may think of influenc-
ing the system with an external control and obtain a desired amount of thrombin
in a given time interval. In Chapter 5 we prove that the linearized system is not
completely controllable, but we will be able to find a controllable subspace.
Although being very compact, the model of Stortelder et al. meets in several points
the established knowledge in the field and constitutes a good starting point for
ongoing research. So, later in Chapter 7 we propose a new approach for modelling
1All the concentrations are in µmol/L and the time is given in minutes
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the common pathway of the blood coagulation system based on a small modi-
fication of this model, giving special relevance to the action of thrombocytes in
the process of thrombin formation and their influence in the amount of thrombin
formed. In addition, we substitute RV V by introducing plasmatic components of
the clotting system that do not play a role in the truncated mechanism studied
by Stortelder and Hemker and extend the model. As starter we use the complex
TF.V IIa
But, first we analyze mathematical aspects like stability and controllability of the
system (3.1.1). This is done in Chapters 4 and 5.
In the sequel we show by representing the numerical soluiton graphically that by
changing the value of some constants we may influence the values of the concentra-
tion at the equilibrium. This will provide some hints that are useful for analysing
controllability aspects.
The influence of changing the values of kiIIaα2M and kiIIaATIII on the course of
thrombin concentration with time
In the next figure we illustrate the influence of changing the values of the constants
kiIIaATIII on the course of thrombin concentration with time. It is easy to see that
increasing the value of k12 = kiIIaATIII results in a decrease in concentration.
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Figure 3.5: Influence of changing the value of kiIIaATIII .
In Figure 3.6 we illustrate the influence of changing the values of the constants
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kiIIaα2M on the course of thrombin concentration with time. This time we observe
that the maximal concentration does not change, but the value of the concentration
at the equilibrium decreases with decreasing values of k13 = kiIIaα2M .
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Figure 3.6: Influence of changing the value of kiIIaα2M .
Notice that the initial lag characteristic of thrombin generation curves is almost
not perceptible.
3.2 The model by Mann and Jones
The model proposed in [JoMa94] describes the tissue factor pathway, also extrinsic
pathway, to thrombin and it involves the activation of the factors IX , X and
V III. Here, all protein-lipid binding reactions were saturated. Hence, lipid binding
equilibria are not included as reactions steps and therefore there was no need to
include a factor for the concentration of lipid, in contrast with the model proposed
in [SHH97]. Moreover, Mann and Jones claim that their model is responsive to
alterations in the concentrations of factors V III and V, as well as in their activated
forms V IIIa and Va. Thus, the effect of thrombin generation in the presence of
disease can be studied.
The model comprises however 19 differential equations, which means an increase
in complexity by comparison with the model presented in [SHH97], making a
straight forward interpretation of the results more difficult. Furthermore, by the
process of developing the model there are some constructive and qualitative aspects
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deserving our special attention. In particular, the authors derive a set of differential
equations using the law of mass action and it turns out that it does not correspond
to the reaction scheme published in the same paper. Moreover, since we are in the
presence of enzyme catalyzed reactions, the Michaelis-Menten approach should
preferably be applied. So, there is no motivation to use the law of mass action
instead.
In this section we start by making a stoichiometric analysis for the reaction scheme
published in [JoMa94](see also Figure 3.7). Analogously as we did in the previous
section for the model of Stortelder and Hemker, and to gain more insights we
also tried to calculate the numerical solution of the set of equations published by
Mann and Jones in [JoMa94] (see also (3.2.1)). However, the addition of the term
−|I − [V IIIaIXa]|+ (I − [V IIIaIXa]) seems to be made a posteriori and the set
of equations does not match the reaction scheme. So, this model asks for some
correction and this will be done in Section 3.2.2. First, like the authors did, we
derive the set of equations using the law of mass action and make the qualitative
analysis in Chapter 4. Other kinetic aspects will be discussed in Chapter 4 and in
Chapter 6.
The reaction scheme published in [JoMa94] including the relevant reactions in
coagulation that are consistent with the experimental results presented by Lawson
et. al. in [LKSM94] is given by:
IX + TF.V IIa IX.TF.V IIa TF.V IIa + IXa
k6
k16
k11
X + TF.V IIa XTF.V IIa TF.V IIa +Xa
k6
k17
k12
X + V IIIa.IXa X.V IIIa.IXa V IIIa.IXa +Xa
k6
k18
k13
IX +Xa Xa + IXa
k15
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V +Xa Xa + Va V a.Xa
k1
k8
k10
V III +Xa Xa + V IIIa
k3
V + IIa IIa + Va
k2
V III + IIa IIa + V IIIa
k4
II + Va.Xa II.Va.Xa Va.Xa +mIIa Va.Xa + IIa
k6
k19
k14 k5
V IIIa + IXa V IIIa.IXa
k7
k9
Figure 3.7: Reaction scheme from [JoMa94], where each complex is represented
only once.
By applying the law of mass action, the corresponding set of differential equations
governing the system was set to be as follows.
d[TFV IIa]
dt
= k11[TFV IIaIX ]− k6[TFV IIa][IX ] + k16[TFV IIaIX ]+
+k12[TFV IIaX ]− k6[TFV IIa][X ] + k17[TFV IIaX ]
d[IX ]
dt
= k16[TFV IIaIX ]− k6[TFV IIa][IX ]−
−k15[IX ][Xa]− k15[IX ][VaXa]
d[X ]
dt
= k17[TFV IIaX ]− k6[X ][TFV IIa]− k6[X ][V IIIaIXa]+
k18[V IIIaIXaX ]
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d[V ]
dt
= −k1[V ][Xa]− k2[V ][IIa]− k2[V ][mIIa]
d[V III]
dt
= −k3[V III][Xa]− k4[V III][IIa]− k4[V III][mIIa]
d[II]
dt
= k19[VaXaII]− k6[II][VaXa]
d[V IIIaIXa]
dt
= k7[V IIIa][IXa]− k9[V IIIaIXa]− k6[V IIIaIXa][X ]+
+k18[V IIIaIXaX ] + k13[V IIIaIXaX ]−
−|I − [V IIIaIXa]|+ (I − [V IIIaIXa]) !!
d[VaXa]
dt
= k8[Xa][Va]− 2k10[VaXa] + k19[VaXaII]− k6[VaXa][II]+
+k14[VaXaII]
d[IIa]
dt
= k5[VaXa][mIIa]
d[VaXaII]
dt
= k6[VaXa][II]− k19[VaXaII]− k14[VaXaII]
d[mIIa]
dt
= k14[VaXaII]− k5[VaXa][mIIa]
d[TFV IIaIX ]
dt
= k6[TFV IIa][IX ]− k16[TFV IIaIX ]− k11[TFV IIaIX ]
d[TFV IIaX ]
dt
= k6[TFV IIa][X ]− k17[TFV IIaX ]− k12[TFV IIaX ]
d[V IIIaIXaX ]
dt
= k6[V IIIaIXa][X ]− k18[V IIIaIXaX ]− k13[V IIIaIXaX ]
d[IXa]
dt
= k9[V IIIaIXa]− k7[V IIIa][IXa] + k11[TFV IIaIX ]+
+k15[IX ][Xa] + k15[IX ][VaXa]
d[Xa]
dt
= k10[VaXa]− k6[Xa][Va] + k12[TFV IIaX ] + k13[V IIIaIXaX ]
d[Va]
dt
= k10[VaXa]− k6[Xa][Va] + k1x4[Xa] + k2[V ][IIa] + k2[V ][mIIa]
d[V IIIa]
dt
= k9[V IIIaIXa]− k7[V IIIa][IXa] + k3[V III][Xa]+
+k4[V III][IIa] + k4[V III][mIIa]
dI
dt
= (−|I − [V IIIaIXa]|+ (I − [V IIIaIXa]))k20 !!
(3.2.1)
The mathematical model was developed in [JoMa94] by following three steps:
(i) identification of the enzymatic reactions that are integral part to the complete
coagulation cascade.
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(ii) empirical restricted approximations for the rate constants.
(iii) adjustment of the rate constants in such a way that the theoretical model
simulates the results derived from laboratory experiments.
The value of the rate constants used to model the activation of thrombin were
based upon published rate constants determined in earlier work and they are
listed in Table 3.2.
Constant Value Description
k1 2× 10
7M−1s−1 Activation of V by Xa
k2 2× 10
7M−1s−1 Activation of V by IIa
k3 1× 10
7M−1s−1 Activation of V III by Xa
k4 2× 10
7M−1s−1 Activation of V III by IIa
k5 1× 10
7M−1s−1 Conversion of mIIa to IIa by VaXa
k6 1× 10
8M−1s−1 On-rate for rapidly formed complexes
k7 1× 10
7M−1s−1 On-rate for V IIIaIXa complex
k8 4× 10
8M−1s−1 On-rate for VaXa complex
k9 0.005s
−1 Off-rate for V IIIaIXa complex
k10 0.4s
−1 Off-rate for VaXa complex
k11 0.3s
−1 Vmax for activation of IX by TF.V IIIa
k12 1.15s
−1 Vmax for activation of X by TF.V IIIa
k13 8.2s
−1 Vmax for activation of X by V IIIaIXa
k14 32s
−1 Vmax for mIIa formation by VaXa
k15 1× 10
5M−1s−1 Activation of IX by Xa
k16 24s
−1 Off-rate for IX on TF.V IIa complex
k17 44s
−1 Off-rate for X on TF.V IIa complex
k18 0.001s
−1 Off-rate for X on V IIIaIXa complex
k19 70s
−1 Off-rate for II on VaXa complex
k20 0.02s
−1 Constant for the slow degradation of V IIIaIXa
complex
Table 3.2: Rate constants, their dimensionalized value and respective description.
For doing parameter identification it is important to say a word about how the
constants were obtained and to mention that Jones and Mann did not exclude
other sets of rate constants that matched the experimental results because mea-
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surements are sometimes made under different circumstances and different values
are obtained.
The values of k1 and k2 were first obtained from the kinetics of factor V activation,
published in a work of Monkovic and Tracy [MoTr90], and then readjusted to
match the empirical results of Lawson et. al in [LKSM94].
The constants k3 and k4 were initially approximated by analogy and then refined
based on the empirical results in [LKSM94]. Moreover, the estimation suffered
another adjustment after fitting the model to experimental data.
Because no scientific papers reporting estimates were available, the value of the
constants k5 and k20 were solely identified by fitting the model to experimental
data.
The value of k6 was assumed for all rapidly formed complexes.
The values of k7, k8 are known from the literature, as well as the ratios
k10
k8
,
k9
k7
.
k11, k12, k13 and k14 were tacked directly from previously published values of the
kcat and Km values for the reactions.
The constant k15 was estimated based on the results published in [LaMa91], while
k16, k17, k18 and k19 were calculated from the Michaelis-Menten relationship.
Jones and Mann reported what they classified as encouraging results after differ-
ent sets for the rate constants were tested and the implications of the changes
made were discussed while providing the validity of the model through graphical
evidence of numeric solutions obtained from Runge-Kutta methods. Furthermore,
they established a reaction profile characterized by:
• a lag or initiation phase;
• a propagation phase;
• a decay of meizothrombin to thrombin observed between 140s and 180s
Before regarding the kinetic aspects inherent to the model (3.2.1) let us first
perform the stoichiometric analysis. Noteworthy is that, we are not going to be
able to apply the concepts given in Chapter 2 in a straight forward way. One of
the reasons is that not all reaction mechanisms of Figure 3.7 have a unambiguous
interpretation. For example consider the reaction scheme
V + IIa IIa + Va
k2
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It could be interpreted als a catalytic reaction, however the term k2[V ][IIa] appears
in the fourth equation with negative sign and in equation 17 with positive sign.
So, we infer that the law of mass action was used to model a second order reaction
corresponding to the reaction scheme
V + IIa Va
k2
The set of species involved remains unchanged, though. The same is not true if
the authors refer to a first order reaction.
3.2.1 Stoichiometric analysis
According to the notations and definitions given in Chapter 2 lets us make the
stoichiometric analysis for this model.
The set of chemical species for the network given in Figure 3.7 is given by:
S = {IX, TF.V IIa, IX.TF.V IIa, IXa, X,X.TF.V IIa, Xa, V IIIa.IXa,
X.V IIIa.IXa, V, Va, Va.Xa, V III, V IIIa, IIa, II, II.VaIIa,mIIa}.
Thus, m := #S = 18.
The set of complexes is given by
C := {IX + TF.V IIa, IX.TF.V IIa, TF.V IIa + IXa, X + TF.V IIa, X.TF.V IIa,
TF.V IIa +Xa, X + V IIIa.IXa, X.V IIIa.IXa, V IIIa.IXa +Xa, IX +Xa,
Xa+IXa, V +Xa, Xa+Va, Va.Xa, V III+Xa, Xa+V IIIa, V +IIa, IIa+V a, V III+
IIa, IIa + V IIIa, II + Va.Xa, II.Va.Xa, Va.Xa +mIIa, Va.Xa + IIa,
V IIIa + IXa, V IIIa.IXa}
and n := #C = 26.
Considering the whole reaction system as a graph, whose nodes are the complexes
and the edges labeled by the reaction rate constants we associate with this graph
its 26 × 26 incidence matrix A = al,m, listing all the edge labels (for instance,
a21 = k1, to indicate a reaction with the rate constant k1, from the first node to
the second node). In this case, the matrix has the representation (3.2.2).
Notice that this matrix is reducible. As a consequence, the graph is not strongly
connected. This means that, given any two complexes there is not necessarily a
path linking them. Furthermore, the reaction network is neither reversible nor
weakly reversible.
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A =


0 k16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
k6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 k11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 k17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 k6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 k12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 k18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 k6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 k13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 k15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 k1 0 k10 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 k8 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 k3 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k2 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k4 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k19 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k6 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k14 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k5 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k9
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 k7 0


. (3.2.2)
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By using the notation of Definition 2.1.5, let the i-th element of C by the order
of appearance be designated by pi, i = 1, . . . , 26. Then, the set R of reactions is
given by:
R = {p1 → p2,p2 → p1,p2 → p3,p4 → p5,p5 → p4,p5 → p6,p7 → p8,
p8 → p7,p8 → p9,p10 → p11,p12 → p13,p13 → p14,p14 → p13,
p15 → p16,p17 → p18,p19 → p20,p21 → p22,p22 → p21,p22 → p23,
p23 → p24,p25 → p26,p26 → p25}.
Thus, r := #R = 22.
Hence, by Remark 2.1.7, each reaction can be written as
Rj ≡
26∑
i=1
νijpi, j = 1, . . . , 22,
where ν = (νij) ∈ R
(26,22) is the stoichiometric matrix.
Our first aim is now to calculate the dimension of the stoichiometric subspace. So,
it is sufficient to determine how many linearly independent reactions are in the
network.
To calculate the coordinates of the reaction vectors we make use of the definition
of the support of a complex (see Section 2.1.1). For the sake of simplicity, let us
first denote each element of S respectively by Sk, k = 1, . . . , 18. Then, we construct
a (26, 18)−matrix with entries 0 or 1. Thus, entry (i, k) = 1 means that
Sk ∈ supppi, i = 1, . . . , 26, k = 1, . . . , 18.
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The matrix has the following representation:


1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0
0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1
0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0
0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0
0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0


. (3.2.3)
Each line defines a vector bi, i = 1, . . . , 26 for each complex. Then, the reaction
vectors are
s1 := b2 − b1 = (−1,−1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T;
s2 := b1 − b2 = (1, 1,−1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T ;
s3 := b3 − b2 = (0, 1,−1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T ;
s4 := b5 − b4 = (0,−1, 0, 0,−1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T;
s5 := b4 − b5 = (0, 1, 0, 0, 1,−1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T ;
s6 := b6 − b5 = (0, 1, 0, 0, 0,−1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T ;
s7 := b8 − b7 = (0, 0, 0, 0,−1, 0, 0,−1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T;
s8 := b7 − b8 = (0, 0, 0, 0, 1, 0, 0, 1,−1, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T ;
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s9 := b9 − b8 = (0, 0, 0, 0, 0, 0, 1, 1,−1, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T ;
s10 := b11 − b10 = (−1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
T;
s11 := b13 − b12 = (0, 0, 0, 0, 0, 0, 0, 0, 0,−1, 1, 0, 0, 0, 0, 0, 0, 0)
T;
s12 := b14 − b13 = (0, 0, 0, 0, 0, 0,−1, 0, 0, 0,−1, 1, 0, 0, 0, 0, 0, 0)
T ;
s13 := b13 − b14 = (0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1,−1, 0, 0, 0, 0, 0, 0)
T;
s14 := b16 − b15 = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,−1, 1, 0, 0, 0, 0)
T;
s15 := b18 − b17 = (0, 0, 0, 0, 0, 0, 0, 0, 0,−1, 1, 0, 0, 0, 0, 0, 0, 0)
T;
s16 := b20 − b19 = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,−1, 1, 0, 0, 0, 0)
T;
s17 := b22 − b21 = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,−1, 0, 0, 0,−1, 1, 0)
T ;
s18 := b21 − b22 = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1,−1, 0)
T;
s19 := b23 − b22 = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0,−1, 1)
T;
s20 := b24 − b23 = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0,−1)
T;
s21 := b26 − b25 = (0, 0, 0,−1, 0, 0, 0, 1, 0, 0, 0, 0, 0,−1, 0, 0, 0, 0)
T ;
s22 := b25 − b26 = (0, 0, 0, 1, 0, 0, 0,−1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0)
T.
Thus, the stoichiometric subspace is the submanifold
D := span{s1, . . . , s22}.
Since there are 12 linearly independent vectors, dimS = 12. We may say,
D :=< s1, s3, s4, s6, s7, s11, s12, s14, s17, s19, s20, s22 > .
This submanifold can also be described as the set of solutions of:
S1 + S3 = S2 + S3 = S3 + S4 = S2 + S6 = S5 + S6 = S6 + S7 = S5 + S9 =
S8+S9 = S10+S11 = S7+S11 = S11+S12 = S13+S14 = S12+S17 = S16+S17 =
S17 + S18 = S15 + S18 = S4 + S8 = S14 + S8 = 0.
Moreover, by Remark 2.2.15 and Definition 2.2.16, each intersection between a
parallel translate of D and the positive orthant is a stoichiometric compatibility
class.
So, each stoichiometric class is given by the nonnegative points in
{S1 + S3 = c1;S2 + S3 = c2;S3 + S4 = c3;S2 + S6 = c4;S5 + S6 = c5;S6 + S7 =
c6;S5 + S9 = c7;S8 + S9 = c8;S10 + S11 = c9;S7 + S11 = c10;S11 + S12 =
c11;S13 + S14 = c12;S12 + S17 = c13;S16 + S17 = c14;S17 + S18 = c15;S15 + S18 =
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c16;S4 + S8 = c17;S14 + S8 = c18},
where ci, i = 1, . . . , 18 are nonnegative constants.
Furthermore, the rank of the network is as well 12 and the network has deficiency
δ = 26− 10− 12 = 4.
However, since the network is not weakly reversible, by using the theorems given
previously we cannot conclude the existence and uniqueness of an equilibrium
point in a stoichiometric class. The same can be said regarding the asymptotic
stability with respect to initial conditions.
Remark 3.2.1. We can associate to the matrix (3.2.3) the following graph:
Figure 3.8: Graph corresponding to the matrix (3.2.3).
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Each node is denoted with the respective chemical specie. An edge connecting
two different species represents a complex of the network. The number of simple
loops is equal to the number of intermediate complexes formed, in the figure they
are denoted by ∆i, i = 3, 6, 9, 8, 12, 17.We observe that the graph is not strongly
connected, but if we eliminate ∆3,∆6,∆9 and ∆17 we obtain a connected graph.
In Chapter 4 we will identify exactly 6 linear first integrals and see that this
elimination is possible.
The previous calculation can also be interpreted in terms of homologies of graphs.
We summarize the principal aspects in the following remark, where the nomencla-
ture is adapted from [Zer00].
Remark 3.2.2. Let Γ = (V,E, ϕ) be a directed finite graph with V representing
the set of vertices, E representing the set of edges and ϕ : E → V ×V, e→ ϕ(e) =
(ϕ1(e), ϕ2(e)) is the incidence map. Suppose that #V = p and that #E = q. If
ϕ(e) = (v1, v2), then v1 is called the initial vertex and v2 the terminal vertex of e.
In our case V = C and E = R. Then p = 26 and q = 22.
Let R be a ring with unity.
We define a function f : V → R as the vertex weight function.
Let the function g : E → R be the edge weight function, which in our case assigns
to the reaction Rl, l = 1, . . . , 22 its rate constant.
We define furthermore the boundary operator ∂ : RE → RV ; i→ ∂(i), where R is
a ring. This operator assigns a vertex weight function to each edge weight function
i : E → R as follows:
∂(i)(v) =
∑
e∈E(v,−)
i(e)−
∑
e∈E(−,v)
i(e),
where E(v,−) = ϕ−11 = {e ∈ E,ϕ1(e) = v} is the set of all edges with initial
vertex v and E(−, v) = ϕ−12 = {e ∈ E,ϕ2(e) = v} is the set of all edges with
terminal vertex v.
In our case, the matrix representation of ∂ is the stoichiometric matrix ν ∈ Zp×q
where
νij =


1 if ϕ1(ej) = vi 6= ϕ2(ej)
−1 if ϕ2(ej) = vi 6= ϕ1(ej)
0 otherwise.
Moreover, we have the following exact sequence:
0 → Rb1
B
−→ Rq
ν
−→ Rp
C
−→ Rb0 −→ 0,
b0 is the number of connected components, or the number of linkage classes if we
want to use the designation of Feinberg, and b1 is the number of fundamental loops
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or the number of cycles existing in Γ. These numbers are called Betti numbers2 of
the graph.
By definition it holds
Im(B) = Ker(ν) and Im(ν) = Ker(C).
Thus,
rank(ν) + b1 = q and rank(ν) + b0 = p
which implies q − b1 = p− b0 or b1 = q − p+ b0. In our case rank(ν) = 16. Thus,
b0 = 10 and b1 = 6. So, we have 10 connected components and 6 cycles.
Furthermore, the deficiency of the network can also be defined by the number
χ = b0 − b1, also known as Euler-Poincare´ characteristic of the graph.
Let C =


1 . . . 1
...
...
1 . . . 1

 ∈ Z10×18. Since Cν = 0, we may discard 10 lines of the
stoichiometric matrix without losing information. We obtain a matrix ν′ ∈ Z12×26.
Finally, let B ∈ Z26×6 be such that
Bij =


1 if the jth loop contains the edge ei
−1 if the jth loop contains the edge −ei
0 otherwise.
,
where −e is defined for each e to be the edge that is directed from the terminal
to the initial vertex of e. It holds νB = 0. The matrices ν′ and BT can be used to
define a transformation that allow us to reduce the dimension of a system, what
is very useful in practice, in particular for systems of very high dimension. For a
more general theory and an example of application to electrical networks we refer
to [Zer00].
Remark 3.2.3. The mass action dynamics can be also summarized by the system
x˙ =
n∑
i=1
n∑
j=1
aijx
b1j
1 x
b2j
2 . . . x
bmj
m (bi − bj),
where xi represents the concentration of the specie i with i = 1, . . . , 18, n = 26.
As already mentioned in Remark 2.2.17, since x˙ ∈ D, trajectories remain in classes,
that is, classes are positive-time invariant manifolds for the dynamical system.
2In algebraic topology, the Betti number is a topologic invariant associated to certain topo-
logical spaces, varieties, graphs, etc. E. g. in a topological space the Betti number gives the
maximum number of cuts that can be made without dividing the space into two pieces, in a con-
nected graph it represents the maximum number of edges that can be removed without violating
the connectivity property of the graph
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Remark 3.2.4. Many drugs work by interrupting either flux or metabolite levels to
an extent that is harmful to the organism, either because they reduce an important
flux to very low levels or because they increase the level of a metabolite to toxic
proportions. Conservation constraints can impose hand limits to the extent to
which fluxes can be altered. Thus, stoichiometric analysis is an important initial
evaluation of whether manipulating a particular target might be effective or not.
Besides this practical implication, there is also a theoretical implication concerning
the analysis of biochemical control which is dependent on the identification of
conserved quantities [SaIn04].
3.2.2 Model correction and numerical integration
As it is given in [JoMa94], SciLab was not able to integrate the system of dif-
ferential equations (3.2.1). Differentiability of the right-hand side is an important
feature to be satisfied, since for implicit integration methods, like the ones in-
cluded in routines for solving systems o stiff ODE’s with SciLab, it is necessary to
supply the Jacobian matrix of the right-hand side of the system. Otherwise, the
program computes the Jacobian numerically with all disadvantages of a numerical
calculation, in particular if the system is not stable. In this case, small changes in
the parameters or in the initial data provided another solution or nonconvergence
followed.
Remark 3.2.5. Observing the right-hand side more carefully and taking the law
of mass action into account and the stoichiometric analysis previously performed,
we see that there are terms included in some equations describing reactions that
cannot arise from the reaction scheme presented in the same paper. Without ex-
cluding the possibility that some of these incorrections may follow from several
typographic errors, we point out more specifically that
(i) the term k15[IX ][VaXa], appears in the second equation of the system (3.2.1)
with a minus and equation 15 with a plus. This means that both factors IX
and complex VaXa interact in a second order reaction to form factor IXa
and only the concentration of IX changes. Physiologically, this would mean
activation of factor IX by the complex V aXa, that acts as enzyme and
catalyzes the reaction. However, this situation is not contemplated in the
reaction scheme published in [JoMa94].
(ii) Similarly, the terms k2[V ][mIIa] and k4[V III][mIIa] appear respectively in
equations 4 and 5 of the system (3.2.1) with a minus sign and, with a plus sign
in equations 17 and 18, respectively. The kind of reaction is the same as the
one described in item (i). Physiologically, this should model the activation of
factors V and V III by mIIa.
(iii) In equation number 8 of (3.2.1), the stoichiometric coefficient of [VaXa] is
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equal to 2, but the corresponding reaction scheme only includes one molecule
of the factor represented by the variable [VaXa] (see Figure 3.9).
(iv) In equations 16 and 17, the reaction constant k6 should be replaced by k8.
V +Xa Xa + Va V a.Xa
k1
k8
k10
Figure 3.9: Reaction scheme number 5 in [JoMa94].
The last remarks, together with the stoichiometric analysis, ask for a correction
of the model. There are two possibilities, either to assume that the set of equa-
tions is correct and the reaction scheme from Figure 3.7 must be completed or to
assume that the reaction scheme is valid and settle the new system of equations.
In physiological context, picking up the first alternative means that factor IX can
also be activated by the action of the complex VaXa with rate k15 and that the
meizothrombin (factor mIIa) also activates factor V and factor V III. So, using
the same notation as the authors, the following reactions would occur:
IX + VaXa VaXa + IXa
k15
V +mIIa mIIa + Va
k2
V III +mIIa mIIa + V IIIa
k4
Figure 3.10: Reaction scheme to complete the one of Figure 3.7 in terms of the
coagulating factors.
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As a matter of fact, there is no guarantee that these three reactions do really
happen. Furthermore, in the actual medical literature (see Chapter 1, Figure 1.1
or [Pru00]) these reactions are not included.
Remark 3.2.6. It is also noteworthy to point out that a physical constraint as-
sociated with the stability of the factor V IIIa - factor IXa complex has been
incorporated into the model based on the empirically established decay of this
complex with time by adding the term −|I − [V IIIaIXa]| + (I − [V IIIaIXa]),
a kind of switch function, to the differential equation that describes the course
of the concentration of this complex with time (see equation 7 of (3.2.1)). This
term appears again multiplied by the constant k20 in the last equation, what leads
one to suspect about the way the model was constructed. Furthermore, it is not
clear why the authors have chosen a nondifferentiable function to cause the de-
sired effect. Moreover, neither the numerical nor structural implications of these
constraints were discussed in [JoMa94]. In Section 4.3, we treat with more detail
the consequence of adding this term.
In the sequel, we restrict ourselves to the reaction scheme of Figure 3.7, settle the
new equations and try to obtain the solution numerically. In a first attempt, we
use, like Mann and Jones did, the law of mass action. But, later in Chapter 6
we propose an approach that uses the Michaelis-Menten equation since, actually,
we are in the presence of enzyme catalyzed reactions. At the same time, we look
critically at some reactions of the reaction scheme proposed by Mann and Jones
in [JoMa94].
Using the law of mass action and taking into account the stoichiometric analysis,
we take the rates of the reactions to be proportional to the concentrations of the
reactants. We thereby obtain systematically the nonlinear autonomous differential
equation system as it follows.
Reaction scheme 1 and respective contribution to rates of change
IX + TF.V IIa IX.TF.V IIa TF.V IIa + IXa
k6
k16
k11
d[TFV IIa]
dt
= −k6[TFV IIa][IX ] + k16[TFV IIaIX ] + k11[TFV IIaIX ]
d[IX ]
dt
= −k6[TFV IIa][IX ] + k16[TFV IIaIX ]
d[TFV IIaIX ]
dt
= k6[TFV IIa][IX ]− k16[TFV IIaIX ]− k11[TFV IIaIX ]
d[IXa]
dt
= k11[TFV IIaIX ]
(3.2.4)
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Reaction scheme 2 and respective contribution to rates of change
X + TF.V IIa XTF.V IIa TF.V IIa +Xa
k6
k17
k12
d[TFV IIa]
dt
= −k6[TFV IIa][X ] + k17[TFV IIaX ] + k12[TFV IIaX ]
d[X ]
dt
= −k6[TFV IIa][X ] + k17[TFV IIaX ]
d[TFV IIaX ]
dt
= k6[TFV IIa][X ]− k17[TFV IIaX ]− k12[TFV IIaX ]
d[Xa]
dt
= k12[TFV IIaX ]
(3.2.5)
Reaction scheme 3 and respective contribution to rates of change
X + V IIIa.IXa X.V IIIa.IXa V IIIa.IXa +Xa
k6
k18
k13
d[V IIIaIXa]
dt
= −k6[X ][V IIIaIXa] + k18[V IIIaIXaX ] + k13[V IIIaIXaX ]
d[X ]
dt
= −k6[X ][V IIIaIXa] + k18[V IIIaIXaX ]
d[V IIIaIXaX ]
dt
= k6[X ][V IIIaIXa]− k18[V IIIaIXaX ]− k13[V IIIaIXaX ]
d[Xa]
dt
= k13[V IIIaIXaX ]
(3.2.6)
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Reaction scheme 4 and respective contribution to rates of change
IX +Xa Xa + IXa
k15
d[IX ]
dt
= −k15[IX ][Xa]
d[IXa]
dt
= k15[IX ][Xa]
(3.2.7)
Reaction scheme 5 and respective contribution to rates of change
V +Xa Xa + Va V a.Xa
k1
k8
k10
d[Xa]
dt
= −k8[Xa][Va] + k10[VaXa]
d[V ]
dt
= −k1[V ][Xa]
d[Va]
dt
= k1[V ][Xa] + k10[VaXa]− k8[Xa][Va]
d[VaXa]
dt
= k8[Xa][Va]− k10[VaXa]
(3.2.8)
Reaction scheme 6 and respective contribution to rates of change
V III +Xa Xa + V IIIa
k3
d[V III]
dt
= −k3[V III][Xa]
d[V IIIa]
dt
= k3[V III][Xa]
(3.2.9)
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Reaction scheme 7 and respective contribution to rates of change
V + IIa IIa + Va
k2
d[V ]
dt
= −k2[V ][IIa]
d[Va]
dt
= k2[V ][IIa]
(3.2.10)
Reaction scheme 8 and respective contribution to rates of change
V III + IIa IIa + V IIIa
k4
d[V III]
dt
= −k4[V III][IIa]
d[V IIIa]
dt
= k4[V III][IIa]
(3.2.11)
Reaction scheme 9 and respective contribution to rates of change
II + Va.Xa II.Va.Xa Va.Xa +mIIa Va.Xa + IIa
k6
k19
k14 k5
d[II]
dt
= −k6[II][VaXa] + k19[VaXaII]
d[VaXa]
dt
= −k6[II][VaXa] + k19[VaXaII] + k14[VaXaII]
d[IIa]
dt
= k5[VaXa][mIIa]
d[VaXaII]
dt
= −k19[VaXaII]− k14[VaXaII] + k6[II][VaXa]
d[mIIa]
dt
= k14[VaXaII]− k5[VaXa][mIIa]
(3.2.12)
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Reaction scheme 10 and respective contribution to rates of change
V IIIa + IXa V IIIa.IXa
k7
k9
d[V IIIa]
dt
= −k7[V IIIa][IXa] + k9[V IIIaIXa]
d[IXa]
dt
= −k7[V IIIa][IXa] + k9[V IIIaIXa]
d[V IIIaIXa]
dt
= −k9[V IIIaIXa] + k7[V IIIa][IXa]
(3.2.13)
Notice that we obtained only 18 equations instead of 19. This is a hint that the
term −|I − [V IIIaIXa]| + (I − [V IIIaIXa]) was added a posteriori. Thus the
introduction of such a term cannot be justified neither by the structural aspects
of the network nor by the implicit kinetics. The 18 equations correspond to the 18
species contained in the set S of species and the second-hand part of the system
suffered some little changes. The changes reflect furthermore the aspects discussed
above in Remark 3.2.5.
The numerical integration was performed in SciLab. As initial values, we used the
vector
x0 = [0.000005; 0.09; 0.2; 0.032; 0.0007; 1.4; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0].
All variables corresponding to activated substances have initial value zero and for
the remaining variables we took the physiological concentrations in blood of the
different factors in µM/L.
The values of the constants in [JoMa94] were adjusted regarding the dimension.
The integration interval was taken to be of 16 minutes. Since some constants are
expressed in s−1, we integrate over the interval [0,960] seconds.
The activity of meizothrombin is known to be about 120 % that of α−thrombin3.
Thus, a relative specific activity of 1.2 is assigned to meizothrombin and 1 to
α−thrombin in order to model thrombin activity in experimental results [JoMa94].
3In the model this corresponds solely to factor II
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In the next figure we visualize the whole amount of thrombin in blood for the first
4 minutes:
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Figure 3.11: Activated thrombin (time=250 seconds ≈ 4 min).
This graphic has the same behavior as the one published in [JoMa94]. The SciLab
code and the remaining graphics are given in Appendix F with concentrations
expressed in µmol/L and time in s.
The experimentally observed decay of the complex V IIIaIXa was also not re-
flected in the corrected model and this we confirm visually in Figure 3.12.
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Figure 3.12: Complex V IIIaIXa does not decay, contrary to the experimental results.
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A possible explanation for this result is that this model does not take into account
the action of inhibitors. As a matter of fact and as already mentioned in Chapter 1,
thrombin is responsible for generating a protease called activated protein C, which
then permanently inactivates the two cofactors, factor Va and factor V IIIa, with
second order kinetics [BeJe95]. So, it is very likely that the complex V IIIaIXa
will decay in a natural fashion. In 2002, the model from Mann and Jones was
extended and the results are published in [HJEM02]. It includes among others the
TFPI−mediated inactivation of the complex TF.V IIa, the inactivation of factors
IIa, V IIa, IXa and Xa by ATIII, the initial activation of cofactors V and V III by
thrombin generated by factor Xa membrane, factor V III dissociation, the bind
competition and kinetic activation steps that exist between TF and factors V II
and V IIa and the activation of factor V II by thrombin, factor Xa and factor
IXa. However, although the reaction scheme was published, the set of differential
equations governing the process was omitted. Moreover, the information published
is neither enough to make a cautious mathematical analysis nor to verify if some
of the aspects discussed in this section were corrected or not.
A challenge for future investigation would be to trace back the set of differential
equations published in [HJEM02] by using the actual knowledge about the mod-
elling of chemical reactions networks involving enzymes and compare the simula-
tion to the experimental results obtained in order to see if it reflects the principal
properties of blood coagulation accepted by the scientific community as been true.
This would provide a more deep understanding of the blood coagulation process
in a more systematic approach in the analysis of such kind of systems.
Chapter 4
Qualitative Analysis of Models
for Thrombin Generation
The aim of this chapter is to perform a qualitative analysis of two mathematical
models for thrombin generation in blood. The first is due to Stortelder, Hemker
and Hemker [SHH97], and the second due to Mann and Jones [JoMa94].
The analysis is carried out applying the concepts given in Appendix A.
4.1 The model by Stortelder, Hemker and Hemker
4.1.1 Positivity analysis
We first write the system of ordinary differential equations (3.1.1) in vector form:
dx
dt
= f(x), where f is a vector function and x is a vector.
In our case, the vector x = x(t) has 9 components, each of which is a function of
time. Let its components be written as xi ≥ 0, i = {1, . . . , 9} and they represent the
concentrations of the different factors involved in the blood coagulation process.
Respectively, we have
x1 = [X ], x2 = [Xa], x3 = [V ], x4 = [Va], x5 = [PL], x6 = [PT ], x7 = [II],
x8 = [IIa], and x9 = [IIaα2M ].
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For simplicity, we also rename the constants present in the model:
k1 := kcatX , k2 := kmX , k3 := kiXa , k4 := kPT , k5 := kPL, k6 := kcatV ,
k7 := kmV , k8 := kcatII , k9 := kmII , k10 := kcat2, k11 := km2,
k12 := kiIIaα2M and k13 := kiIIaATIII .
Then, the system (3.1.1) can now be written as follows:
dx1
dt
= −
k1x1RV V
k2 + x1
dx2
dt
=
k1x1RV V
k2 + x1
− k3x2 − k4x4x2x5 + k5x6
dx3
dt
= −
k6x3x8
k7 + x3
dx4
dt
=
k6x3x8
k7 + x3
− k4x4x2x5 + k5x6
dx5
dt
= −k4x4x2x5 + k5x6
dx6
dt
= k4x4x2x5 − k5x6
dx7
dt
= −
k8x7x6
k9 + x7
−
k10x7x2
k11 + x7
dx8
dt
=
k8x7x6
k9 + x7
+
k10x7x2
k11 + x7
− k12x8 − k13x8
dx9
dt
= k12x8.
(4.1.1)
Furthermore, the components fi(x) of f(x) are defined for i = 1, . . . , 9 by
f1(x) := −
k1x1RV V
k2 + x1
, f2(x) :=
k1x1RV V
k2 + x1
− k3x2 − k4x4x2x5 + k5x6,
f3(x) := −
k6x3x8
k7 + x3
, f4(x) :=
k6x3x8
k7 + x3
− k4x4x2x5 + k5x6,
f5(x) := −k4x4x2x5 + k5x6, f6(x) := k4x4x2x5 − k5x6,
f7(x) := −
k8x7x6
k9 + x7
−
k10x7x2
k11 + x7
, f8(x) :=
k8x7x6
k9 + x7
+
k10x7x2
k11 + x7
− k12x8 − k13x8
and f9(x) := k12x8, respectively.
In the sequel we prove that the positive orthant of R9 and its closure are positively
invariant sets for the system (4.1.1) by applying Proposition A.3.10. This shows in
particular that any orbit starting with positive initial values will remain positive
for all times.
Let P = {x ∈ R9 : x1 > 0, . . . , x9 > 0} be the positive orthant of R
9.
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Proposition 4.1.1. P and P are positively invariant for the system (4.1.1).
Proof. The vector x represents a vector of concentrations, this means that
xi ≥ 0, i = 1, . . . , 9, then the system is defined in a relative open subset of P with
f(x) = (f1(x) , . . . , f9(x))
T , where the function f is C∞.
For x ∈ ∂P , define Cx = P . Setting furthermore xk = 0 in fk, k = 1, . . . , 9 we
obtain:
f1(0, x2, . . . , x9) = 0 for all x2 ≥ 0, . . . x9 ≥ 0;
f2(x1, 0, x3, . . . , x9) =
k1x1RV V
k2 + x1
+ k5x6 ≥ 0 for all xj ≥ 0, j 6= 2;
f3(x1, x2, 0, . . . , x9) = 0 for all xj ≥ 0, j 6= 3;
f4(x1, x2, x3, 0, . . . , x9) =
k6x3x8
k7 + x3
+k5x6 ≥ 0 for all xj ≥ 0, j 6= 4;
f5(x1, x2, x3, x4, 0, . . . , x9) = k5x6 ≥ 0 for all xj ≥ 0, j 6= 5;
f6(x1, . . . , x5, 0, x7, x8, x9) = k4x4x2x5 ≥ 0 for all xj ≥ 0, j 6= 6;
f7(x1, . . . , x6, 0, x8, x9) = 0 for all xj ≥ 0, j 6= 7;
f8(x1, . . . , x7, 0, x9) =
k8x7x6
k9 + x7
+
k10x7x2
k11 + x7
≥ 0 for all xj ≥ 0, j 6= 8;
f9(x1, . . . , x8, 0) = k12x8 ≥ 0 for all xj ≥ 0, j 6= 9.
Thus, for every i ∈ {1, . . . , 9}, fi(x1, . . . , xi−1, 0, xi+1, . . . , x9) ≥ 0, and therefore
f(x) ∈ Cx, for all x ∈ ∂P . Hence, P and P are positively invariant for the system
(4.1.1). 
4.1.2 Invariance principle applied to Hemker’s model
Since 

x˙5 + x˙6 = 0
x˙3 + x˙4 + x˙6 = 0
x˙7 + x˙8 +
(
1 +
k13
k12
)
x˙9 = 0,
(4.1.2)
we conclude that there are at least three conserved quantities in the system (4.1.1).
In fact, we have the following proposition:
Proposition 4.1.2. The scalar valued functions ϕ1(x) = x6 + x5, ϕ2(x) = x3 +
x4 + x6 and ϕ3(x) = x7 + x8 +
(
1 +
k13
k12
)
x9 defined on R
9 are first integrals of
the system (4.1.1).
78 Chapter 4. Qualitative Analysis of Models for Thrombin Generation
Corollary 4.1.3. Given any solution of (4.1.1) with nonnegative initial values, the
components x3(t), x4(t), x5(t), x6(t), x7(t), x8(t), x9(t) are bounded.
Proof. By directly applying the last theorem and Remark A.1.5 we conclude
that the solutions of the system (4.1.1) remain in the level set of ϕ1, ϕ2 and
of ϕ3, in which they start. Hence, ϕ1(xi(t)), ϕ2(xi(t)) and ϕ3(xi(t)) are con-
stant functions of t for all solutions and therefore bounded. Thus, the components
xi(t), i = 3, 4, 5, 6, 7, 8, 9 are bounded. 
Moreover, for the components x1(t) and x2(t) a similar proposition holds.
Corollary 4.1.4. Given any solution of (4.1.1) with nonnegative initial values, the
components x1(t), x2(t) are bounded.
Proof. Consider ϕ4(x) = x1 + x2 + x6 and ϕ5(x) = x1 defined on R
9. Let us
calculate the Lie derivative of these functions. By applying Theorem A.1.2 we
have
Lf (ϕ4)(x) = Dx(ϕ4)f(x) = (1, 1, 0, 0, 0, 1, 0, 0, 0)


f1(x)
...
f9(x)


= f1(x) + f2(x) + f6(x) = −k3x2
and
Lf (ϕ5)(x) = Dx(ϕ5)f(x) = (1, 0, 0, 0, 0, 0, 0, 0, 0)


f1(x)
...
f9(x)


= f1(x) = −
k1x1RV V
k2 + x1
.
Since x2 ≥ 0 and x1 ≥ 0 we have
Lf (ϕ4)(x) ≤ 0, and Lf (ϕ5)(x) ≤ 0 (4.1.3)
As sum of one or more nonnegative functions xi(t), i = 1, . . . , 9, the functions
ϕj(x) ≥ 0, j = 4, 5. Together with (4.1.3), we conclude that the functions ϕj are
non increasing and bounded for j = 4, 5 along a trajectory. That is, there are
constants βj such that 0 ≤ ϕj(x) ≤ βj , j = 4, 5. Hence every trajectory remains
in the subset of P defined by ϕj(x) ≤ βj , which is bounded. Consequently, the
components xi(t), i = 1, 2 are defined and bounded. 
It would be desirable to find out more first integrals before proceeding. However,
there is no general principle for finding first integrals of a nonlinear system of first
order differential equations. So, we try to do it first by visual inspection.
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A closer look at the right-hand side of the system (4.1.1) reveals that the third
equation is actually of separable variables and as a consequence x9 can be written
explicitly as a function of x3. In fact, for x3 > 0, we have
x˙3(k7 + x3)
x3
= −k6x8 = −
k6
k12
x˙9.
Integrating now both sides with respect to t and knowing that x3 > 0, because of
its physiological meaning, we obtain:
k7 lnx3
∣∣∣t
0
+ x3
∣∣∣t
0
= −
k6
k12
x9
∣∣∣t
0
or
d
dt
(
k7 lnx3 + x3 +
k6
k12
x9
)
= 0.
Therefore
k6
k12
x9 + k7 lnx3 + x3 = k7 lnx3(0) + x3(0).
So, the following proposition holds.
Proposition 4.1.5. The scalar valued function defined on R9 by
ψ(x) =
k6
k12
x9 + k7 lnx3 + x3
is a first integral of the system (4.1.1).
Theorem 4.1.6. The positive limit set ω(y) of (4.1.1) is contained in
N := {x ∈ P : x1 = 0, x2 = 0, x4 + x3 + x6 = x3(0), x6 + x5 = x5(0), x8 = 0,
x7 + x8 +
(
1 +
k13
k12
)
x9 = x7(0)}.
Furthermore, every solution starting in N is stationary and the equilibrium point
is stable.
Proof. The two previous results together with Theorem A.3.11 imply that the
compact sets Mα := {x ∈ P : ϕj(x) ≤ α, j = 1, . . . , 5} are positively invariant for
all α ∈ [0, βj). Theorem A.3.15 guarantees that the solution of the initial value
problem exists on [0,∞). Moreover, this solution approaches its positive limit set
ω(y), as t → ∞. So, ω(y) is nonempty, compact and connected. By Theorem
A.3.16 ω(y) is also invariant.
Hence, by applying LaSalle’s principle stated in Theorem A.4.1 we conclude that
ω(y) ⊂ N.
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Let furthermore z(t) = (z1(t), . . . , z9(t))
T be a solution of (4.1.1) in N. We prove
that z(t) is stationary. It holds, z(t) = (0, 0, z3(t), z4(t), z5(t), z6(t), z7(t), 0, z9(t))
T .
Thus, together with (4.1.1) we have
z˙(t) =


0
0
z˙3
z˙4
z˙5
z˙6
z˙7
0
z˙9


!
=


0
k5z6
0
k5z6
k5z6
−k5z6
−
k8z7z6
k9 + z7
k8z7z6
k9 + z7
0


.
This means, in particular, that z˙2 = 0 and z˙8 = 0, since z8 = 0 and z2 = 0. This
implies z6 = 0 and
z˙(t) = (0, 0, 0, 0, 0, 0, 0, 0, 0)T .
That is, z(t) is constant and the solution is stationary.
The ω−limit set of (4.1.1) is nonempty. However, we still do not know exactly its
representation. To calculate the equilibrium points we set the right-hand side of
the system equal to zero and solve for x. The set of stationary points belongs to
the set E given by:
E =α3


0
0
1
0
0
0
0
0
0


+ α4


0
0
0
1
0
0
0
0
0


+ α5


0
0
0
0
1
0
0
0
0


+ α7


0
0
0
0
0
0
1
0
0


+ α9


0
0
0
0
0
0
0
0
1


, α3, α4, α5, α7, α9 ∈ R
+
0 .
(4.1.4)
The points of E belong to N if α3+α4 = 0.03 = x3(0), α7 = 1.4−
(
k12 + k13
k12
)
α9
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and α5 = 0.05 = x5(0). In other words, they belong to the triangle Π with para-
metric equation
P =


0
0
0
x3(0)
x5(0)
0
x7(0)
0
0


+ β3


0
0
1
−1
0
0
0
0
0


+ β9


0
0
0
0
0
0
−(1 + k13
k12
)
0
0


, (4.1.5)
where 0 ≤ β3 ≤ 0.03 and 0 ≤ β9 ≤ 1.4
k12
k12 + k13
to exclude negative concentra-
tions.
To study the nature of the equilibrium we first take a look at the general repre-
sentation of the Jacobian at any point of Π :
J =


−
k1[RV V ]
k2
0 0 0 0 0 0 0 0
k1[RV V ]
k2
−k3 − k4α4α5 0 0 0 k5 0 0 0
0 0 0 0 0 0 0
−k6α3
k7 + α3
0
0 −k4α4α5 0 0 0 k5 0
k6α3
k7 + α3
0
0 −k4α4α5 0 0 0 k5 0 0 0
0 k4α4α5 0 0 0 −k5 0 0 0
0 −
k10α7
k11 + α7
0 0 0 −
k8α7
k9 + α7
0 0 0
0
k10α7
k11 + α7
0 0 0
k8α7
k9 + α7
0 −k12 − k13 0
0 0 0 0 0 0 0 k12 0


.
We observe that the Jacobian at any stationary point has 5 zero columns. In
particular, this means that zero is an eigenvalue of the matrix with algebraic and
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geometric multiplicities equal to 5 and that there are conserved quantities present.
However, by Proposition 4.1.5 and Proposition 4.1.2 the order of the system may be
reduced from 9 to 5. The reduced system has furthermore a non-isolated singularity
that can be deduced from (4.1.5).
The Jacobian of the reduced system at the equilibrium has the representation
Jr :=


a1 0 0 0 0
−a1 a2 0 a3 0
0 0 0 0 a4
0 a5 0 a3 0
0 a6 0 a7 a8

 . (4.1.6)
It holds however that a2 = −k3 + a5, with k3 > 0. Under this condition we may
write
Jr :=


a1 0 0 0 0
−a1 −k3 + a5 0 a3 0
0 0 0 0 a4
0 a5 0 a3 0
0 a6 0 a7 a8

 . (4.1.7)
In this case, the eigenvalues of the matrix (4.1.7) can be calculated explicitly as:
λ1 = 0,
λ2 = a1 = −
k1RV V
k2
,
λ3 = a8 = −k12 − k13,
λ4 =
1
2
(a3 + (a5 − k3)) +
1
2
√
(a3 + (a5 − k3))2 + 4a3k3,
λ5 =
1
2
(a3 + (a5 − k3))−
1
2
√
(a3 + (a5 − k3))2 + 4a3k3.
Since k1, k2, k12 and k13 are positive follows λ2, λ3 < 0.
From the physiological meaning of the constants involved we also have immediately
a3 = −k5 < 0.
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Since 0 < y3 ≤ 0.03 then 0.03 − y3 ≥ 0. I. e., a2 = −k3 − 0.05k4(0.03 − y3) < 0.
And the same argument holds to justify that a5 = −0.05k4(0.03− y3) < 0.
Thus, λ4 and λ5 have negative real parts.
Since the reduced system has a non-isolated singularity we are in the conditions of
Theorem A.2.8 and the equilibrium point of the reduced system is stable but not
asymptotically stable. Moreover, the system converges to a single point where the
coordinate corresponding to λ1 = 0 is a constant depending on the initial value
problem and the remaining ones are equal zero.
Furthermore, because of the stationarity of every solution starting in N, we con-
clude immediately that the system converges to a nonisolated equilibrium point
where the coordinates corresponding to the eigenvalues equal zero are constants
depending on the initial value problem and the remaining ones are equal zero.
Then the equilibrium point of the system (4.1.1) is stable. 
In the sequel we reduce the order of the system (4.1.1).
4.2 Model reduction
The aim of this section is to reduce the dimension of system (4.1.1) in different
steps. Three of the conserved quantities can immediately be eliminated by means
of the three first integrals given already in Proposition 4.1.2 and a coordinate
transformation. For this purpose, we consider first the initial values
x3(0)=0.03, x4(0)=0, x5(0)=0.05, x6(0)=0, x7(0)=1.4, x8(0)=0 and x9(0)=0.
We obtain
ϕ1(x) = x6 + x5, ϕ2(x) = x3 + x4 + x6 and
ϕ3(x) = x7 + x8 +
(
1 +
k13
k12
)
x9.
The number of equations will be reduced to 6 by setting
x4 = x5 − x3 − 0.02; x6 = −x5 + 0.05 x7 = −x8 −
(
1 +
k13
k12
)
x9 + 1.4.
Hence, the 4th, the 6th and the 7th equations can be omitted. By Proposition 4.1.5
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every occurrence of x9 can be substituted by
k12
k6
(k7 lnx3(0)− k7 lnx3 + x3(0)− x3)
and, since the last equation is a simple integration of x8, we can omit the 9
th
equation.
Remark 4.2.1. As x˙3 ≤ 0, then x3 is monotonically decreasing. Thus, x3(0)−x3 ≥
0, which implies k7 lnx3(0)− k7 lnx3(0) ≥ 0. Hence, x9 ≥ 0.
Altogether we are now able to reduce the dimension of the system to 5 after
performing the following coordinate transformation
y1 := x1; y2 := x2; y3 := x3; y4 := x5; y5 := x8,
and each occurrence of x4, x6, x7 and x9 is substituted respectively by:
x4 = y4 − y3 − 0.02;
x6 = −y4 + 0.05;
x7 = 1.4− y5 −
k12 + k13
k6
(c− k7 ln y3 − y3);
x9 =
k12
k6
(c− k7 ln y3 − y3), where c = k7 lnx3(0) + x3(0).
The reduced system comprises the following system of differential equations:
dy1
dt
= −
k1y1RV V
k2 + y1
dy2
dt
=
k1y1RV V
k2 + y1
− k3y2 − k4(y4 − y3 − 0.02)y2y4 + k5(−y4 + 0.05)
dy3
dt
= −
k6y3y5
k7 + y3
dy4
dt
= −k4(y4 − y3 − 0.02)y2y4 + k5(−y4 + 0.05)
dy5
dt
=
k8
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)(−y4 + 0.05)
k9 +
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)
+
k10
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)y2
k11 +
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)
− k12y5 − k13y5
(4.2.1)
Setting the right-hand side of the system (4.2.1) to zero and solving to y
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that all the equilibrium points of this system belong to the segment of line:
P =


0
0
0
0.05
0

+ µ3


0
0
1
0
0

 , where 0 ≤ µ3 ≤ 0.03. (4.2.2)
Remark 4.2.2. Notice that 0.05 = y4(0) and that 0.03 = y3(0).
4.2.1 Linearization around an equilibrium point
At any point of the segment of line (4.2.2), the Jacobian matrix of (4.2.1) has the
following representation:
Jr =


−
k1 RVV
k2
0 0 0 0
k1 RVV
k2
−k3 − 0.05 k4 (0.03− y3 ) 0 −k5 0
0 0 0 0 −
k6 y3
k7 + y3
0 −0.05 k4 (0.03− y3 ) 0 −k5 0
0 a6 0 a7 −k13 − k12


,
(4.2.3)
where a6 =
k10(1.4k6 − (k12 + k13 ) (c− k7 ln (y3 )− y3 ))
k11 k6 + 1.4k6 − (k12 + k13 ) (c− k7 ln (y3 )− y3 )
and
a7 = −
k8 (1.4k6 − (k12 + k13 ) (c− k7 ln (y3 )− y3 ))
k6 k9 + 1.4k6 − (k12 + k13 ) (c− k7 ln (y3 )− y3 )
.
We see that 0 is an eigenvalue of the Jacobian matrix which eigenvector is the
direction vector of (4.2.2). This eigenvector is in particular the canonical vector
pointing in the same direction as the Cartesian nonnegative axis corresponding to
the variable represented by y3.
Remark 4.2.3. We can say more about the nature of the reaction mechanism
according to the signs of the entries of the Jacobian matrix. So, a positive entry in
the Jacobian matrix Jij indicates that near steady state an increase in a substance
yj gives rise to production of yi, whereas negative elements in the matrix indicate
that yi is removed as a direct result of an increase in yj, indicating an inhibitory
interaction. If the elements in the principal diagonal are positive then we can
speak about autocatalysis. A zero element of the matrix indicates that there is no
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direct interaction between yj and yi. Indirect interactions can nevertheless also be
inferred: if yi acts on yj which acts on yk, then yi acts indirectly on yk whereas
the sign of this indirect influence is determined by the signs of the direct steps.
Moreover, these steps can be interpreted in terms of positive and negative feedback
loops [CSM04]. Thus, it is also of interest to investigate the signs of the entries
denoted by a6 and a7.
The first observation is that a6 and a7 have signs, which will uniquely depend on
the sign of the term
1.4k6 − (k12 + k13 ) (c− k7 ln (y3 )− y3 ) . (4.2.4)
Let us suppose that (4.2.4) is positive. Then it holds,
1.4 >
k12 + k13
k6
(c− k7 ln (y3 )− y3 ) ,
which is equivalent to
x
eq
7 < x7(0).
This last inequality is always true since x7 is monotonically decreasing, because
x˙7 ≤ 0 (see equation 7 of (4.1.1)).
Hence, a6 > 0 and a7 < 0.
4.2.2 Heuristic approach for reducing the number of equations
For each 0 < y3 ≤ 0.03 fixed, we obtain a subsystem of (4.2.1) in the variables
y1, y2, y4 and y5 with a single equilibrium point.
Since 0.05 = y4(0) := c1, the subsystem in the variables y1, y2, y4 and y5 may be
written in a more general form and comprises the following equations:
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dy1
dt
= −
k1y1RV V
k2 + y1
dy2
dt
=
k1y1RV V
k2 + y1
− k3y2 − k4(y4 − y3 − 0.02)y2y4 + k5(−y4 + c1)
dy4
dt
= −k4(y4 − y3 − 0.02)y2y4 + k5(−y4 + c1)
dy5
dt
=
k8
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)(−y4 + c1)
k9 +
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)
+
k10
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)y2
k11 +
(
1.4− y5 −
(
k12+k13
k6
))
(c− k7 ln y3 − y3)
− k12y5 − k13y5
(4.2.5)
the equilibrium point being E := (0, 0, c1, 0).
The general expression of the Jacobian at E can be directly deduced from (4.2.3)
and is given by:
J =


−
k1 RVV
k2
0 0 0
k1 RVV
k2
−k3 − 0.05 k4 (0.03− y3 ) −k5 0
0 −0.05 k4 (0.03− y3 ) −k5 0
0 a5 a6 −k13 − k12


, (4.2.6)
where a5 =
k10 (1.4k6 − (k12 + k13 )) (c− k7 ln (y3 )− y3 )
k11 k6 + 1.4k6 − (k12 + k13 ) (c− k7 ln (y3 )− y3 )
and
a6 = −
k8 (1.4k6 − (k12 + k13 )) (c− k7 ln (y3 )− y3 )
k6 k9 + 1.4k6 − (k12 + k13 ) (c− k7 ln (y3 )− y3 )
with 0 < y3 ≤ 0.03
fixed.
All eigenvalues of the Jacobian (4.2.6) have real part less than zero and they
are equal to the nonzero eigenvalues of Jr. By using Lyapunov’s direct method
described in Section A.2 we conclude that the system (4.2.5) is asymptotically
stable.
Let us now evaluate numerically the result of the linearization of (4.2.5) at E for
the set of constants published in [SHH97].
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Evaluating the results with concrete values for the reaction constants published
in [SHH97].
To illustrate numerically the results of the analysis performed, let us substitute
the values of the constants published in [SHH97], perform the linearization of the
system (4.2.5) at E and make further conclusions.
After substituting the values of the constants, the Jacobian matrix is given by:
A =


−0.3033 0 0 0
0.3033 −4.536 −801.4 0
0 −0.00541 −801.4 0
0 11.54 −0.593 −0.9621

 .
The matrix A is stable and all the solutions can be written explicitly. As an
example, we present the solution of the initial value problem x˙(t) = Ax(t),x(0) =
(0.2, 0, 0.05, 0) and compare it graphically with the solution obtained while solving
numerically the non-linear system (4.2.5).
This step was performed in SciLab by using the following code:
T=[0:0.001:30];- integration interval
x0=[0.2;0;0.05;0]; - starting values
xeq=[0;0;0.05;0]; - equilibrium point
The function representing the right hand-side of the linear system
x˙ = BCoagHemk4jv(xeq) ∗ x,
where BCoagHemk4jv(xeq) is the function defined by the Jacobian of the system
evaluated at the equilibrium point.
function xdot=lincoag4(t,x)
xdot=BCoagHemk4jv(xeq)*x
endfunction
sm=x0-xeq; - shifting the equilibrium to the origin.
ylin=ode(sm,0,T,lincoag4); - storing all the solutions in ylin
Plotting simultaneously the solutions of thrombin generation of both the non-linear
and the linear system we obtain Figure 4.1.
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Figure 4.1: Course of thrombin from the solution of the non-linear system versus
the solution from the linear system.
We observe that both graphics can hardly be distinguished from each other. To-
gether with the theoretical analysis already performed, we conclude that the linear
approximation preserved the global behavior of the system. Since it is more conve-
nient for mathematical analysis and parameter estimation, it constitutes a helpful
tool in addition to experimental blood coagulation investigation and can be con-
sidered as a good basis for model extension.
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4.3 Model from Jones and Mann
The model proposed by Jones and Mann in [JoMa94] comprises a system of 19
nonlinear differential equations and is reproduced in this thesis in Chapter 3 in
the equation set (3.2.1). The qualitative analysis of this system should follow the
same pattern as the one done for the model of Stortelder et. al. However, from the
analysis made in Chapter 3 we concluded that given the reaction scheme (3.2.1),
the system proposed by Jones and Mann in [JoMa94] does not satisfy the law of
mass action and some correction was done. In this section we first prove that the
mathematical property of positivity that must be inherent to this kind of systems
is not satisfied by the system published in [JoMa94]. Moreover, we prove that the
corrected model with mass action kinetics does have this property and further
analysis regarding stability of the corrected system was made.
4.3.1 Positivity analysis
Like we did before for Stortelder’s model, we start by writing the system (3.2.1) in
vector form as
dx
dt
= f(x). Now the vector x has 19 components xi, i = 1, . . . , 19.
For that matter, let
x1 = [TFV IIa]; x2 = [IX ]; x3 = [X ]; x4 = [V ]; x5 = [V III]; x6 = [II];
x7 = [V IIIaIXa]; x8 = [V aXa]; x9 = [IIa]; x10 = [V aXaII]; x11 = [mIIa];
x12 = [TFV IIaIX ]; x13 = [TFV IIaX ]; x14 = [V IIIaIXaX ]; x15 = [IXa];
x16 = [Xa]; x17 = [V a]; x18 = [V IIIa] and x19 = [I].
(4.3.1)
The autonomous system of nonlinear differential equations (3.2.1) can now be
written as:
dx1
dt
= k11x12 − k6x1x2 + k16x12 + k12x13 − k6x1x3 + k17x13
dx2
dt
= k16x12 − k6x1x2 − k15x2x16 − k15x2x8
dx3
dt
= k17x13 − k6x3x1 − k6x3x7 + k18x14
dx4
dt
= −k1x4x16 − k2x4x9 − k2x4x11
dx5
dt
= −k3x5x16 − k4x5x9 − k4x5x11
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dx6
dt
= k19x10 − k6x6x8
dx7
dt
= k7x18x15 − k9x7 − k6x7x3 + k18x14 + k13x14 − |x19 − x7|+ (x19 − x7)
dx8
dt
= k8x16x17 − 2k10x8 + k19x10 − k6x8x6 + k14x10
dx9
dt
= k5x8x11
dx10
dt
= k6x8x6 − k19x10 − k14x10
dx11
dt
= k14x10 − k5x8x11
dx12
dt
= k6x1x2 − k16x12 − k11x12
dx13
dt
= k6x1x3 − k17x13 − k12x13
dx14
dt
= k6x7x3 − k18x14 − k13x14
dx15
dt
= k9x7 − k7x18x15 + k11x12 + k15x2x16 + k15x2x8
dx16
dt
= k10x8 − k6x16x17 + k12x13 + k13x14
dx17
dt
= k10x8 − k6x16x17 + k1x4x16 + k2x4x9 + k2x4x11
dx18
dt
= k9x7 − k7x18x15 + k3x5x16 + k4x5x9 + k4x5x11
dx19
dt
= (−|x19 − x7|+ (x19 − x7))k20.
(4.3.2)
The positive orthant of R19 is defined as P = {x ∈ R19 : x1 > 0, . . . , x19 > 0}.
Proposition A.3.10 is again applied to prove that there are orbits starting with pos-
itive initial values not remaining positive for all times. The following proposition
holds:
Proposition 4.3.1. P is not positively invariant for the system (4.3.2).
Proof. It is sufficient to prove that the solutions of
dx19
dt
= f19(x) do not remain
positive for all times.
The term −|x19 − x7|+ (x19 − x7) is in both the 7
th and 19th equations. In fact,
we have:
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−|x19 − x7|+ (x19 − x7) =
{
0 , x19 ≥ x7
2(x19 − x7) , x19 < x7
Setting furthermore xk = 0, in fk, k = 7, 19 we obtain:
f7(x1, . . . , x6, 0, x8, . . . , x19) = k7x18x15 + k18x14 + k13x14, because x19 ≥ x7 = 0.
Thus, f7(x1, . . . , x6, 0, x8, . . . , x19) ≥ 0 for all xj ≥ 0, j 6= 7.
But
f19(x1, . . . , x18, 0) = −2k20x7 < 0, for all xj ≥ 0, j 6= 19, because x7 > x19 = 0
by definition.
This means that the solutions of
dx19
dt
= f19(x) do not remain positive for all
times. 
Remark 4.3.2. We recall that, in the paper [JoMa94], Jones and Mann report that,
based on empirical data, there is a decay in the activity of the factor denoted by
the variable x7. To model this decay, they introduced a posteriori a new variable,
x19 that represents the maximal concentration of the variable x7 and claim that
the corresponding equation should cause a decreasing maximal concentration of
the variable x7 with time. So, a similar factor is also used in determining the
changing concentration of the factor V IIIa - factor IXa complex. However, it
is not clear why they used a nondifferentiable function to produce this kind of
behavior. In addition, positivity of the system is also not preserved for all times.
In Chapter 6 we propose another function to model such effect.
In the sequel, we make the same analysis as before for the corrected model pre-
sented in Section 3.2.2.
4.3.2 Positivity of the corrected model
The concentrations of the substrates, enzymes, complexes and products involved
are denoted as in (4.3.1).
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Altogether, we obtain the following system of 18 differential equations:
dx1
dt
= k11x12 − k6x1x2 + k16x12 + k12x13 − k6x1x3 + k17x13
dx2
dt
= k16x12 − k6x1x2 − k15x2x16
dx3
dt
= k17x13 − k6x3x1 − k6x3x7 + k18x14
dx4
dt
= −k1x4x16 − k2x4x9
dx5
dt
= −k3x5x16 − k4x5x9
dx6
dt
= k19x10 − k6x6x8
dx7
dt
= k7x18x15 − k9x7 − k6x7x3 + k18x14 + k13x14
dx8
dt
= k8x16x17 − k10x8 + k19x10 − k6x8x6 + k14x10
dx9
dt
= k5x8x11
dx10
dt
= k6x8x6 − k19x10 − k14x10
dx11
dt
= k14x10 − k5x8x11
dx12
dt
= k6x1x2 − k16x12 − k11x12
dx13
dt
= k6x1x3 − k17x13 − k12x13
dx14
dt
= k6x7x3 − k18x14 − k13x14
dx15
dt
= k9x7 − k7x18x15 + k11x12 + k15x2x16
dx16
dt
= k10x8 − k8x16x17 + k12x13 + k13x14
dx17
dt
= k10x8 − k8x16x17 + k1x4x16 + k2x4x9
dx18
dt
= k9x7 − k7x18x15 + k3x5x16 + k4x5x9
(4.3.3)
The positive orthant of R18 is defined as P = {x ∈ R18 : x1 > 0, . . . , x18 > 0}. The
following proposition states that the system (4.3.3) only admits positive solutions
for positive starting values. Since the proof has the same structure as the proof of
Proposition 4.1.1 we keep it short by indicating only the major steps.
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Proposition 4.3.3. P and P are positively invariant for the system (4.3.3).
Proof. The vector x represents again a vector of concentrations, this means that
xi ≥ 0, i = 1, . . . , 18. Then the system is defined in a relative open subset of P
with f(x) = (f1(x) , . . . , f18(x))
T , where the function f is C∞.
For x ∈ ∂P , define Cx = P . Set xk = 0, in fk, k = 1, . . . , 18.
For every i ∈ {1, . . . , 18}, fi(x1, . . . , xi−1, 0, xi+1, . . . , x18) ≥ 0, and therefore
f(x) ∈ Cx, for all x ∈ ∂P . Hence, P and P are positively invariant for the system
(4.3.3) and, as a consequence, for positive initial values it admits only positive
solutions . 
4.3.3 Linear first integrals and boundedness of the solutions
Corollary 4.3.4. Given any solution of (4.3.3) with nonnegative initial values, all
the components xi(t), i = 1, . . . , 18 are bounded.
Proof. In this case, since all variables are involved, it is sufficient to prove that
the scalar valued functions defined on R18 by
ϕ1(x) = x1 + x12 + x13;
ϕ2(x) = x2 + x12 + x15 + x7 + x14;
ϕ3(x) = x3 + x13 + x14 + x16 + x8 + x10;
ϕ4(x) = x4 + x17 + x8 + x10;
ϕ5(x) = x5 + x18 + x7 + x14;
ϕ6(x) = x6 + x11 + x10 + x9
are first integrals of the system (4.3.3). Indeed by applying again Definition A.1.4:
Lf (ϕ1)(x) = Dx(ϕ1)f(x) = (1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0)


f1(x)
...
f18(x)


= f1(x) + f12(x) + f13(x) = 0.
Lf (ϕ2)(x) = Dx(ϕ2)f(x) = (0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0)


f1(x)
...
f18(x)


= f2(x) + f7(x) + f12(x) + f15(x) = 0.
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Lf (ϕ3)(x) = Dx(ϕ3)f(x) = (0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 0, 1, 0, 0)


f1(x)
...
f18(x)


= f3(x) + f8(x) + f10(x) + f13(x) + f14(x) + f16(x) = 0.
Lf (ϕ4)(x) = Dx(ϕ4)f(x) = (0, 0, 0, 1, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0)


f1(x)
...
f18(x)


= f4(x) + f8(x) + f10(x) + f17(x) = 0.
Lf (ϕ5)(x) = Dx(ϕ5)f(x) = (0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1)


f1(x)
...
f18(x)


= f5(x) + f7(x) + f14(x) + f18(x) = 0.
Lf (ϕ6)(x) = Dx(ϕ6)f(x) = (0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0)


f1(x)
...
f18(x)


= f6(x) + f9(x) + f10(x) + f11(x) = 0.
By directly applying Proposition 4.3.3 and Remark A.1.5, we conclude that the
solutions of the system (4.3.3) remain in the level set of ϕj , j = 1, . . . , 6 in which
they start. Hence, ϕj(xi(t)), j = 1, . . . , 6 are constant functions of t for all solutions
and therefore bounded. Thus, the components xi(t), i = 1, . . . , 18 are bounded. 
Proposition 4.3.5. Let ϕ7(x) = x6 + x10, ϕ8(x) = x3 + x13 + x14, ϕ9(x) = x4 and
ϕ10(x) = x5 be scalar functions defined on R
18. Then Lf (ϕi)(x) ≤ 0, i = 7, . . . , 10.
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Proof.
Lf (ϕ7)(x) = Dx(ϕ7)f(x) = (0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0)


f1(x)
...
f18(x)


= f6(x) + f10(x) = −k14x10 ≤ 0, since x10 ≥ 0;
Lf (ϕ8)(x) = Dx(ϕ8)f(x)
= (0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0)


f1(x)
...
f18(x)


= −(k12x13 + k13x14) ≤ 0, since x13, x14 ≥ 0;
Lf (ϕ9)(x) = Dx(ϕ9)f(x)
= (0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)


f1(x)
...
f18(x)


= x4(−k1x16 − k2x9) ≤ 0, since x4, x9, x16 ≥ 0;
Lf (ϕ10)(x) = Dx(ϕ10)f(x)
= (0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)


f1(x)
...
f18(x)


= x5(−k3x16 − k4x9) ≤ 0, since x5, x9, x16 ≥ 0.

Remark 4.3.6. As sum of one or more nonnegative functions xi(t), i = 1, . . . , 18,
the functions ϕj(x) ≥ 0, j = 7, . . . , 10. Together with the previous result, we
conclude that the functions ϕj are non increasing and bounded for j = 7, . . . , 10
along a trajectory. That is, there are constants βj such that 0 ≤ ϕj(x) ≤ βj , j =
7, . . . , 10. Hence every trajectory remains in the subset of P defined by ϕj(x) ≤ βj ,
which is bounded.
Proposition 4.3.7. The positive limit set ω(y) of (4.3.3) is contained in the set
N := {x ∈ P : x10 = 0, x1+x12+x13 = x1(0), x2+x12+x15+x7+x14 = x2(0),
x6 + x11 + x10 + x9 = x6(0), x3 + x13 + x14 + x16 + x8 + x10 = x3(0),
x4 + x17 + x8 + x10 = x4(0), x5 + x18 + x7 + x14 = x5(0), x13 = 0, x14 = 0}.
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Proof. The two previous results together with Theorem A.3.11 imply that the
compact sets Mα := {x ∈ P : ϕj(x) ≤ α, j = 1, . . . , 10} are positively invariant
for all α ∈ [0, βj). Theorem A.3.15 guarantees that the solution of the initial value
problem exists on [0,∞). Moreover, this solution approaches its positive limit set
ω(y), as t → ∞. So, ω(y) is nonempty, compact and connected. By Theorem
A.3.16 ω(y) is also invariant.
Hence, by applying LaSalle’s principle stated in Theorem A.4.1 we conclude that
ω(y) ⊂ N.

Remark 4.3.8. The conditions definingN are not enough to prove that any solution
in N is stationary. This set contains invariant sets other than the set of stationary
points.
In the sequel we derive further conditions to be satisfied by the set of equilibrium
points.
Deriving further conditions for the set of equilibrium points
While trying to find new conditions to be satisfied by an equilibrium point, one
can easily see that the value of some variables at the equilibrium depend on other
variables and their value at the equilibrium.
In order to gain more insights, we set the right-hand side of the system (4.3.3)
equal to zero and solve for xi, i = 1, . . . , 18 by using the modules TriSer and Tsolve
implemented in the software package epsilon of MAPLE 10 (see Appendix C for a
brief explanation). Altogether, 34 different sets were obtained but only 4 of them
were relevant for further analysis. The excluded sets contained either negative
values for some variable xi, i = 1, . . . , 18 or x1 = 0. The sets with x1 = 0 are those
for which the constant solution is obtained and this justifies the exclusion.
The selected sets are:
E1 := {x ∈ P : x2 = 0, x3 = 0, x4 = 0, x5 = 0, x6 = 0, x7 =
k7x18x15
k9
,
x8 =
k8x16x17
k10
, x10 = 0, x11 = 0, x12 = 0, x13 = 0, x14 = 0}
E2 := {x ∈ P : x2 = 0, x3 = 0, x4 = 0, x5 = 0, x7 =
k7x18x15
k9
,
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x8 = 0, x10 = 0, x12 = 0, x13 = 0, x14 = 0, x17 = 0}.
E3 := {x ∈ P : x2 = 0, x3 = 0, x4 = 0, x5 = 0, x7 =
k7x18x15
k9
,
x8 = 0, x10 = 0, x12 = 0, x13 = 0, x14 = 0, x16 = 0}.
E4 := {x ∈ P : x2 = 0, x3 = 0, x7 =
k7x18x15
k9
, x8 = 0,
x9 = 0, x10 = 0, x12 = 0, x13 = 0, x14 = 0, x16 = 0}.
The only set that matches the numerical results is E1. In the other three sets
x8 = 0 and this only happens at t = 0. However, at the beginning we have x2 6= 0.
This yields a contradiction and constitutes the first sign of instability.
The following proposition holds:
Proposition 4.3.9. Any solution z(t) starting in N given in Proposition 4.3.7 is
stationary if z15(t), z16(t), z17(t) and z18(t) are stationary.
Proof. Let z(t) be a solution in N satisfying the given conditions, i. e.
z(t) = (z1(t), z2(t), z3(t), z4(t), z5(t), z6(t), z7(t), z8(t), z9(t), 0, z11(t), z12, 0, 0,
z15(t), z16(t), z17(t), z18(t))
T .
Thus,
z˙(t) = (z˙1, z˙2, z˙3, z˙4, z˙5, z˙6, z˙7, z˙8, z˙9, 0, z˙11, z˙12, 0, 0, 0, 0, 0, 0)
T .
z˙10(t) = 0 implies k6z8z6 = 0. Since z8 6= 0 it follows z6 = 0 and z˙6(t) = 0.
Conditions z˙13(t) = 0 and z˙14(t) = 0 imply k6z1z3 = 0 and k6z7z3 = 0.
Since z1 6= 0 it holds z3(t) = 0 and consequently z˙3(t) = 0.
z18(t), z15(t) stationary imply z7(t) stationary and z˙7(t) = 0.
As z5 + z18 + z7 = c5 then z5(t) is constant and therefore z˙5(t) = 0.
On the other hand, z˙15(t) = 0 implies k11z12 + k15z2z16 = 0. That is z12 = 0 and
z2z16 = 0 because of positivity. But, z12 = 0 implies z˙12(t) = 0 and z2 = 0 as a
consequence. I. e., z˙2(t) = 0. Furthermore, z1 must be constant because z12 = 0
and z˙1(t) = 0 follows.
z16(t), z17(t) stationary imply z8 constant and z˙8(t) = 0. Moreover, z4 is also
constant and z˙4(t) = 0 holds.
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A positivity argument can be used to justify z9 = 0 and z˙9(t) = 0. This implies in
particular that k5z8z11 = 0 or z˙11(t) = 0.
Altogether, z˙(t) = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)T and z(t) is station-
ary.

For practical reasons, the stability question will be handled after reducing the num-
ber of equations to 12, since the Jacobian at the equilibrium will have eigenvalues
only with real part different from zero.
4.3.4 Model reduction
Let us now reduce the number of equations of the system (4.3.3) to 12. From the
first integrals given in Proposition 4.3.4 we eliminate the variables x1, x2, x3, x4, x6
and x7. This yields a system of differential equations where all the variables corre-
spond to activated substances and this is important, because we can only control
activated substances. On the other hand, the equation for factor V III is included,
so we are able to study one of the types of haemophilia from the model more
directly.
Setting
x1 = −x12 − x13 + c1;
x2 = −x12 − x15 + x5 + x18 + c2;
x3 = −x13 − x14 − x16 − x8 − x10 + c3;
x4 = −x17 − x8 − x10 + c4;
x6 = −x11 − x10 − x9 + c6;
x7 = −x5 − x18 − x14 + c5,
where c1 = x1(0); c2 = x2(0); c3 = x3(0); c4 = x4(0); c5 = x5(0) and c6 = x6(0),
are different from zero,
and making the following coordinate transformation:
y1 := x5; y2 := x8; y3 := x9; y4 := x10; y5 := x11; y6 := x12; y7 := x13; y8 :=
x14; y9 := x15; y10 := x16; y11 := x17; y12 := x18;
we obtain the following system of differential equations:
dy1
dt
= −k3y1y10 − k4y1y3 (4.3.4)
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dy2
dt
= k8y10y11 − k10y2 + k19y4 − k6y2(−y5 − y4 − y3 + c6) + k14y4 (4.3.5)
dy3
dt
= k5y2y5 (4.3.6)
dy4
dt
= k6y2(−y5 − y4 − y3 + c6)− k19y4 − k14y4 (4.3.7)
dy5
dt
= k14y4 − k5y2y5 (4.3.8)
dy6
dt
= k6(−y6 − y7 + c1)(−y6 − y9 + y1 + y12 − c5 + c2)−
−k16y6 − k11y6 (4.3.9)
dy7
dt
= k6(−y6 − y7 + c1)(−y7 − y8 − y10 − y2 − y4 + c3)−
−k17y7 − k12y7 (4.3.10)
dy8
dt
= k6(−y1 − y12 − y8 + c5)(−y7 − y8 − y10 − y2 − y4 + c3)−
−k18y8 − k13y8 (4.3.11)
dy9
dt
= k9(−y1 − y12 − y8 + c5)− k7y12y9 + k11y6+
k15(−y6 − y9 + y1 + y12 − c5 + c2)y10 (4.3.12)
dy10
dt
= k10y2 − k8y10y11 + k12y7 + k13y8 (4.3.13)
dy11
dt
= k10y2 − k8y10y11 + k1(−y11 − y2 − y4 + c4)y10+
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k2(−y11 − y2 − y4 + c4)y3 (4.3.14)
dy12
dt
= k9(−y1 − y12 − y8 + c5)− k7y12y9 + k3y1y10 + k4y1y3 (4.3.15)
Since this set of equations was obtained from a coordinate transformation of the
system (4.3.3) it follows that the equilibrium point belongs to the set
E5 := {y ∈ R
12 : y1 = 0, y2 =
k8
k10
y10y11, y4 = 0, y5 = 0, y6 = 0, y7 = 0, y8 = 0}.
Substituting these conditions in the system of equations (4.3.4) to (4.3.15) it is
easy to see that we obtain a zero of the functions defined by the right-hand side
of equations (4.3.4), (4.3.6) ,(4.3.8) and (4.3.13).
Further conditions can be deduced by setting to zero the right-hand side of the
remaining equations evaluated at a point of E5. Systematically we obtain:
- from (4.3.7)
y3 = c6.
This condition is also necessary for the right-hand side of (4.3.5) to be equal
zero;
- from (4.3.10)
dy7
dt
= 0⇔ y6 = c1 or y2 + y10 = c3.
Since c1 6= 0, it holds y2 + y10 = c3 or y10 =
c3k10
k8y11 + k10
.
Furthermore, this condition also sets the right-hand side of (4.3.11) to zero.
- from (4.3.14) we have
dy11
dt
= 0⇔ (−y11 − y2 + c4)(k1y10 + k2y3) = 0⇔ y11 + y2 = c4,
because k1y10 + k2y3 6= 0, since k1, k2, k3, y10 > 0.
The equilibrium point must still set to zero the right-hand side of
dy6
dt
= k6c1(−y9 + y12 − c5 + c2) (4.3.16)
dy9
dt
= k9(−y12 + c5)− k7y12y9 + k15(−y9 + y12 − c5 + c2)y10 (4.3.17)
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dy12
dt
= k9(−y12 + c5)− k7y12y9. (4.3.18)
By (4.3.16) we have
dy6
dt
= 0⇔ y12 − y9 = c5 − c2. (4.3.19)
By (4.3.18) we obtain
dy12
dt
= 0⇔ y12 =
k9c5
k9 + k7y9
. (4.3.20)
If (4.3.19) and (4.3.20) are simultaneously satisfied it follows immediately
dy9
dt
= 0.
Moreover, substituting (4.3.19) in (4.3.17) and solving for y9 we obtain
y9 =
−(k9 + k7(c5 − c2))±
√
(k9 + k7(c5 − c2))2 + 4k7k9c2
2k7
.
Taking the physiological meaning into account, c5 ≤ c2 and −(k9 + k7(c5 − c2)) is
a number between 0 and 1. Thus y9 > 0.
Remark 4.3.10. From the considerations done in Chapter 1 we observe that if
c5 = 0, we are in the presence of hemophilia A and if c2 = 0 of hemophilia B. So,
some reactions will not take place.
Remark 4.3.11. Substituting the values given in Table 3.2 and ci, i = 1, . . . , 5 by
the respective initial concentrations we obtain for the equilibrium point the same
values like the ones that can be deduced by visual inspection of the numerical
solution.
Remark 4.3.12. Altogether we obtained the coordinates of the unique equilibrium
point towards which the system comprising equations (4.3.4) to (4.3.15) converges.
Thus, by applying Theorem A.4.1 follows asymptotic stability of the equilibrium
point of this system.
In the sequel we substitute the values of the constants ki, i = 1, . . . , 20 given in
[JoMa94] in the system with the 12 equations and linearize the system. Since some
of these constants were not measured (see Section 3.2), we could use the Jacobian
matrix of the 12 equation system to make parameter identification. So, we give
some information regarding this.
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4.3.5 Linearization around an equilibrium point. Parameter iden-
tification by using the Jacobian
The general expression of the Jacobian at the equilibrium point of the system of
equations (4.3.4) to (4.3.15) is given by (4.3.21).
Substituting the values of the constants, we obtain the representation of the matrix
A given in (4.3.22).
The eigenvalues of this matrix are:
−104, 147; −67, 64; −45.2; −31.38; −29.68; −25.29;
−8.30; −0.90; −0.89; −0.3099; −0.031; −0.023.
Thus, the matrix is stable, but there are reactions occurring in different time
scales.
As before, we can additionally say more about the nature of the reaction mech-
anism, as a positive entry in the Jacobian matrix Aij indicates that near steady
state an increase in a substance yj gives rise to production of yi, whereas negative
elements in the matrix indicate that yi is removed as a direct result of an increase
in yj , indicating an inhibitory interaction. If the elements in the principal diagonal
are positive then we can speak about autocatalysis. A zero element of the matrix
indicates that there is no direct interaction from yj to yi. Indirect interactions can
also be inferred: if yi acts on yj which acts on yk, then yi acts indirectly on yk
whereas the sign of this indirect influence is determined by the signs of the direct
steps. Moreover, these steps can be interpreted in terms of positive and negative
feedback loops [CSM04].
One of the possibilities to determine the properties of the Jacobian is to use
perturbation to system parameters [CSM04]. But, before proceeding to parameter
identification by using the Jacobian there are some important points to consider.
In that context, it should be clear whether it is necessary to measure the concen-
tration of all species, or whether the measurement of a subset of the constituent
species is sufficient to determine system properties. Furthermore, since the most
direct approach to evaluating the Jacobian matrix for a biochemical network is to
experimentally perturb one or more concentrations from steady state and monitor
the response of each of the chemical species as the system relaxes, one should pick
up a perturbation strategy. In order to achieve this, one should decide whether
all or just a subset of the species need to be perturbed and, whether random per-
turbations are applied at regular intervals or a uniform perturbation is applied at
irregular time intervals.
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A =


a1 0 0 0 0 0 0 0 0 0 0 0
0 a3 a6 a8 a6 0 0 0 0 a13 a14 0
0 0 0 0 k5
k6
a6 0 0 0 0 0 0 0
0 0 −a6 −a8 −a6 0 0 0 0 0 0 0
0 0 0 a9 −
k5
k6
a6 0 0 0 0 0 0 0
a2 0 0 0 0 a2 − k16 − k11 0 0 −a2 0 0 a2
0 −a2 0 −a2 0 a11 a18 −a2 0 −a2 0 0
a11 a4 0 a4 0 0 a4 a19 0 a4 0 a11
−k9 + a10 0 0 0 0 k11 − a10 0 −k9 a12 − a10 0 0 a16
0 −a3 0 0 0 0 k12 k13 0 −a13 −a14 0
0 −a3 + a5 a7 a5 0 0 0 0 0 −a13 +
k1
k2
a7 a15 0
−k9 − a1 0 0 0 0 0 0 −k9 −a12 0 0 a17


. (4.3.21)
a1 = −k3y10(eq)− k4c6; a8 = k19 + a6 + a9; a15 = −
k8
k15
a10 −
k1
k15
a10 − k2c6;
a2 = k6c1; a9 = k14 a16 = −k9 − k7y9(eq) + a10;
a3 = −k10; a10 = k15y10(eq); a17 = −k9 − k7y9(eq);
a4 = −k6(−y9(eq) + c2); a11 = −k6(−y10(eq)−
k8
k10
y10(eq)y11(eq) + c3); a18 = a11 − a2 − k12 − k17;
a5 = −k1y10(eq)− k2c6; a12 = −k7(y9(eq) + c5 − c2); a19 = a11 + a4 − k18 − k13.
a6 = k6
k8
k10
y10(eq)y11(eq); a13 = k8y11(eq);
a7 = k2(−y11(eq)−
k8
k10
y10(eq)y11(eq) + c4); a14 =
k8
k15
a10;
0yi(eq) denotes the concentration of the variable yi at the equilibrium point
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A =


−29.68 0 0 0 0 0 0 0 0 0 0 0
0 −0.4 3.1 105.1 3.1 0 0 0 0 0.0776 67.2 0
0 0 0 0 0.31 0 0 0 0 0 0 0
0 0 −3.1 −105.1 −3.1 0 0 0 0 0 0 0
0 0 0 32 −0.31 0 0 0 0 0 0 0
0.0005 0 0 0 0 −25.2995 0 0 −0.0005 0 0 0.0005
0 −0.0005 0 −0.0005 0 −0.1 −45.25 −0.0005 0 −0.005 0 0
−0.1 −0.03 0 −0.03 0 0 −0.03 −8.331 0 −0.003 0 −0.1
0.0118 0 0 0 0 0.28232 0 −0.005 −0.0208 0 0 −0.8782
0 0.4 0 0 0 0 1.15 8.2 0 −0.0776 −67.2 0
0 −30.96 0.01612 −31.36 0 0 0 0 0 −0.06148 −98.56 0
29.675 0 0 0 0 0 0 −0.005 −0.004 0 0 −0.895


.
(4.3.22)
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One in all, if we assume that a reaction mechanism involving n species is described
by the system of equations
dyi
dt
= fi(y1, . . . , yn; p1, . . . , pnp), i = 1, . . . , n,
where yi is the concentration of the i− th chemical species and fi is the in general
nonlinear function describing the production and consumption of yi. Expanding
in a Taylor series about the steady state y∗, the system kinetics is determined by
the system of equations
ui
dt
=
n∑
j=1
(
∂fi
∂yj
)
y∗
uj + o(|u|), i = 1, . . . , n, (4.3.23)
where ui(t) = yi(t)− y
∗
i . For the linear system
ui
dt
= Jiu(t)
arising from (4.3.23), where the vector Ji is the i− th row of the Jacobian matrix,
the identification problem is essentially an exercise in linear regression.
Notice that the steady state concentration must be known in order to calculate
u = y − y∗.
The system comprising equations (4.3.4) to (4.3.15) is polynomial. Thus, the pa-
rameters enter linearly and the model can be fitted to the data using least squares
and singular value decomposition. Because of the large number of parameters to
be fitted that multivariate polynomial models may comprise, this kind of model
have limited usefulness. However, the analysis made in this chapter and the infor-
mation given in Section 3.2 allows to reduce to three the number of constants to
be identified, namely k5, k15 and k6. The remaining reaction constants have been
already published and validated through experimental data. Moreover, given the
representation (4.3.21) of the Jacobian at the equilibrium point, we observe that
the entries of the matrix are influenced by the steady state concentration of the
variables y9, y10 and y11 and initial concentration of 6 variables, that can be used
as control variables since they represent the physiologic concentration of some of
the factors involved in the process of blood coagulation system.
Chapter 5
Steering Stortelder’s Model
As there are some substances like heparin capable of influencing the action of
substances present in the blood, like ATIII, one of the goals of this work was to
verify whether it is possible to steer or influence the blood coagulation system by
means of a control function. Those variables are modelled as input variables of the
system. It turned out that the linearized system is not completely controllable. So
we investigate whether the system is flat and describe briefly how flatness can be
used to solve the control problem.
5.1 Stating the control problem of the linearized system
In this section we state the control problem for the system (4.2.1) and prove that
the linearized system around the equilibrium point is not completely controllable.
However we could identify a controllable subspace and give an example using the
constants given in Table 3.1. Nevertheless, the system is completely observable.
The variables y2(t) and y5(t) describe the behavior of the activated forms of factor
X and factor II, respectively. These substances belong to the same stoichiometric
class, so it is possible to influence the course of their concentrations with time by
using drops of the same substance. In the sequel we denote the concentration of
this substance by the scalar function u.
Let therefore y ∈ R5 denote the state vector of the system (4.2.1) and u ∈ R
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denote the control variable. Consider furthermore the matrix B ∈ R(5,1) given by
B =


0
1
0
0
1

 .
Let furthermore f be the function defined by the right-hand side of (4.2.1). Then
f is of class C∞ and the nonlinear initial value control problem can be stated as
y˙ = f(y) +Bu, with y(0) = y0.
The equilibrium point y∗ can be shifted to the origin by introducing the new
variable ξ := y − y∗.
The Taylor expansion around y∗ yields:
y˙ = ξ˙ = f(y∗ + ξ) +Bu = Aξ +Bu+ o(ξ),
where A is the Jacobian of the system at y∗ having the representation given in
(4.2.3).
By neglecting the terms of order o(ξ) we obtain linear approximations ξl for ξ and
the following initial value problem:
ξ˙l = Aξl +Bu, with ξl(0) = y0 − y
∗. (5.1.1)
Proposition 5.1.1. The system (5.1.1) is not completely controllable.
Proof. Since rankB = 1 we check the controllability of the system (5.1.1) by using
Corollary B.1.8.
Let U = [B,AB,A2B,A3B,A4B] be the controllability matrix, where
A =


a1 0 0 0 0
−a1 a2 0 a3 0
0 0 0 0 a4
0 a5 0 a3 0
0 a6 0 a7 a8

 and B =


0
1
0
0
1

 .
Then U has the following representation:
U=
0
BBBBBB@
0 0 0 0 0
1 a2 a
2
2 + a3a5 (a
2
2 + a3a5)a2 + (a2a4 + a
2
3)a5 ⋆
0 a4 a4a6 + a8a4 a4a6a2 + a4a7a5 + a4a8a6 + a4a
2
8 ⋆
0 a5 a5a2 + a3a5 (a5a2 + a3a5)a2 + (a3a5 + a
2
3)a5 ⋆
1 a6 + a8 a6a2 + a7a5 + a8a6 + a
2
8 (a6a2 + a7a5 + a8a6)a2+ ⋆
+(a6a3 + a7a3 + a8a7)a5 + a
2
8a6 + a
3
8
1
CCCCCCA
.
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rankU ≤ 4 < n and as a consequence the system (5.1.1) is not completely con-
trollable. 
Remark 5.1.2. This result means in particular that there might be some reaction
missing that influences the controllability of the system and that this linear system
cannot be influenced only by using a single control substance.
Remark 5.1.3. MAPLE calculates the rank symbolically and generically yielding
rankU = 4, but there are certain choices of the values of the constants ai, i =
1, . . . , 8 such that rankU < 4. It is easy to find general conditions for rankU ≥ 2,
however to exclude the possibility that rankU 6= 3 is not a simple matter due to
the complexity of some of the elements of this matrix. On the other hand, there
are not so many constellations of values that would generate linearly dependent
rows or columns. And, for a given set of starting values, the probability that this
happens is almost zero. So, we may state that rankU = 4 almost surely.
If rankU = 4 then, by Lemma B.1.9, it is possible to find a controllable subspace
of dimension 4.
Let T :=


0 0 0 0 1
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
1 0 0 0 0

 ∈ GL(5). Then T
−1 := T and we obtain
A˜ = T−1AT =


a8 a6 0 a7 0
0 a2 0 a3 −a1
a4 0 0 0 0
0 a5 0 a3 0
0 0 0 0 a1

 B˜ = T
−1B =


1
1
0
0
0

 .
Thus,
A1 =


a8 a6 0 a7
0 a2 0 a3
a4 0 0 0
0 a5 0 a3

 and B1 =


1
1
0
0

 .
By Lemma B.1.9 it follows immediately:
Proposition 5.1.4. If rankU = 4 then the pair [A1, B1] is controllable.
This means, in particular, that there is a possibility of influencing the latter system
through the inputs [Sw84].
Example 5.1.5. Suppose that we administrate a substance acting on the activated
factors Xa and IIa in one unity dose and want to see how long does it take until
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an equilibrium is reached. In other words, we apply several impulses to the system
and want to know the response of the system to these impulses. Therefore, we
consider as control function the unit pulse function
δT (t) =


0 if t ≤ 0
1
T
if 0 < t < T
0 if t ≥ T ,
where T denotes the time at which an impulse is applied.
We may hypothetically be interested in increasing the maximal concentration of
thrombin in about 20 % and change the value at the equilibrium. We achieve
this by steering the system by an impulse of 0.045µmol/L of the control substance
administrated in every minute. The course of thrombin concentration as a function
of time corresponding to this situation is plotted in the following figure:
0 4 8 12 16 20 24 28 32
0.00
0.04
0.08
0.12
0.16
0.20
0.24
Original
Steered
Figure 5.1: Comparison between the course of the concentration of thrombin as a
function of time before and after the system was influenced by a control substance
acting in the system.
The hypothetical inactivation of ATIII and α2M in one minute step and the
increase of the maximum concentration of thrombin until a maximum of 1.4µmol/L
is reached is illustrated in Figure 5.2. This effect can be achieved after steering
the system by an impulse of 0.37µmol/L of the control substance administrated
in every minute.
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Figure 5.2: Comparison between the course of the concentration of thrombin as a
function of time before and after hypothetical inactivation of ATIII and α2M .
Observability and detectability
Observability of the systems means that it is possible to reconstruct each state of
the system from the outputs [Sw84].
Theorem 5.1.6. The system (5.1.1) with output η
η = Cξl, C ∈ R
(4,5)
with C =


1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 0 1

 is completely observable.
Proof. Because the system is time-invariant, we prove that the system is com-
pletely observable by using item (i) of Theorem B.1.1.
Let V =


C
CA
CA2
CA3
CA4

 be the observability matrix.
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Since
A =


a1 0 0 0 0
−a1 a2 0 a3 0
0 0 0 0 a4
0 a5 0 a3 0
0 a6 0 a7 a8

 and C =


1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 0 1


the observability matrix has size 20 by 5.
As rankC = 4 it holds rankV ≥ 4. I. e. rankV = 4 or rankV = 5.
Since CA =


a1 0 0 0 0
−a1 a2 0 a3 0
0 0 0 0 a4
0 a6 0 a7 a8

 and a3 = −k5 < 0 then rankV = 5.
Thus, the system is observable and the assertion follows. 
Remark 5.1.7. The pair [A1, B1] with output η˜ = C˜ξ˜l, ξ˜l ∈ R
4 is also completely
observable. Thereby, we may consider C˜ = I4.
5.2 Flatness. Application to motion planning
Since the linearization of the system (4.2.1) is not completely controllable, let us
check if the system obtained from (4.1.1) after reduction by using the linear first
integrals given in (4.1.2) is flat. Furthermore, we describe briefly how flatness can
be used for solving the control problem.
For convenience, let the vector x denote the state vector. Thus, x1 = [X ]; x2 =
[Xa]; x3 = [V ]; x4 = [PL]; x5 = [II] and x6 = [IIa].
The coordinate transform yields the following system of 6 equations:
dx1
dt
= −
k1x1RV V
k2 + x1
dx2
dt
=
k1x1RV V
k2 + x1
− k3x2 − k4(x4 − x3 − 0.02)x2x4 + k5(−x4 + 0.05)
dx3
dt
= −
k6x3x6
k7 + x3
dx4
dt
= −k4(x4 − x3 − 0.02)x2x4 + k5(−x4 + 0.05)
dx5
dt
= −
k8x5(−x4 + 0.05)
k9 + x5
−
k10x5x2
k11 + y5
dx6
dt
=
k8x5(−x4 + 0.05)
k9 + x5
+
k10x5x2
k11 + x5
− k12x6 − k13x6.
(5.2.1)
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In the sequel we state the control problem and model the influence of heparin
and of an hypothetical drug D capable of influencing the activity of α2M on the
course of thrombin concentration with time. For that matter, let u ∈ R3≥0 denote
the input vector.
The parameter RV V gives the first impulse to the system and can be considered
as an input variable. So, u1 =: RV V is the first component of the vector u.
As already mentioned, heparin works as a catalyst for ATIII, which in its turn
inactivates factors Xa and IIa. The influence of ATIII on the motion of these
two factors is represented in the system (5.2.1) by the constants k3 and k13, re-
spectively. So, let u2 represent the action of heparin.
In the model (5.2.1), thrombin is also inhibited by α2M and the inhibitory activity
is represented by the constant k12. As a matter of fact, we discussed already in
Chapter 3 how changes in the value of this constant are reflected in the course
of thrombin concentration with time. Therefore, let the third component of u be
denoted as u3 and represent the action of an hypothetical drug D.
We obtain the following control system:
dx1
dt
= −
k1x1u1
k2 + x1
dx2
dt
=
k1x1u1
k2 + x1
− k3(1 + u2)x2 − k4(x4 − x3 − 0.02)x2x4 + k5(−x4 + 0.05)
dx3
dt
= −
k6x3x6
k7 + x3
dx4
dt
= −k4(x4 − x3 − 0.02)x2x4 + k5(−x4 + 0.05)
dx5
dt
= −
k8x5(−x4 + 0.05)
k9 + x5
−
k10x5x2
k11 + y5
dx6
dt
=
k8x5(−x4 + 0.05)
k9 + x5
+
k10x5x2
k11 + x5
− k12(1 + u3)x6 − k13(1 + u2)x6
dx7
dt
= u1
dx8
dt
= u2
dx9
dt
= u3.
(5.2.2)
This system is of the form (B.3.1) with dimx = 9, and dimu = 3.
Proposition 5.2.1. The system (5.2.2) is flat and y = (x1, k3(1 + u2)x2, x4) is a
flat output.
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Proof. Consider the parametrization:
y1 = x1 = ϕ1(x1);
y2 = k3(1 + u2)x2 = ϕ2(x1, x2, x3, x4, u2);
y3 = x4 = ϕ3(x2, x3, x4).
(5.2.3)
Thus, the variables yi, i = 1, 2, 3 can be expressed as a function ϕi, i = 1, 2, 3 of
the state vector and of the input vector and item (i) of Definition B.3.1 is fulfilled.
The state and the input variables can also be expressed as a function of yi, i =
1, 2, 3 and a finite number of its time derivatives as follows:
x1 = y1
x2 =
y2
k3(1 + u2)
x4 = y3.
Substituting the parametrization (5.2.3) in the fourth equation of the system
(5.2.2) we obtain:
−k4(y˙3 − x3 − 0.02)
y2y3
k3(1 + u2)
+ k5(−y3 + 0.05) = y˙3 ⇔
−k4(y˙3 − x3 − 0.02)y2y3 + k5k3(1 + u2)(−y3 + 0.05)− y˙3k3(1 + u2) = 0.
Solving for x3 and considering y2 6= 0 and y3 6= 0 we obtain furthermore
x3 =
1
k4y2y3
[k4(y˙3 − 0.02)y2y3 − k5k3(1 + u2)(−y3 + 0.05) + k5k3(1 + u2)y˙3] .
From the third equation of (5.2.2) we obtain for x6 the following representation
as a function of y3 and of y˙3
x6 = −
(k7 + y3)y˙3
k6y3
, with y3 6= 0.
We still need to prove that the state variable x5 such a representation also exists.
From equation five of the system (5.2.2) we have
x˙5 = −
k8x5(−x4 + 0.05)
k9 + x5
−
k10x5x2
k11 + y5
.
On the other hand, by equation number six it holds
x˙5 = −x˙6 − k12(1 + u3)x6 − k13(1 + u2)x6.
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Using again the parametrization (5.2.3) and equating the right hand-side of these
two last equations we obtain
ξ1(y,u)(k9 + x5)(k11 + x5) = ξ2(y,u)(k11 + x5)x5 − ξ3(y,u)(k9 + x5)x5 ⇔
ξ1(k9k11 + (k9 + k11)x5 + x
2
5)− (k11ξ2 − k9ξ3)x5 − (ξ2 − ξ3)x
2
5 = 0 ⇔
(ξ1 − ξ2 + ξ3)x
2
5 + (ξ1(k9 + k11)− k11ξ2 + k9ξ3)x5 + ξ1k9k11 = 0,
where,
ξ1(y,u) = ξ1 = (−x˙6 − k12(1 + u3)x6 − k13(1 + u2)x6)k3(1 + u2);
ξ2(y,u) = ξ2 = −k8(−y3 + 0.05)k3(1 + u2);
ξ3(y,u) = ξ3 = k10y2.
By solving the second degree equation and taking into account that x5 > 0 and
x˙5 < 0 we obtain x5 as a function of y and a finite number of its time derivatives,
as well as a function of u.
Moreover, there is a function ψ such that u = ψ(y, y˙, y¨) as
u1 = −
x˙1(k2 + x1)
k1x1
= −
y˙1(k2 + y1)
k1y1
, with y1 6= 0.
u2 =
−x˙1 − x˙2 + x˙4 − k3x2
k3x2
=
−y˙1 − y˙2 + y˙3 − k3y2
k3y2
, with y2 6= 0 and
u3 =
−x˙5 − x˙6 − k13(1 + u2)x6 − k12x6
k12x6
= ζ(y, y˙, y¨), with y3 6= 0.
Thus, item (ii) of Definition B.3.1 is satisfied. Moreover, by Remark B.3.2 and since
dimu = dimy, it follows immediately that item (iii) also holds and therefore the
system is flat with flat output y. 
Remark 5.2.2. In the proof of Proposition 5.2.1, we assume the flat output to
be everywhere nonsingular, so that we could invert it and express x and u as a
function ϕ of y and its derivatives,
(y, y˙, . . . ,y(q)) 7→ (x,u) = ϕ(y, y˙, . . . ,y(q)).
However, it can happen that a singularity is an interesting point of operation
while motion planning. Since, ϕ is not defined at such a point and the previous
calculation does not apply. To overcome the problem one can for instance ”blow
up” the singularity by considering trajectories t→ y(t) such that
t→ ϕ(y(t), y˙(t), . . . ,y(q)(t))
can be extended into a smooth mapping at points where ϕ is not defined, which
requires a detailed study of the singularity. The development of a general statement
regarding motion planning with singularities is not in the scope of this work. For
a more substantial application see [FLMR95].
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Application to motion planning
Let us consider the problem of steering from an initial state x(τ0) = x0 to a final
state x(τf ) = xf . We parametrize the components of the flat output yi, i = 1, 2, 3
by
yi(t) :=
N∑
j
Aijλj(t),
where the λj(t), j = 1, . . . , N are basis functions. This reduces the problem from
finding a function in an infinite dimensional space to finding a finite set of pa-
rameters. The values of the flat output and its derivatives from the desired points
in state space and then solve for the coefficients Aij in the following system of
equations:
yi(τ0) =
∑
j Aijλj(τ0) yi(τf ) =
∑
j Aijλj(τf )
...
...
y
(q)
i (τ0) =
∑
j Aijλ
(q)
j (τ0) y
(q)
i (τf ) =
∑
j Aijλ
(q)
j (τf ).
This approach is merely algebraic in theory and yields efficient computationally
algorithms in practice. Moreover, the number of states that are needed to know in
order to find a reasonable state space representation can be considerably reduced
in comparison to traditional approaches to trajectory generation, such as optimal
control. This is a very relevant aspect for systems like the blood coagulation mech-
anism where it is not easy to obtain experimental data for all the states of the
system.
Chapter 6
Modelling Blood Thrombin
Generation
In this chapter we first rewrite the equations for the reaction scheme given in Figure
3.7 concerning the extrinsic pathway model published in [JoMa94] by using the
Michaelis-Menten kinetics. This approach takes into consideration that we are in
the presence of enzymatic reactions with positive and negative feedback loops. The
constants that are not given directly in Jones and Mann’s paper are deduced from
the empirical research of Leipold et al. [LBRD95] that includes the reaction scheme
in [JoMa94]. Moreover, we study the influence of changing the concentrations of the
complex TFV IIa and of factor V III in the new model. The qualitative analysis
and model reduction followed the same pattern as in Chapter 4. Based on this
new approach to modelling the extrinsic pathway we propose furthermore a new
model for the intrinsic pathway leading to the formation of thrombin. The intrinsic
pathway will start with the activation of factor XII and for the simulation we use
for the reaction constants a value 20% inferior to the ones published in [JoMa94],
since the intrinsic pathway for thrombin formation is slower in comparison to the
extrinsic. As a motivation for considering a model only for the intrinsic pathway we
give the following clinical situation. A patient is subjected to a valve replacement.
These valves are usually artificial and the material used may trigger the intrinsic
coagulation process. Such a kind of patients must take anticoagulatory medication
for the rest of their lives.
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6.1 Building the model for the extrinsic pathway
In Chapter 3 we described and made the stoichometric analysis of the model devel-
oped by Mann and Jones published in [JoMa94]. Due to inconsistent information,
we derived the set of differential equations governing the system of reactions by
using the law of mass action. Thereby, the primary intention was to correct the
given system following the same principle as the authors did. Like this, we ob-
tained a set of differential equations that differ from the original one only in a few
aspects with the advantage that it remains positive for positive initial values. The
numerical solution was in all similar to the one in [JoMa94] so that the occurrence
in this paper of several typographic mistakes cannot be excluded. In this section
we focus on the reaction scheme itself and question whether the law of mass action
is adequate since, after all, the blood coagulation cascade is a series of enzymatic
reactions. As we have seen in Chapter 2, under certain circumstances, this kind of
reactions are well described by the Michaelis-Menten equation.
By applying the concepts exposed in Chapter 2 we identify each factor in its
inactive form as the substract and we are interested in showing the role of the
enzyme as an input to the transformation of this substract into product, i. e., the
activated form of the coagulation factor. The product has catalytic properties,
therefore it will play the role of the enzyme in some subsequent reaction. The
constants ki, i = 1, ..., 19 keep the same meaning as in [JoMa94] but sometimes it
will be necessary to introduce some other constants.
Reaction scheme 1 and respective contribution to rates of change
IX + TF.V IIa IX.TF.V IIa TF.V IIa + IXa
k6
k16
k11
d[IX ]
dt
= −
k11[IX ][TFV IIa]
kmIX + [IX ]
;
d[IXa]
dt
= −
d[IX ]
dt
, (6.1.1)
where kmIX =
k11 + k16
k6
.
Substituting the values of the constants published in [JoMa94] after converting
the units, we get kmIX = 0.253 µmol/L.
Reaction scheme 2 and respective contribution to rates of change
X + TF.V IIa XTF.V IIa TF.V IIa +Xa
k6
k17
k12
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d[X ]
dt
= −
k12[X ][TFV IIa]
kmX + [X ]
;
d[Xa]
dt
= −
d[X ]
dt
, (6.1.2)
where kmX =
k12 + k17
k6
.
Substituting the values of the constants published in [JoMa94] after converting
units, we get kmX = 4.515 µmol/L.
Reaction scheme 3 and respective contribution to rates of change
X + V IIIa.IXa X.V IIIa.IXa V IIIa.IXa +Xa
k6
k18
k13
d[X ]
dt
= −
k13[X ][V IIIaIXa]
km10 + [X ]
;
d[Xa]
dt
= −
d[X ]
dt
, (6.1.3)
where km10 =
k13 + k18
k6
.
Substituting the values of the constants published in [JoMa94] after converting
units, we get km10 = 0.8201 µmol/L.
Reaction scheme 4 and respective contribution to rates of change
IX +Xa Xa + IXa
k15
This reaction scheme can be interpreted in several ways, depending on the reaction
constants and on the concentration of the different factors involved.
If this reaction scheme represents a catalytic reaction it should have been written
as:
IX +Xa IX.Xa IXa +Xa
c1
c2
c3
The change in time of the concentration of factor IX can then be given by the
Michaelis-Menten relation. Thus,
d[IX ]
dt
= −
c3[IX ][Xa]
km9 + [IX ]
;
d[IXa]
dt
= −
d[IX ]
dt
, (6.1.4)
where km9 =
c3 + c2
c1
.
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As we have seen in Chapter 2, the expression (6.1.4) may be replaced by closely
related expressions.
If km9 ≫ [IX ] or if km9 ≪ [IX ] then it transforms, without loss of accuracy,
respectively into the alternatives
d[IX ]
dt
= −
c3[IX ][Xa]
km9
;
d[IXa]
dt
= −
d[IX ]
dt
(6.1.5)
or
d[IX ]
dt
= −c3[Xa];
d[IXa]
dt
= −
d[IX ]
dt
. (6.1.6)
A third possibility follows when we are in the presence of a first order reaction.
The reaction scheme should then be replaced by
IX IXa
kXa
and
d[IX ]
dt
= −kXa [IX ];
d[IXa]
dt
= −
d[IX ]
dt
. (6.1.7)
Notice that (6.1.5) is the same as to assume that a second order reaction occurs.
This means, in particular, that one could directly use the law of mass action as
Mann and Jones did.
It is furthermore noteworthy that the activation of factor IX by factor Xa is not
considered in the paper [LBRD95] written by Leipold, Bozarth, Racanelli, and
Dicker of the same laboratory as Mann and Jones, which is prior to [JoMa94].
Moreover, this reaction is also not included in the reaction scheme published in
[HJEM02], an article where both Mann and Jones are also two of the authors.
So, it seems that there is some controversy regarding the existence or not of this
reaction. For our purpose, we first assume that it exists and then observe what are
the consequences of changing the value of the constant in the course of thrombin
concentration with time. From the value of the constant kXa := k15 in [JoMa94]
and from [KKK01], we estimated km9 = 2 µmol/L and c3 = 0.2s
−1.
Reaction scheme 5 and respective contribution to rates of change
V +Xa Xa + Va V a.Xa
k1
k8
k10
We split this reaction scheme into two and set the governing differential equations
as follows.
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1-
V +Xa V.Xa Va +Xa
c4
c5
c6
d[V ]
dt
= −
c6[V ][Xa]
kmV + [V ]
;
d[Va]
dt
= −
d[V ]
dt
, (6.1.8)
where kmV =
c6 + c5
c4
and c4 = k1. Then,
if kmV ≫ [V ] or if kmV ≪ [V ] we have respectively
d[V ]
dt
= −
c6[V ][Xa]
kmV
;
d[Va]
dt
= −
d[V ]
dt
(6.1.9)
or
d[V ]
dt
= −c6[Xa];
d[Va]
dt
= −
d[V ]
dt
. (6.1.10)
The third possibility reads
d[V ]
dt
= −k1[V ];
d[Va]
dt
= −
d[V ]
dt
. (6.1.11)
2-
Va +Xa Va.Xa
k8
k10
d[Va]
dt
= −k8[Xa][Va] + k10[VaXa]
d[Xa]
dt
= −k8[Xa][Va] + k10[VaXa]
d[VaXa]
dt
= k8[Xa][Va]− k10[VaXa].
(6.1.12)
In [LBRD95] one reads c4 = 100 µmol/L; c5 = 1s
−1 and c6 = 0.043s
−1. Thus,
kmV = 0.0143 µmol/L. Since kmV is about
1
3 [V ] one replace (6.1.8) by (6.1.9)
without losing accuracy.
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Reaction scheme 6 and respective contribution to rates of change
V III +Xa Xa + V IIIa
k3
Following the same argument as for the reaction scheme number four, we have:
V III +Xa V III.Xa V IIIa +Xa
c7
c8
c9
in the case of a catalytic reaction. Thus,
d[V III]
dt
= −
c9[V III][Xa]
kmV III + [V III]
;
d[V IIIa]
dt
= −
d[V III]
dt
, (6.1.13)
where kmV III =
c9 + c8
c7
and c7 = k3.
If kmV III ≫ [V III] or if kmV III ≪ [V III] then respectively we have
d[V III]
dt
= −
c9[V III][Xa]
kmV III
;
d[V IIIa]
dt
= −
d[V III]
dt
(6.1.14)
or
d[V III]
dt
= −c9[Xa];
d[V IIIa]
dt
= −
d[V III]
dt
. (6.1.15)
The third possibility reads
d[V III]
dt
= −k3[V III];
d[V IIIa]
dt
= −
d[V III]
dt
. (6.1.16)
In [LBRD95] one reads c7 = 100 µmol/L; c8 = 2.1s
−1 and c9 = 0.023s
−1. Thus,
kmV III = 0.02123 µmol/L. Since kmV III ≫ [V III] one could replace (6.1.13) by
(6.1.14) without losing accuracy.
Reaction scheme 7 and respective contribution to rates of change
V + IIa IIa + Va
k2
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Following the same argument as before we have
V + IIa V.IIa Va + IIa
c10
c11
c12
in the case of a catalytic reaction. Thus,
d[V ]
dt
= −
c12[V ][IIa]
km5 + [V ]
;
d[Va]
dt
= −
d[V ]
dt
, (6.1.17)
where km5 =
c12 + c11
c10
and c10 = k2.
If km5 ≫ [V ] or if km5 ≪ [V ] then respectively we have
d[V ]
dt
= −
c12[V ][IIa]
km5
;
d[Va]
dt
= −
d[V ]
dt
(6.1.18)
or
d[V ]
dt
= −c12[IIa];
d[Va]
dt
= −
d[V ]
dt
. (6.1.19)
The third possibility reads
d[V ]
dt
= −k2[V ];
d[Va]
dt
= −
d[V ]
dt
. (6.1.20)
In [LBRD95] one reads c10 = 100 µmol/L; c11 = 1s
−1 and c12 = 0.043s
−1. Thus,
km5 = 0.0746 µmol/L. Since km5 is about 3.7[V ] one could possibly replace
(6.1.17) by (6.1.18). Convergence problems arise while solving the system numer-
ically, though. Therefore, for the set of constants and starting data available, one
may discard this possibility from now on.
Reaction scheme 8 and respective contribution to rates of change
V III + IIa IIa + V IIIa
k4
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In case of a catalytic reaction, we have
V III + IIa V III.IIa V IIIa + IIa
c13
c14
c15
Thus,
d[V III]
dt
= −
c15[V III][IIa]
km8 + [V III]
;
d[V IIIa]
dt
= −
d[V III]
dt
, (6.1.21)
where km8 =
c15 + c14
c13
and c13 = k4.
If km8 ≫ [V III] or if km8 ≪ [V III] then respectively we have
d[V III]
dt
= −
c13[V III][IIa]
km8
;
d[V IIIa]
dt
= −
d[V III]
dt
(6.1.22)
or
d[V III]
dt
= −k4[IIa];
d[V IIIa]
dt
= −
d[V III]
dt
. (6.1.23)
The third possibility reads
d[V III]
dt
= −
c15[V III]
km8
;
d[V IIIa]
dt
= −
d[V III]
dt
. (6.1.24)
In [LBRD95] one reads c13 = 100 µmol/L; c14 = 15s
−1 and c15 = 0.9s
−1. Thus,
km8 = 0.0143 µmol/L. Since km8 ≫ [V III] one can replace (6.1.21) by (6.1.22)
without losing accuracy.
Reaction scheme 9 and respective contribution to rates of change
II + Va.Xa II.Va.Xa Va.Xa +mIIa Va.Xa + IIa
k6
k19
k14 k5
Once again we split the reaction scheme into two.
1-
II + VaXa II.VaXa VaXa +mIIa
k6
k19
k14
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This is a typical reaction to apply Michaelis and Menten equation. Hence,
d[II]
dt
= −
k14[II][VaXa]
kmII + [II]
;
d[mIIa]
dt
= −
d[II]
dt
, (6.1.25)
where kmII =
k14 + k19
k6
.
Substituting the values of the constants published in [JoMa94] after converting
units, we get kmII = 1.06 µmol/L.
2-
mIIa + VaXa VaXa + IIa
k5
We were already confronted with this kind of reaction. So, if we are in the presence
of a catalytic reaction, the reaction scheme should be
mIIa + VaXa mIIa.VaXa VaXa + IIa
c16
c17
c18
Thus, the Michaelis and Menten equation is used to establish the equations of
motion
d[mIIa]
dt
= −
c18[mIIa][VaXa]
kmmIIa + [mIIa]
;
d[IIa]
dt
= −
d[mIIa]
dt
, (6.1.26)
where kmmIIa =
c18 + c17
c16
, with c16 = k5.
If kmmIIa ≫ [mIIa] or if kmmIIa ≪ [mIIa] then respectively we have
d[mIIa]
dt
= −
c18[mIIa][VaXa]
kmmIIa
;
d[IIa]
dt
= −
d[mIIa]
dt
(6.1.27)
or
d[mIIa]
dt
= −c18[VaXa];
d[IIa]
dt
= −
d[mIIa]
dt
. (6.1.28)
The third possibility reads
d[mIIa]
dt
= −k5[mIIa];
d[IIa]
dt
= −
d[mIIa]
dt
. (6.1.29)
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In [LBRD95] one reads c16 = 100 µmol/L; c17 = 15s
−1 and c18 = 0.9s
−1. Thus,
kmmIIa = 0.81 µmol/L. The relation (6.1.27) could possibly replace the relation
(6.1.26), but only at the beginning of the reaction where [mIIa] = 0.
Reaction scheme 10 and respective contribution to rates of change
Reaction scheme and differential equations equal to (3.2.13).
In [LBRD95] it is assumed moreover that factor V IIIa can be inactivated by
factor IXa. Since this may influence the final equilibrium state of the complex
V IIIaIXa we consider in addition for our model the following reaction scheme:
Reaction scheme 11 and respective contribution to rates of change
V IIIa + IXa V IIIaIXa V III
∗
a + IXa
c19
c20
c21
d[V IIIa]
dt
= −
c21[V IIIa][IXa]
kmV IIIa + [V IIIa]
;
d[V III∗a ]
dt
= −
d[V IIIa]
dt
,
(6.1.30)
where kmV IIIa =
c21 + c20
c19
.
If kmV IIIa ≫ [V IIIa] or if kmV IIIa ≪ [V IIIa] then respectively we have
d[V IIIa]
dt
= −
c21[V IIIa][IXa]
kmV IIIa
;
d[V III∗a ]
dt
= −
d[V IIIa]
dt
(6.1.31)
or
d[V IIIa]
dt
= −c21[IXa];
d[V III∗a ]
dt
= −
d[V IIIa]
dt
. (6.1.32)
The third possibility reads
d[V IIIa]
dt
= −kiV IIIa [V IIIa];
d[V III∗a ]
dt
= −
d[V IIIa]
dt
. (6.1.33)
In [LBRD95] one reads c19 = 100 µmol/L; c20 = 0.17s
−1 and c21 = 0.00008s
−1.
Thus, kmV IIIa = 0.0017 µmol/L.
Altogether, this leads to a large number of candidate models, specially because the
considerations made while setting the differential equations for reaction scheme 4
are theoretically valid each time we make use of the Michaelis Menten equation.
However, from all the candidates one should select that model which:
(i) meets the established knowledge in the field;
6.1. Building the model for the extrinsic pathway 127
(ii) does not contain redundant steps;
(iii) fits the phenomena observed.
In this thesis, due to the lack of experimental data, we will chose the model that
best approximates the numerical results obtained by Mann and Jones in [JoMa94].
Thus, to decide which mathematical description is more adequate, we need to make
use of the values of the constants ki, i = 1, . . . , 19, listed in Table 3.2, and of the
constants calculated above based on the published articles from [JoMa94] and
[LBRD95].
While testing several combinations of possible reaction schemes and respective
mathematical description, we concluded after adjusting the values of some con-
stants that a another mathematical approach describing the extrinsic pathway
is given if we consider the following reaction scheme and the following set of 14
differential equations:
IX + TF.V IIa IX.TF.V IIa TF.V IIa + IXa
k6
k16
k11
X + TF.V IIa XTF.V IIa TF.V IIa +Xa
k6
k17
k12
X + V IIIa.IXa X.V IIIa.IXa V IIIa.IXa +Xa
k6
k18
k13
IX IXa
kXa
V +Xa V.Xa Va +Xa
c4
c5
c6
Va +Xa Va.Xa
k8
k10
128 Chapter 6. Modelling Blood Thrombin Generation
V III +Xa V III.Xa V IIIa +Xa
c7
c8
c9
V + IIa V.IIa Va + IIa
c10
c11
c12
V III + IIa V III.IIa V IIIa + IIa
c13
c14
c15
II + VaXa II.VaXa VaXa +mIIa
k6
k19
k14
mIIa + VaXa mIIa.VaXa VaXa + IIa
c16
c17
c18
V IIIa + IXa V IIIa.IXa
k7
k9
V IIIa V III
∗
a
kiV IIIa
d[IX ]
dt
= −
k11[IX ][TFV IIa]
kmIX + [IX ]
− k15[IX ] !
d[IXa]
dt
=
k11[IX ][TFV IIa]
kmIX + [IX ]
+ k15[IX ]− k7[V IIIa][IXa] + k9[V IIIaIXa]!
d[X ]
dt
= −
k12[X ][TFV IIa]
kmX + [X ]
−
k13[X ][V IIIaIXa]
km10 + [X ]
d[Xa]
dt
=
k12[X ][TFV IIa]
kmX + [X ]
+
k13[X ][V IIIaIXa]
km10 + [X ]
− k8[Va][Xa] + k10[VaXa]
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d[V ]
dt
= −
c6[V ][Xa]
kmV
−
c12[V ][IIa]
km5 + [V ]
!
d[Va]
dt
=
c6[V ][Xa]
kmV
+
c12[V ][IIa]
km5 + [V ]
− k8[Va][Xa] + k10[VaXa] !
d[VaXa]
dt
= k8[Va][Xa]− k10[VaXa]
d[V III]
dt
= −
c9
kmV III
[V III][Xa]−
c15
km8
[V III][IIa] !
d[V IIIa]
dt
=
c9
kmV III
[V III][Xa] +
c15
km8
[V III][IIa] !
−k7[V IIIa][IXa] + k9[V IIIaIXa]− kiV IIIa [V IIIa]
d[II]
dt
= −
k14[II][VaXa]
kmII + [II]
d[IIa]
dt
=
c18[mIIa][VaXa]
kmmIIa + [mIIa]
d[mIIa]
dt
=
k14[II][VaXa]
kmII + [II]
−
c18[mIIa][VaXa]
kmmIIa + [mIIa]
d[V IIIaIXa]
dt
= k7[V IIIa][IXa]− k9[V IIIaIXa]
d[V III∗a ]
dt
= kiV IIIa [V IIIa] !
(6.1.34)
The symbol ! at the end of the equation means that at least one term was simplified
from the Michaelis and Menten equation taking into account the discussion above.
6.1.1 Numerical integration
The values of the constants used for the numerical integration are listed in Ta-
ble 6.1. The values of some constants were adjusted in order to obtain a better
agreement between the solutions of the two models, in particular regarding the
course of the concentration of activated thrombin with time (see Figure 6.1). This
adjustment was done within a range of possible values that can be justified by the
many varied conditions under which the empirical rates are derived and such that
the assumptions made above while constructing the model remain valid. Never-
theless, with the original values of the constants we would get a curve exactly with
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the same qualitative behavior that would fit the experimental data presented in
[JoMa94] with approximately the same error.
Constant Value [µM−1s−1] Constant Value [s−1]
kmIX 0.253 c3 0.2
km9 2 c6 0.043
kmX 4.515 c9 0.023
km10 2.8901 c12 0.26
kmV 1.43× 10
−3 c15 0.9
km5 0.0746 c18 15
kmV III 0.02123
km8 2.159
kmII 0.9
kmmIIa 1.06
kiV IIIa 0.8
Table 6.1: Rate constants used for the numerical integration of (6.1.34).
Based on the results from [LBRD95], we put [TFV IIa] = 0.000048µmol/L as
starting input and considered the following vector of initial values corresponding
to the physiologic concentrations in µmol/L of the coagulation factors involved.
Once again, the initial value of the activated factors was taken equal to zero:
[0.09; 0; 0.20; 0; 0.02; 0; 0; 0.0007; 0; 1.4; 0; 0; 0; 0]T.
In Figure 6.1, we represent the first 4 minutes of the course of activated thrombin
with time given by (6.1.34) versus the model by Mann and Jones given in [JoMa94],
corrected in Section 3.2.2 and reduced to 12 equations in one of the subsections of
Section 4.3.
The remaining solutions behave in the same manner as before excepting the one
corresponding to the complex V IIIaIXa. In fact, contrary to the original model
from Mann and Jones, there is a decay in the course of the concentration of the
complex V IIIaIXa with time after some maximal concentration was reached (see
Figure 6.2). This result make us believe that the reaction of reaction scheme 11
above was missing in [JoMa94] and this may actually be the reason why there was
a contradiction between the estimated curve and the experimental data.
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Figure 6.1: First 4 minutes of thrombin formation.
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Figure 6.2: Decay of complex V IIIaIXa after (6.1.34).
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In [JoMa94], the validation of the model proposed was done by comparing the
model response to experimental results. Despite of the importance of this con-
frontation it would be out of the scope of this thesis to write down and discuss
with our model all the aspects covered by Mann and Jones. However, some atten-
tion will be devoted in the sequel to two of them, namely the influence of changing
the concentration of the complex TFV IIa and the effect of factor V III on the
reaction progress.
6.1.2 Influence of changing complex TFV IIa concentration
Mann and Jones reported that changing the concentration of TFV IIa has only
minimal effects on the maximal rate of thrombin formation during the propagation
phase of the reaction, while having the greatest influence on the initiation phase.
As a consequence, the major effect observed was the propagation of the lag or
initiation phase with decreasing values of the complex concentration. This effect
can be observed also in the solution given by our model (see Figure 6.3).
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Figure 6.3: Course of thrombin formation for different TFV IIa concentrations.
6.1.3 The effect of changing factor V III concentration
It is known from the literature (see [Lin95]) that factor V III plays a critical role
in the initiation of the coagulation and that in absence of factor V III, the ac-
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tivated partial thromboplastin time (APT1) is extended. However, factor V III
deficiency does not extend the prothrombin-time (PT2). The simulation of throm-
bin formation was modelled using the same rate constants and setting the initial
concentration of factor V III to zero. When lower concentrations of TFV IIa are
used in experiments without factor V III, the propagation phase is depressed.
By contrast, at high concentrations of TFV IIa, omitting factor V III from the
reaction mixture has a minimal effect on the time course or form of the throm-
bin generation curve. This means that the complex TFV IIa form the threshold
levels of factor Xa required to achieve explosive prothrombin activation without
the need of the complex V IIIaIXa. Our model can reproduce this happening
and, as an example, the next figure illustrates the course of thrombin generation
at [TFV IIa] = 0.000048µmol/L in normal blood and in hemophilic blood with
factor V III deficiency during the first 4 minutes. Time is given in seconds.
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Figure 6.4: Course of thrombin formation: normal blood versus hemophilic blood.
1Laboratory test specially sensitive to levels of factors V III and IX below 25%
2Test of the coagulation system sensitive to deficiencies of factors V II,X, V, and II
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In the next section we proceed with the qualitative analysis of (6.1.34). We will
see furthermore that the order of the system can still be reduced because of the
existence of first integrals.
6.1.4 Qualitative analysis
Positivity
Let us start as usual by rewriting the system (6.1.34) of ordinary differential
equations in vector form:
x = f(x),
where the components of x are given by x1 = [IX ], x2 = [IXa], x3 = [X ], x4 =
[Xa], x5 = [V ], x6 = [Va], x7 = [VaXa], x8 = [V III], x9 = [V IIIa], x10 =
[II], x11 = [IIa], x12 = [mIIa], x13 = [V IIIaIXa] and x14 = [V III
∗
a ].
The system (6.1.34) can now be written as
dx1
dt
= −
k11x1[TFV IIa]
kmIX + x1
− k15x1
dx2
dt
=
k11x1[TFV IIa]
kmIX + x1
+ k15x1 − k7x9x2 + k9x13
dx3
dt
= −
k12x3[TFV IIa]
kmX + x3
−
k13x3x13
km10 + x3
dx4
dt
=
k12x3[TFV IIa]
kmX + x3
+
k13x3x13
km10 + x3
− k8x6x4 + k10x7
dx5
dt
= −
c6x5x4
kmV
−
c12x5x11
km5 + x5
dx6
dt
=
c6x5x4
kmV
+
c12x5x11
km5 + x5
− k8x6x4 + k10x7
dx7
dt
= k8x6x4 − k10x7
dx8
dt
= −
c9
kmV III
x8x4 −
c15
km8
x8x11
dx9
dt
=
c9
kmV III
x8x4 +
c15
km8
x8x11 − k7x9x2 + k9x13 − kiV IIIax9
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dx10
dt
= −
k14x10x7
kmII + x10
dx11
dt
=
c18x12x7
kmmIIa + x12
dx12
dt
=
k14x10x7
kmII + x10
−
c18x12x7
kmmIIa + x12
dx13
dt
= k7x9x2 − k9x13
dx14
dt
= kiV IIIax9.
(6.1.35)
Let furthermore
P = {x ∈ R14 : x1 > 0, . . . , x14 > 0}
be the positive orthant of R14.
Proposition 6.1.1. P and P are positively invariant for the system (6.1.35).
Proof. Similarly as before, the vector x represents a vector of concentrations, and
this means that xi ≥ 0, i = 1, . . . , 14. Then, the system is defined in a relative
open subset of P with f(x) = (f1(x), . . . , f14(x))
T , where the function f is C∞
and the components fi, i = 1, . . . , 14 are defined by the right-hand side of (6.1.35).
For x ∈ ∂P , define Cx = P . Setting furthermore xk = 0 in fk, k = 1, . . . , 14 yields
fi(x1, . . . , xk−1, 0, xk+1, . . . , x14) ≥ 0 for all xj ≥ 0, j 6= k and i = 1, . . . , 14.
Therefore, f(x) ∈ P, for all x ∈ ∂P . Hence, P and P are positively invariant for
the system (6.1.35). 
As a consequence of the last proposition, any orbit starting with positive initial
values will remain positive for all times.
Linear first integrals and boundedness of the solutions
Proposition 6.1.2. Given any solution of (6.1.35) with nonnegative initial values,
all the components xi(t), i = 1, . . . , 14 are bounded.
Proof. In this case, since all variables are involved, it is sufficient to prove that
the scalar valued functions defined on R14 by
ϕ1(x) = x1 + x2 + x13;
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ϕ2(x) = x3 + x4 + x7;
ϕ3(x) = x5 + x6 + x7;
ϕ4(x) = x8 + x9 + x13 + x14;
ϕ5(x) = x10 + x11 + x12
are first integrals of the system (6.1.35).
Indeed by applying again Definition A.1.4:
Lf (ϕ1)(x) = Dx(ϕ1)f(x) = (1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0)


f1(x)
...
f14(x)


= f1(x) + f2(x) + f13(x) = 0.
Lf (ϕ2)(x) = Dx(ϕ2)f(x) = (0, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0)


f1(x)
...
f14(x)


= f3(x) + f4(x) + f7(x) = 0.
Lf (ϕ3)(x) = Dx(ϕ3)f(x) = (0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0)


f1(x)
...
f14(x)


= f5(x) + f6(x) + f7(x) = 0.
Lf (ϕ4)(x) = Dx(ϕ4)f(x) = (0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1)


f1(x)
...
f14(x)


= f8(x) + f9(x) + f13(x) + f14(x) = 0.
Lf (ϕ5)(x) = Dx(ϕ5)f(x) = (0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0)


f1(x)
...
f14(x)


= f10(x) + f11(x) + f12(x) = 0.
By directly applying Proposition 6.1.1 and Remark A.1.5, we conclude that the
solutions of the system (6.1.35) remain in the level set of ϕj , j = 1, . . . , 5 in which
they start. Hence, ϕj(xi(t)), j = 1, . . . , 5 are constant functions of t for all solutions
and therefore bounded. Thus, the components xi(t), i = 1, . . . , 14 are bounded. 
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Convergence to a stationary point
The next proposition gives us more conditions that define the set containing the
positive limit set ω(y) of the system (6.1.35). However, since the proof follows
exactly the same pattern as the proof of Proposition 4.3.5 it is immediate and
there is no need to repeat it here.
Proposition 6.1.3. Let ϕ6(x) = x1, ϕ7(x) = x3, ϕ8(x) = x5, ϕ9(x) = x8, and
ϕ10(x) = −x9 be scalar functions defined on R
14. Then Lf (ϕi)(x) ≤ 0, i =
6, . . . , 10. Equality follows only if x1 = x3 = x5 = x8 = x9 = 0.
Remark 6.1.4. Together with Proposition 6.1.1, we conclude that the functions ϕj
are non increasing and bounded for j = 6, . . . , 10 along a trajectory. That is, there
are constants βj such that 0 ≤ ϕj(x) ≤ βj , j = 6, . . . , 10. Hence every trajectory
remains in the subset of P defined by ϕj(x) ≤ βj , which is bounded.
Proposition 6.1.5. The positive limit set ω(y) of (6.1.35) is contained in the set
N := {x ∈ P : x1+x2+x13 = x1(0), x3+x4+x7+ = x3(0), x5+x6+x7 = x5(0),
x8 + x9 + x13 + x14 = x8(0), x10 + x11 + x12 = x10(0), x1 = 0, x3 = 0,
x5 = 0, x8 = 0, x9 = 0}.
Proof. The two previous results together with Theorem A.3.11 imply that the
compact sets Mα := {x ∈ P : ϕj(x) ≤ α, j = 1, . . . , 10} are positively invariant
for all α ∈ [0, βj). Theorem A.3.15 guarantees that the solution of the initial value
problem exists on [0,∞). Moreover, this solution approaches its positive limit set
ω(y), as t → ∞. So, ω(y) is nonempty, compact and connected. By Theorem
A.3.16 ω(y) is also invariant.
Hence, by applying LaSalle’s principle stated in Theorem A.4.1 we conclude that
ω(y) ⊂ N.

Remark 6.1.6. The conditions definingN are not enough to prove that any solution
in N is stationary. This set, like before, contains invariant sets other than the set
of stationary points.
In the sequel we derive further conditions to be satisfied by the set of equilibrium
points by setting the right-hand side of the system (6.1.35) to zero and solving for
x.
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Deriving further conditions for the set of equilibrium points
While trying to find new conditions to be satisfied by an equilibrium point, one
observes that the value of the variable x7 at the equilibrium depend on the variables
x6 and x4 and their value at the equilibrium. We get
E1 := {x ∈ P : x1 = 0, x3 = 0, x5 = 0, x7 =
k8x6x4
k10
, x8 = 0, x9 = 0, x10 = 0,
x12 = 0, x13 = 0}.
The following proposition holds:
Proposition 6.1.7. If z7 =
k8
k10
z6(t)z4(t), z10(t) = 0 and z12(t) = 0 then any
solution z(t) starting in N given in Proposition 6.1.5 is stationary.
Proof. Let z(t) be a solution in N satisfying the given conditions, i. e.
z(t) = (0, z2(t), 0, z4(t), 0, z6(t),
k8
k10
z6(t)z4(t), 0, 0, 0, z11(t), 0, z13(t), z14(t))
T .
Thus,
z˙(t) = (0, z˙2, 0, z˙4, 0, z˙6,
k8
k10
(z˙6z4 + z6z˙4), 0, 0, 0, z˙11, 0, z˙13, z˙14)
T .
Since z9 = 0 and z12 = 0 it holds z˙14 = 0 and z˙11 = 0.
On the other hand,
z13(t) + z14(t) = x8(0) ⇔ z˙13(t) + z˙14(t) = 0. This implies z13(t) = 0 and thus
z˙13 = 0 and z˙2(t) = 0.
Furthermore, x7 =
k8
k10
z6(t)z4(t) implies z˙4 = 0, z˙6 = 0 and z7 = 0.
Altogether, z˙(t) = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)T and z(t) is stationary.

For practical reasons, the stability question will be handled after reducing the
number of equations to 9.
Model reduction
Let us now reduce the number of equations of the system (6.1.35) to 9. From the
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first integrals given in Proposition 6.1.2 we eliminate the variables x3, x5, x8, x10
and x13.
Setting
x13 = −x1 − x2 + d1; x3 = −x4 − x7 + d2;
x10 = −x11 − x12 + d3; x5 = −x7 − x6 + d4;
x8 = −x9 − x13 − x14 + d5,
where d1 = x1(0); d2 = x3(0); d3 = x10(0); d4 = x5(0); d5 = x8(0) are different
from zero,
and making the following coordinate transformation:
y1 := x1; y2 := x2; y3 := x4; y4 := x6; y5 := x7; y6 := x9; y7 := x11; y8 := x12;
y9 = x14
we obtain the following system of differential equations:
dy1
dt
= −
k11y1[TFV IIa]
kmIX + y1
− k15y1
dy2
dt
=
k11y1[TFV IIa]
kmIX + y1
+ k15y1 − k7y6y2 + k9(d1 − y1 − y2)
dy3
dt
=
k12(d2 − y3 − y5)[TFV IIa]
kmX + (d2 − y3 − y5)
+
k13(d2 − y3 − y5)(d1 − y1 − y2)
km10 + (d2 − y3 − y5)
−k8y4y3 + k10y5
dy4
dt
=
c6(d4 − y4 − y5)y3
kmV
+
c12(d4 − y4 − y5)y7
km5 + (d4 − y4 − y5)
− k8y4y3 + k10y5
dy5
dt
= k8y4y3 − k10y5
dy6
dt
=
c9
kmV III
(d5 − y6 − d1 + y1 + y2 − y9)y3 − kiV IIIay6+
c15
km8
(d5 − y6 − d1 + y1 + y2 − y9)y7 − k7y6y2 + k9(d1 − y1 − y2)
dy7
dt
=
c18y8y5
kmmIIa + y8
dy8
dt
=
k14(d3 − y7 − y8)y5
kmII + (d3 − y7 − y8)
−
c18y8y5
kmmIIa + y8
dy9
dt
= kiV IIIay6.
(6.1.36)
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This system has a single equilibrium point and its coordinates can be calculated
explicitly by setting the right-hand side of (6.1.36) to zero and solving to y. There
are very complicated terms involved and surely lots of impossible solutions due to
the physiological meaning of the variables, so we are going to make use of all the
information available about the system to exclude some candidates.
From
dy1
dt
= 0 and
dy9
dt
= 0 we obtain y1 = 0 and y6 = 0. Substituting these in
the second equation we have
dy2
dt
= 0 only if y2 = d1.
The variable y3 corresponds to factor Xa, the activated form of factor X, and the
variable y4 to factor Va. Together they build the prothrombinase complex, which
here is represented by variable y5. So the value at the equilibrium will depend on
the value at the equilibrium of y4 and y3. Thus the fifth equation will be equal
zero if y5 =
k8
k10
y4y3. From the numerical results, we see that this value is different
from zero, so at equilibrium y4 > 0 and y3 > 0.
Hence,
dy7
dt
= 0⇔ y8 = 0. This implies furthermore that
dy8
dt
= 0 only if y7 = 0.
Moreover, after substituting the previous conditions in the remaining sixth, third
and fourth equations we get the conditions y9 = d5, y3+y5 = d2 and y5+y4 = d4,
respectively.
Substituting the value of y5 in the two last equations we obtain a system of two
equations on y4 and y3.
Solving for y3 we obtain following relation between y3 and y4 :
y3 =
d2 − d4
k10
+ y4.
Notice that d2 = [X ](0) and d4 = [V ](0) and d2 > d4, so y3 > 0.
The value of y4 at equilibrium is the positive solution of the following second
degree equation:
k10y
2
4 + (k
2
10 + k8(d2 − d4))y4 − k10d4 = 0.
Notice furthermore that this equation only admits real solutions.
Remark 6.1.8. Substituting the values of the constants involved we obtain for the
equilibrium point the same values like the ones that can be deduced by visual
inspection of the numerical solution.
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Remark 6.1.9. Altogether we obtained the coordinates of the unique equilibrium
point towards which the system (6.1.36) converges. Thus, by applying Theorem
A.4.1 follows asymptotic stability of the equilibrium point of this system.
In comparison with the original model from Jones and Mann that was corrected
and reduced to 12 equations in Section 4.3.4, the model (6.1.36) gives the same
results, but is more compact. Nevertheless, a more realistic approach to modelling
the extrinsic pathway would take into account the action of inhibitors.
In the next section we give a first approach to modelling the intrinsic pathway for
thrombin generation based on the previous analysis.
6.2 Building the model for the intrinsic pathway
Our starting point is the model (6.1.34). As already said in Chapter 1, the two
pathways are thought to merge at the level of factor X activation. So, we consider
the same reactions until the activation of factor X and the remaining reactions
will be substituted by the reactions that are thought to occur in the intrinsic
pathway. The reaction where factor IX is activated by factor Xa will be not
considered here, because, on the one hand, it is not included in none of the articles
of the current literature at our disposal concerning the intrinsic pathway (see for
instance [Lin95]) and, on the other hand, its existence in the reaction scheme for
the extrinsic pathway is rather questionable. Nevertheless, we will refer to this
reaction later on.
It is known from the literature that thrombin formation by the extrinsic pathway is
circa 30 seconds faster than thrombin formation by the intrinsic pathway. Reducing
in 20% the values of the constants used by Mann and Jones in the paper referred
above and integrating the system using the same vector of starting values, it is
possible to gain a first visual impression and to compare the course of activated
thrombin with time in both pathways. This situation is illustrated in Figure 6.5.
We observe that thrombin formation in the extrinsic pathway starts after 30 sec-
onds while in the intrinsic it takes approximately 20 seconds longer. Moreover,
the maximum of thrombin concentration is attained at approximately 2′49′′ and
3′40′′, respectively.
Since no experimental data is available, we will compare the result of our final
simulation with these ones.
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Figure 6.5: Course of activated thrombin with time in both pathways.
The activation of factor XII follows after contact with a foreign substance u.
Let us assume that the decay of factor XII concentration with time follows some
exponential like behavior so that factor XII will be completely activated. So, the
following reaction occurs:
XII + u XII.u u+XIIa
ku1
ku−1
kcatXII
The contribution to the rate of change will be described by:
d[XII]
dt
= −
kcatXII [XII]u
kmXII + [XII]
and
d[XIIa]
dt
= −
d[XII]
dt
.
Once activated, factor XIIa activates factor XI in a catalytic reaction, so the
following reaction occurs:
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XI +XIIa XI.XIIa XIIa +XIa
i1
i2
i3
The contribution to the rate of change is then given by:
d[XI]
dt
= −
kcatXI [XI][XIIa]
kmXI + [XI]
and
d[XIa]
dt
= −
d[XI]
dt
.
In the intrinsic pathway, factor IX is activated by factor XIa in a catalytic reac-
tion:
IX +XIa IX.XIa XIa + IXa
i4
i5
i6
The remaining reactions leading to thrombin formation are also part of the extrin-
sic pathway. Altogether we obtain the following reaction scheme for the intrinsic
pathway:
XII + u XII.u u+XIIa
ku1
ku−1
kcatXII
XI +XIIa XI.XIIa XIIa +XIa
i1
i2
i3
IX +XIa IX.XIa XIa + IXa
i4
i5
i6
X + V IIIa.IXa X.V IIIa.IXa V IIIa.IXa +Xa
k6
k18
k13
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V +Xa V.Xa Va +Xa
c4
c5
c6
Va +Xa Va.Xa
k8
k10
V III +Xa V III.Xa V IIIa +Xa
c7
c8
c9
V + IIa V.IIa Va + IIa
c10
c11
c12
V III + IIa V III.IIa V IIIa + IIa
c13
c14
c15
II + VaXa II.VaXa VaXa +mIIa
k6
k19
k14
mIIa + VaXa mIIa.VaXa VaXa + IIa
c16
c17
c18
V IIIa + IXa V IIIa.IXa
k7
k9
V IIIa V III
∗
a
kiV IIIa
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Following the same strategy as for the extrinsic pathway, we derive the correspond-
ing set of differential equations by applying the Michaelis-Menten assumption on
catalytic reactions and the law of mass action otherwise.
d[XII]
dt
= −
kcatXII [XII]u
kmXII + [XII]
d[XIIa]
dt
=
kcatXII [XII]u
kmXII + [XII]
d[XI]
dt
= −
kcatXI [XI][XIIa]
kmXI + [XI]
d[XIa]
dt
=
kcatXI [XI][XIIa]
kmXI + [XI]
d[IX ]
dt
= −
kcatIX [IX ][XIa]
kmIX + [IX ]
d[IXa]
dt
= −k7[V IIIa][IXa] + k9[V IIIaIXa]
d[X ]
dt
= −
kcat10[X ][V IIIaIXa]
km10 + [X ]
d[Xa]
dt
=
kcat10[X ][V IIIaIXa]
km10 + [X ]
− k8[Va][Xa] + k10[VaXa]
d[II]
dt
= −
kcatII [II][VaXa]
kmII + [II]
d[IIa]
dt
=
kcat2[mIIa][VaXa]
km2 + [mIIa]
d[V III]
dt
= −
kcatV III
kmV III
[V III][Xa]−
kcat8
km8
[V III][IIa]
d[V IIIa]
dt
=
kcatV III
kmV III
[V III][Xa] +
kcat8
km8
[V III][IIa]
−k7[V IIIa][IXa] + k9[V IIIaIXa]− kiV IIIa [V IIIa]
d[V IIIaIXa]
dt
= k7[V IIIa][IXa]− k9[V IIIaIXa]
d[V ]
dt
= −
kcatV [V ][Xa]
kmV
−
kcat5[V ][IIa]
km5 + [V ]
d[Va]
dt
=
kcatV [V ][Xa]
kmV
+
kcat5[V ][IIa]
km5 + [V ]
− k8[Va][Xa] + k10[VaXa]
d[VaXa]
dt
= k8[Va][Xa]− k10[VaXa]
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d[mIIa]
dt
=
kcatII [II][VaXa]
kmII + [II]
−
kcat2[mIIa][VaXa]
km2 + [mIIa]
d[V III∗a ]
dt
= kiV IIIa [V IIIa].
(6.2.1)
6.2.1 Numerical solution
Due to the lack of experimental data, for the simulation, the constants k7, k8, k9
and k10 are 20% of the corresponding value given in Table 3.2. The values of the
remaining constants are either taken or slightly adjusted from the original values
of the constants given in [KKK01] or in [JoMa94]. The adjustment was done within
the range of possible values that the constants may take and differ in the literature
due to the different circumstances under which the experiments are realized. The
constants are summarized in Table 6.2.
Constant Value [µM−1s−1] Constant Value [s−1] Reference
kmXII 0.51 kcatXII 5.7 [KKK01]
kmXI 2 kcatXI 9.5× 10
−4† [KKK01]
kmIX 4
† kcatIX 0.4167 [KKK01]
km10 0.19 kcat10 29 [KKK01]
kmII 0.848 kcatII 28.6
† [JoMa94]
km2 0.78 kcat2 12 [JoMa94]
kmV III 0.56 kcatV III 0.0184 [JoMa94]
km8 0.016 kcat8 0.72 [JoMa94]
kmV 0.001144; kcatV 0.0344 [JoMa94]
km5 0.5968 kcat5 0.208 [JoMa94]
Table 6.2: Rate constants used for the numerical integration of (6.2.1). The values
signalized with † were adjusted.
To trigger the system, we set u = 0.0058 and used the following vector of initial
concentration values:
x0 = [0.3; 0; 0.025; 0; 0.09; 0; 0.2; 0; 1.4; 0; 0.0007; 0; 0; 0.032; 0; 0; 0]
T .
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The numerical solution was again obtained using SCILAB. In the following figure,
we compare the total amount of thrombin generated by using the model for the
intrinsic pathway (6.2.1)- in the figure Intrinsic2 - to the total amount of thrombin
given by the model for the extrinsic pathway (6.1.34) and to the curve for the
course of thrombin concentration with time obtained from (6.1.34) by reducing
the value of the constants in 20% - in the figure Intrinsic1.
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Figure 6.6: Course of thrombin concentration after 4 minutes: intrinsic versus
extrinsic.
We observe that the two curves for the intrinsic pathway are rather similar and
when compared to the curve for the extrinsic pathway they provide the same
qualitative information regarding the time at which maximal concentration of
thrombin is achieved. The lag phase is approximately 12 seconds longer. The
maximum value for thrombin concentration is attained after 3′40′′.
Remark 6.2.1. As happened before for different values of [TF.V IIa], for different
values of u, we may influence the system by delaying it or by accelerating it.
Remark 6.2.2. We also simulated the course of thrombin concentration with time
including the reaction
IX IXa
kXa
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The result was that the total amount of thrombin was merely generated by the
reactions that are thought to belong to the extrinsic pathway. In other words,
setting u = 0 in this case did not had any effect on the shape of the curve for the
course of thrombin with time. Of course, we cannot exclude the possibility that
the value of the constants used has an influence on the result.
Remark 6.2.3. As already said for the extrinsic pathway, a more realistic approach
to modelling the intrinsic pathway would also include the action of inhibitors.
In the sequel we proceed with the qualitative analysis of the system (6.2.1).
6.2.2 Qualitative analysis
Positivity
Let us start as usual by rewriting the system (6.2.1) of ordinary differential equa-
tions in vector form:
x = f(x),
where the components of x are given by x1 = [XII], x2 = [XIIa], x3 =
[XI], x4 = [XIa], x5 = [IX ], x6 = [IXa], x7 = [X ], x8 = [Xa], x9 =
[II], x10 = [IIa], x11 = [V III], x12 = [V IIIa], x13 = [V IIIaIXa], x14 =
[V ], x15 = [Va], x16 = [VaXa], x17 = [mIIa] and x18 = [V III
∗].
The system (6.2.1) can now be written as
dx1
dt
= −
kcatXIIx1u
kmXII + x1
dx2
dt
=
kcatXIIx1u
kmXII + x1
dx3
dt
= −
kcatXIx3x2
kmXI + x3
dx4
dt
=
kcatXIx3x2
kmXI + x3
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dx5
dt
= −
kcatIXx5x4
kmIX + x5
dx6
dt
=
kcatIXx5x4
kmIX + x5
− k7x12x6 + k9x13
dx7
dt
= −
kcat10x7x13
km10 + x7
dx8
dt
=
kcat10x7x13
km10 + x7
− k8x15x8 + k10x16
dx9
dt
= −
kcatIIx9x16
kmII + x9
dx10
dt
=
kcat2x17x16
km2 + x17
dx11
dt
= −
kcatV III
kmV III
x11x8 −
kcat8
km8
x11x10
dx12
dt
=
kcatV III
kmV III
x11x8 +
kcat8
km8
x11x10
−k7x12x6 + k9x13 − kiV IIIax11
dx13
dt
= k7x12x6 − k9x13
dx14
dt
= −
kcatV x14x8
kmV
−
kcat5x14x10
km5 + x14
dx15
dt
=
kcatV x14x8
kmV
+
kcat5x14x10
km5 + x14
− k8x15x8 + k10x16
dx16
dt
= k8x15x8 − k10x16
dx17
dt
=
kcatIIx9x16
kmII + x9
−
kcat2x17x16
km2 + x17
dx18
dt
= kiV IIIax11.
(6.2.2)
Let furthermore
P = {x ∈ R18 : x1 > 0, . . . , x18 > 0}
be the positive orthant of R18.
Proposition 6.2.4. P and P are positively invariant for the system (6.2.2).
Proof. Similarly as before, the vector x represents a vector of concentrations, and
this means that xi ≥ 0, i = 1, . . . , 18. Then, the system is defined in a relative
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open subset of P with f(x) = (f1(x), . . . , f18(x))
T , where the function f is C∞
and the components fi, i = 1, . . . , 18 are defined by the right-hand side of (6.2.2).
For x ∈ ∂P , define Cx = P . Setting furthermore xk = 0 in fk, k = 1, . . . , 18 yields
fi(x1, . . . , xk−1, 0, xk+1, . . . , x18) ≥ 0 for all xj ≥ 0, j 6= k and i = 1, . . . , 18.
Therefore, f(x) ∈ P, for all x ∈ ∂P . Hence, P and P are positively invariant for
the system (6.2.2). 
As a consequence of the last proposition, any orbit starting with positive initial
values will remain positive for all times.
Linear first integrals and boundedness of the solutions
Proposition 6.2.5. Given any solution of (6.2.2) with nonnegative initial values,
all the components xi(t), i = 1, . . . , 18 are bounded.
Proof. In this case, since all variables are involved, it is sufficient to prove that
the scalar valued functions defined on R18 by
ϕ1(x) = x1 + x2;
ϕ2(x) = x3 + x4;
ϕ3(x) = x5 + x6 + x13;
ϕ4(x) = x7 + x8 + x16;
ϕ5(x) = x9 + x10 + x16;
ϕ6(x) = x11 + x12 + x13 + x18;
ϕ7(x) = x14 + x15 + x16
are first integrals of the system (6.2.2).
The proof that ϕj , j = 1, . . . , 7 are first integrals is immediate by applying Defini-
tion A.1.4 as we did in Proposition 6.1.2.
Hence, by directly applying Proposition 6.2.4 and Remark A.1.5, we conclude that
the solutions of the system (6.2.2) remain in the level set of ϕj , j = 1, . . . , 7 in
which they start. Hence, ϕj(xi(t)), j = 1, . . . , 7 are constant functions of t for all
solutions and therefore bounded. Thus, the components xi(t), i = 1, . . . , 18 are
bounded. 
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Convergence to a stationary point
The next proposition gives us more conditions that define the set containing the
positive limit set ω(y) of the system (6.2.2). Again, since the proof follows exactly
the same pattern as the proof of Proposition 6.1.3 it is immediate and there is no
need to repeat it here.
Proposition 6.2.6. Let ϕ8(x) = x1, ϕ9(x) = x3, ϕ10(x) = x5, ϕ11(x) = x7, ϕ12(x) =
x9, ϕ13(x) = x14 and ϕ14(x) = x9 − x10 be scalar functions defined on R
18. Then
Lf (ϕi)(x) ≤ 0, i = 8, . . . , 14. Equality follows only if x1 = x3 = x5 = x7 = x9 =
x11 = x14 = x17 = 0.
Remark 6.2.7. Together with Proposition 6.2.4, we conclude that the functions ϕj
are non increasing and bounded for j = 8, . . . , 14 along a trajectory. That is, there
are constants βj such that 0 ≤ ϕj(x) ≤ βj , j = 8, . . . , 14. Hence every trajectory
remains in the subset of P defined by ϕj(x) ≤ βj , which is bounded.
Proposition 6.2.8. The positive limit set ω(y) of (6.2.2) is contained in the set
N := {x ∈ P : x1 + x2 = x1(0), x3 + x4 = x3(0), x5 + x6 + x13 = x5(0),
x7+x8+x16 = x7(0), x9+x10+x17 = x9(0), x11+x12+x13+x18 = x11(0),
x14 + x15 + x16 = x14(0), x1 = 0, x3 = 0, x5 = 0, x7 = 0, x9 = 0,
x11 = 0, x14 = 0, x17 = 0}.
Proof. The two previous results together with Theorem A.3.11 imply that the
compact sets Mα := {x ∈ P : ϕj(x) ≤ α, j = 1, . . . , 14} are positively invariant
for all α ∈ [0, βj). Theorem A.3.15 guarantees that the solution of the initial value
problem exists on [0,∞). Moreover, this solution approaches its positive limit set
ω(y), as t → ∞. So, ω(y) is nonempty, compact and connected. By Theorem
A.3.16 ω(y) is also invariant.
Hence, by applying LaSalle’s principle stated in Theorem A.4.1 we conclude that
ω(y) ⊂ N.

Remark 6.2.9. The conditions definingN are not enough to prove that any solution
in N is stationary. This set, like before, contains invariant sets other than the set
of stationary points.
In the sequel we derive further conditions to be satisfied by the set of equilibrium
points by setting the right-hand side of the system (6.2.2) to zero and solving for
x.
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Deriving further conditions for the set of equilibrium points
While trying to find new conditions to be satisfied by an equilibrium point, one
observes that the value of the variables x13 and x16 at the equilibrium depend
on the value at the equilibrium of the variables x6 and x12, and x8 and x15,
respectively. We get
E := {x ∈ P : x1 = 0, x3 = 0, x5 = 0, x7 = 0, x9 = 0, x11 = 0, x14 = 0,
x13 =
k7x6x12
k9
, x16 =
k8x8x15
k10
, x17 = 0}.
The following proposition holds:
Proposition 6.2.10. If z13 =
k7z6(t)z12(t)
k9
and z16 =
k8z8(t)z15(t)
k10
then any solu-
tion z(t) starting in N given in Proposition 6.2.8 is stationary.
Proof. Let z(t) be a solution in N satisfying the given conditions, i. e.
z(t) = (0, z2(t), 0, z4(t), 0, z6(t), 0, z8(t), 0, z10(t), 0, z12(t),
k7z6(t)z12(t)
k9
,
0, z15(t),
k8z8(t)z15(t)
k10
, 0, z18(t))
T .
Thus,
z˙(t) = (0, z˙2(t), 0, z˙4(t), 0, z˙6(t), 0, z˙8(t), 0, z˙10(t), 0, z˙12(t),
k7
k9
(z˙6z12 + z6z˙12),
0, z˙15(t),
k8
k10
(z˙8z15 + z8z˙15), 0, z˙18(t))
T .
The given conditions imply immediately
z˙(t) = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)T and z(t) is stationary. 
Remark 6.2.11. The previous result could also have been stated as: If x6(t) and
x8(t) are stationary then any solution z(t) starting in N given in Proposition 6.2.8
is stationary.
For practical reasons, the stability question will be handled after reducing the
number of equations to 11.
Model reduction
Let us now reduce the number of equations of the system (6.2.2) to 11. From the
first integrals given in Proposition 6.2.5 we eliminate the variables x1, x3, x5, x7, x9,
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x13 and x16.
Setting
x1 = −x2 + d1; x3 = −x4 + d2;
x5 = −x6 − x13 + d3; x7 = −x8 − x16 + d4;
x9 = −x10 − x17 + d5; x16 = −x14 − x15 + d7
x13 = −x11 − x12 − x18 + d6,
where d1 = x1(0); d2 = x3(0); d3 = x5(0); d4 = x7(0); d5 = x9(0), d6 = x11(0), d7 =
x14(0) are different from zero,
and making the following coordinate transformation:
y1 := x2; y2 := x4; y3 := x6; y4 := x8; y5 := x10; y6 := x11; y7 := x12; y8 :=
x14; y9 = x15; y10 = x17; y11 = x18
we obtain the following system of differential equations:
dy1
dt
=
kcatXII(−y1 + d1)u
kmXII + (−y1 + d1)
dy2
dt
=
kcatXI(−y2 + d2)y1
kmXI + (−y2 + d2)
dy3
dt
=
kcatIX(−y3 − (−y6 − y7 − y11 + d6) + d3)y2
kmIX + (−y3 − (−y6 − y7 − y11 + d6) + d3)
−k7y7y3 + k9(−y6 − y7 − y11 + d6)
dy4
dt
=
kcat10(−y4 − (−y8 − y9 + d7) + d4)(−y6 − y7 − y11 + d6)
km10 + (−y4 − (−y8 − y9 + d7) + d4)
−k8y9y4 + k10(−y8 − y9 + d7)
dy5
dt
=
kcat2y10(−y8 − y9 + d7)
km2 + y10
dy6
dt
= −
kcatV III
kmV III
y6y4 −
kcat8
km8
y6y5
dy7
dt
=
kcatV III
kmV III
y6y4 +
kcat8
km8
y6y5
−k7y7y3 + k9(−y6 − y7 − y11 + d6)− kiV IIIay6
dy8
dt
= −
kcatV y8y4
kmV
−
kcat5y8y5
km5 + y8
dy9
dt
=
kcatV y8y4
kmV
+
kcat5y8y5
km5 + y8
− k8y9y4 + k10(−y8 − y9 + d7)
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dy10
dt
=
kcatII(−y5 − y10 + d5)(−y8 − y9 + d7)
kmII + (−y5 − y10 + d5)
−
kcat2y10(−y8 − y9 + d7)
km2 + y10
dy11
dt
= kiV IIIay6.
(6.2.3)
This system has a single equilibrium point and its coordinates can be calculated
explicitly by setting the right-hand side of (6.2.3) to zero and solving to y. There
are again very complicated terms involved and surely lots of impossible solutions
due to the physiological meaning of the variables, so we are going to make use of all
the information available about the system once more to exclude some candidates.
y1
dt
= 0⇔ y1 = d1,
y2
dt
= 0⇔ y2 = d2 and
y11
dt
= 0⇔ y6 = 0.
This implies in particular that the right-hand side of the sixth equation of (6.2.3)
equals zero.
Because of the physiological meaning, y4 > 0 and y5 > 0. Then,
y8
dt
= 0⇔ y8 = 0
as the remaining variables involved are strictly positive.
The same kind of argument can be used to infer y7 = 0 and y11 = d6 after setting
y7
dt
= 0.
Substituting these conditions we get furthermore that:
y3
dt
= 0⇔ y3 = d3.
Moreover,
y5
dt
= 0⇔ y10 = 0 or y9 = d7.
y9 = d7 implies at the same time that
y9
dt
= 0 only if y4 = 0. But y4 6= 0, a
contradiction. Hence, y10 = 0.
This implies in particular that
y10
dt
= 0 only if y5 = d5.
On the other hand,
y9
dt
= 0⇔ −k8y9y4 + k10(−y9 + d7) = 0⇔ y9 =
k10d7
k8y4 + k10
.
Finally,
y4
dt
= 0⇔ −y4 + y9 − d7 + d4 = 0.
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After substituting the condition for y9 we obtain the following second degree equa-
tion in y4 :
k8y
2
4 + (k10 + k8(d7 − d4))y4 − d4k10 = 0.
This equation admits only real roots and the value of y4 at the equilibrium is
uniquely determined by the positive root.
Remark 6.2.12. Substituting the values of the constants involved we obtain for
the equilibrium point the same values like the ones that can be deduced by visual
inspection of the numerical solution.
Remark 6.2.13. Altogether we obtained the coordinates of the unique equilibrium
point towards which the system (6.2.3) converges. Thus, by applying Theorem
A.4.1 follows asymptotic stability of the equilibrium point of this system.
6.3 Discussion
Taking into account that there are some anticoagulatory drugs capable of influ-
encing the system only in the presence of a physiological anticoagulant factor3,
the analysis of controllability makes more sense in a model including inhibitors.
From the sigmoidal like shape of the numerical solution of some variables, we
infer that there are cooperativity effects in the blood coagulation network. So,
besides using only Michaelis and Menten kinetics, one could think in modelling
these behaviors as explained in Section 2.3.3. Another challenge for forthcoming
research.
In [Lin95] we are given two schemes that correspond to two models that postulate
that coagulation is initiated by the extrinsic pathway. The main difference is the
way factor IX becomes activated. One theory emphasizes furthermore the role of
factor XI in blood coagulation and the other not even considers its activation.
Both models could provide an explanation for the fact that some patients with
factor XI deficiency bleed and some do not but not in a satisfactory way. Nev-
ertheless, one could derive the differential equations governing both systems and
compare them with the results given by the models we study in this chapter.
In [Pru00] we are given an approach modelling the intrinsic pathway that is very
similar to the model developed above. The main difference is that factor XI is
activated by thrombin by means of a feedback reaction instead of factor XIIa
directly. So, in order to make another bridge for a more complete understanding
one could establish the mathematical model for the reaction scheme published in
[Pru00] and make further analysis.
3Heparin is an example of an anticoagulatory drug that is only effective in the presence of
ATIII (see Chapter 1)
Chapter 7
Extending Stortelder’s Model
In this chapter we present two possibilities for extending the model from Stortelder
and Hemker. Although the physiological background has already been given in
Section 1.1.2 of Chapter 1, we recall that platelets are an essential component
of the blood coagulation process in vivo. Aggregated, activated platelets provide
procoagulant phospholipid-equivalent surfaces upon which the complex-dependent
reactions of the blood coagulation network are localized. Thus, our first approach
models thrombocyte contribution for blood thrombin formation in the model con-
cerning the common pathway published in [SHH97]. For the set of constants pub-
lished in [SHH97], the lag that characterizes the course of thrombin concentration
with time is hardly noticed by observing the numerical solution. The reason for
that may be the fact that the reaction process starts with a purified enzyme RV V.
So, in the second approach, we substitute RV V by introducing the remaining plas-
matic factors and chemical reactions occurring in the extrinsic pathway, including
the action of inhibitors and having the complex TF.V IIa as an activator. Since no
experimental data is available and the value of the constants cannot be estimated
by others, we limit our selves to present a possible mechanism of action, together
with the set of differential equations governing the system and reduce the order
of the system by using first integrals.
7.1 Modelling platelet’s contribution
As it has been seen in Section 5.2, there is a possibility of steering the course
of thrombin by means of an external control. Experimentally, one may add for
instance platelets in form of phospholipids to a blood sample in order to accelerate
the process of thrombin formation.
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Although controllability of the system is an important feature, we wish to have
a model where the action of thrombocytes is considered without external inputs.
Therefore, we propose in this section a first approach based on a small modification
of the system (3.1.1) by modelling a possible mechanism of action of thrombocytes
or platelets after being activated by thrombin. At this stage of the common path-
way, the major influence of thrombocytes occurs at the level of factor X activation
(see Figure 1.1).
Since this approach is an extension of the model proposed in [SHH97], let us go
through some aspects that will help to gain some more insights and to give some
hints about how this extension can be done.
Ranging the initial concentration of the phospholipids from 0.05 to 200 µmol does
not influence the maximal amount of thrombin generated, much likely due to the
third order term appearing for instance in the 5th equation of (3.1.1). The reason
why this term was included in the model can be understood by taking a look at
the model developed by Nesheim, Russel, Tracy and Mann in [NeTrMa84] for the
activation of thrombin by the prothrombinase complex.
As already mentioned, prothrombinase is a multicomponent enzymatic complex in-
volved in blood coagulation that proteolytically converts the vitaminK−dependent
zymogen prothrombin to the blood clotting enzyme thrombin. The components
are activated factors Va and Xa. This proteins form a 1:1 complex through Ca
2+−
dependent interaction on negatively charged phospholipid vesicles (PCPS).
Figure 7.1 illustrates the development of the model of prothrombinase action pub-
lished in [NeTrMa84].
Figure 7.1: Development of the model of prothrombinase taken from [NeTrMa84]
In the figure there are represented three different regions. These regions consist
of the bulk solution, the PCPS vesicle and a region in between called interface
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shell1. As Nesheim and coworkers state, the volume of this region is proportional
tho the PCPS concentration and it is given by
V = δ[L]0,
where V is the summed volume around the vesicles in the reaction, [L]0 is the
nominal concentration of PCPS, and δ is a constant of proportionality.
Prothrombin is the substrate of this reaction. The model takes the factor Xa as
the solution phase catalyst, whereas the complex XaVa is the catalyst on the
phospholipid surface, what implies that factor Va is primarily associated with the
phospholipid under conditions in which the model is applicable. Comparing with
the model (3.1.1), we may identify [L] with [PL] and this interaction is precisely
described by the term of third order in the 5th equation. Moreover, in the equation
describing the course of thrombin formation, the term
kcatII [II][PT ]
kmII + [II]
+
kcat2[II][Xa]
km2 + [II]
,
where [PT ] represents the concentration of the prothrombinase complex, is the
sum of the rates in the two components and is of the form of the equation given
in Figure 7.1.
7.1.1 The model
In our approach we include the activation of factor X by thrombin at the surface
of activated thrombocytes by positive feedback. The reaction is assumed to be of
second order with reaction constant kT :
IIa +X
kT−→ Xa, (7.1.1)
such that the term kT [IIa][X ] is added to the second equation and subtracted to
the eight equation. Moreover, similarly to what was done for IIaα2M by Stortelder
and Hemker, we include two more equations, one for IIaATIII and the other for
XaATIII in order to balance the system.
The reaction scheme is essentially the same as the one in Figure 3.2 together with
the reaction (7.1.1).
We obtain the following set of 11 differential equations:
1The interface shell constitutes an element of volume in which PCPS− bound proteins in-
teract
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d[X ]
dt
= −
kcatX [X ][RV V ]
kmX + [X ]
d[Xa]
dt
=
kcatX [X ][RV V ]
kmX + [X ]
− kiXa [Xa]
−kPT [Va][Xa][PL] + kPL[PT ] + kT [IIa][X ]
d[V ]
dt
= −
kcatV [V ][IIa]
kmV + [V ]
d[Va]
dt
=
kcatV [V ][IIa]
kmV + [V ]
− kPT [Va][Xa][PL] + kPL[PT ]
d[PL]
dt
= −kPT [Va][Xa][PL] + kPL[PT ]
d[PT ]
dt
= kPT [Va][Xa][PL]− kPL[PT ]
d[II]
dt
= −
kcatII [II][PT ]
kmII + [II]
−
kcat2[II][Xa]
km2 + [II]
d[IIa]
dt
=
kcatII [II][PT ]
kmII + [II]
+
kcat2[II][Xa]
km2 + [II]
−kiIIaα2M [IIa]− kiIIaATIII [IIa]− kT [IIa][X ]
d[IIaα2M ]
dt
= kiIIaα2M [IIa]
d[IIaATIII]
dt
= kiIIaATIII [IIa]
d[XaATIII]
dt
= kiXa [Xa].
(7.1.2)
We proceed by presenting the results of the numerical integration and with a
qualitative analysis of the new system.
7.1.2 Numerical integration
Numerical integration for t ∈ [0, 30] (in minutes) of the system was again made in
SCILAB. RV V was once more set equal to 0.03 and the vector of initial values
was given by
x0 = (0.2, 0, 0.03, 0, 0.05, 0, 1.4, 0, 0, 0, 0)
T .
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No convergence problems arouse.
In the Figure 7.2 one may observe the course of the amidolytic activity of thrombin
with time and compare the original model from Stortelder and Hemker (kT = 0)
to the model where kT = 5.53.
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KT=0
Figure 7.2: Course of the amidolytic activity of thrombin with time with kT = 0
and kT = 5.53.
In the model where kT = 5.53, the concentration increases more than 50 % but
the system attains the equilibrium state faster when compared with the original
model.
Figure 7.3 illustrates what happens by changing the value kT = 5.53 to the half
and to the double for the same value kiIIaα2M = 0.2762.
We observe that with an increase of kT , the reaction is much faster and that the
maximal concentration also increases.
The values of kT are here fictitious and for a more realistic estimate experimental
data should be collected, followed by parameter identification and realization of
statistical significance tests.
The SCILAB code and the remaining graphics can be seen in Appendix E.
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Figure 7.3: Course of the amidolytic activity of thrombin with time where
kiIIaα2M = 0.2762 and kT = 11, kT = 5.53 and kT = 2.7.
7.1.3 Qualitative analysis
Positivity
Let us again rewrite the system (7.1.2) of ordinary differential equations in vector
form:
x = f(x),
where the components of x are given by x1 = [X ], x2 = [Xa], x3 = [V ], x4 =
[Va], x5 = [PL], x6 = [PT ], x7 = [II], x8 = [IIa], x9 = [IIaα2M ], x10 =
[IIaATIII] and x11 = [XaATIII].
The system (7.1.2) can now be written as
dx1
dt
= −
k1x1RV V
k2 + x1
dx2
dt
=
k1x1RV V
k2 + x1
− k3x2 − k4x4x2x5 + k5x6 + k14x8x1
dx3
dt
= −
k6x3x8
k7 + x3
dx4
dt
=
k6x3x8
k7 + x3
− k4x4x2x5 + k5x6
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dx5
dt
= −k4x4x2x5 + k5x6
dx6
dt
= k4x4x2x5 − k5x6
dx7
dt
= −
k8x7x6
k9 + x7
−
k10x7x2
k11 + x7
dx8
dt
=
k8x7x6
k9 + x7
+
k10x7x2
k11 + x7
− k12x8 − k13x8 − k14x8x1
dx9
dt
= k12x8
dx10
dt
= k13x8
dx11
dt
= k3x2,
(7.1.3)
where the constants ki, i = 1, . . . , 13 have the same meaning as in Section 4.1, and
k14 = kT .
Let furthermore
P = {x ∈ R11 : x1 > 0, . . . , x11 > 0}
be the positive orthant of R11.
Proposition 7.1.1. P and P are positively invariant for the system (7.1.3).
Proof. The vector x represents a vector of concentrations, and this means that
xi ≥ 0, i = 1, . . . , 11. Then, the system is defined in a relative open subset of P
with f(x) = (f1(x), . . . , f11(x))
T , where the function f is C∞ and the components
fi, i = 1, . . . , 11 are defined by the right-hand side of (7.1.3).
For x ∈ ∂P , define Cx = P . Setting furthermore xk = 0 in fk, k = 1, . . . , 11 yields
fi(x1, . . . , xk−1, 0, xk+1, . . . , x11) ≥ 0 for all xj ≥ 0, j 6= k and i = 1, . . . , 11.
Therefore, f(x) ∈ P, for all x ∈ ∂P . Hence, P and P are positively invariant for
the system (7.1.3). 
As a consequence of the last proposition, any orbit starting with positive initial
values will remain positive for all times.
First integrals and analysis of stability
Since 

x˙5 + x˙6 = 0
x˙3 + x˙4 + x˙6 = 0
x˙1 + x˙2 + x˙6 + x˙11 + x˙7 + x˙8 + x˙9 + x˙10 = 0,
(7.1.4)
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we conclude that there are at least three conserved quantities in the system (7.1.3).
In fact, we have the following proposition:
Proposition 7.1.2. The scalar valued functions ϕ1(x) = x6 + x5, ϕ2(x) = x3 +
x4 + x6 and ϕ3(x) = x1 + x2 + x6 + x11 + x7 + x8 + x9 + x10 defined on R
11 are
first integrals of the system (7.1.3).
Corollary 7.1.3. Given any solution of (7.1.3) with nonnegative initial values, all
the components xi(t), i = 1, . . . , 11 are bounded.
Proof. By directly applying the last proposition and Remark A.1.5 we conclude
that the solutions of the system (7.1.3) remain in the level set of ϕ1, ϕ2 and of
ϕ3, in which they start. Hence, ϕ1(xi(t)), ϕ2(xi(t)) and ϕ3(xi(t)) are constant
functions of t for all solutions and therefore bounded. Thus, all the components
xi(t), i = 1, . . . , 11 are bounded. 
Furthermore, the following proposition holds:
Proposition 7.1.4. The scalar valued functions defined on R11 by ψ1(x) = k13x9−
k12x10 and ψ2 =
k6
k12
x9 + k7 lnx3 + x3 are first integrals of the system (7.1.3).
Proof. Applying directly the definition we show that Lf (ψi) = 0, i = 1, 2.
Lf (ψ1)(x) = Dx(ψ1)f(x) = (0, 0, 0, 0, 0, 0, 0, 0, k13,−k12, 0)


f1(x)
...
f11(x)


= k13k12x8 − k12k13x8 = 0;
Lf (ψ2)(x) = Dx(ψ2)f(x) = (0, 0,
k7
x3
+ 1, 0, 0, 0, 0, 0,
k6
x12
, 0, 0)


f1(x)
...
f11(x)


=
(
k7
x3
+ 1
)(
−
k6x3x8
k7 + x3
)
+
k6
k12
k12x8
= −k6x8 + k6x8 = 0;

The proof of the next proposition is in all similar to the proof of Proposition 4.3.5
and therefore there is no need to repeat it here. So we state without proof that:
Proposition 7.1.5. Let ϕ4(x) = x1, ϕ5(x) = −x11, ϕ6(x) = −x10 and ϕ7(x) = x7
be scalar functions defined on R11. Then Lf (ϕi)(x) ≤ 0, i = 4, . . . , 7.
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Theorem 7.1.6. The positive limit set ω(y) of (7.1.3) is contained in
N := {x ∈ P : x1 = 0, x2 = 0, x4 + x3 + x6 = 0.03, x6 + x5 = 0.05, x8 = 0,
x1 + x2 + x6 + x11 + x7 + x8 + x9 + x10 = 1.6}.
Furthermore, any solution in N is stationary and the equilibrium point is stable.
Proof. The two previous results together with Theorem A.3.11 imply that the
compact sets Mα := {x ∈ P : ϕj(x) ≤ α, j = 1, . . . , 7} are positively invariant
for all α ∈ [0, βj). Theorem A.3.15 guaranties that the solution of the initial value
problem exists on [0,∞). Moreover, this solution approaches its positive limit set
ω(y), as t → ∞. So, ω(y) is nonempty, compact and connected. By Theorem
A.3.16 ω(y) is also invariant.
Hence, by applying LaSalle’s principle stated in Theorem A.4.1 we conclude that
ω(y) ⊂ N.
Let furthermore z(t) = (z1(t), . . . , z11(t))
T be a solution of (7.1.3) in N. We prove
that z(t) is stationary. It holds,
z(t) = (0, 0, z3(t), z4(t), z5(t), z6(t), z7(t), 0, z9(t), z10(t), z11(t))
T . Thus, together
with (7.1.3) we have
z˙(t) =


0
0
z˙3
z˙4
z˙5
z˙6
z˙6
0
z˙9
z˙10
z˙11


!
=


0
k5z6
0
k5z6
k5z6
−k5z6
−
k8z7z6
k9 + z7
k8z7z6
k9 + z7
0
0
0


.
This means, in particular, that z6 = 0 since z˙2 = 0, and
z˙(t) = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)T .
That is, z(t) is constant and the solution is stationary.
The ω−limit set of (7.1.3) is nonempty. However, we still do not know exactly its
representation. To calculate the equilibrium points we set like in Theorem 4.1.6 the
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right-hand side of the system equal to zero and solve for x. The set of stationary
points belongs to the set E given by:
E =α3


0
0
1
0
0
0
0
0
0
0
0


+ α4


0
0
0
1
0
0
0
0
0
0
0


+ α7


0
0
0
0
0
0
1
0
0
0
0


+ α9


0
0
0
0
0
0
0
0
1
0
0


+ α10


0
0
0
0
0
0
0
0
0
1
0


+ α11


0
0
0
0
0
0
0
0
0
0
1


,
α3, α4, α5, α7, α9 ∈ R
+
0 .
The points of E belong to N if α3+α4 = 0.03 = x3(0), α7 = 1.6−(x9+x10+x11) =
(x1(0) + x7(0))− (x9 + x10 + x11) So, we may write instead:
P =


0
0
0
x3(0)
x5(0)
0
x7(0) + x1(0)
0
0
0
0


+ β3


0
0
1
−1
0
0
0
0
0
0
0


+ β9


0
0
0
0
0
0
−1
0
1
0
0


+ β10


0
0
0
0
0
0
−1
0
0
1
0


+ β11


0
0
0
0
0
0
−1
0
0
0
1


,
(7.1.5)
where 0 ≤ β3 ≤ 0.03 and 0 ≤ β9 + β10 + β11 ≤ x1(0) + x7(0) to exclude negative
concentrations.
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The Jacobian of (7.1.3) at any equilibrium point has the representation:
0
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB@
−
k1[RV V ]
k2
0 0 0 0 0 0 0 0 0 0
k1[RV V ]
k2
−k3 − k4α4α5 0 0 0 k5 0 0 0 0 0
0 0 0 0 0 0 0
−k6α3
k7 + α3
0 0 0
0 −k4α4α5 0 0 0 k5 0
k6α3
k7 + α3
0 0 0
0 −k4α4α5 0 0 0 k5 0 0 0 0 0
0 k4α4α5 0 0 0 −k5 0 0 0 0 0
0 −
k10α7
k11 + α7
0 0 0 −
k8α7
k9 + α7
0 0 0 0 0
0
k10α7
k11 + α7
0 0 0
k8α7
k9 + α7
0 −k12 − k13 0 0 0
0 0 0 0 0 0 0 k12 0 0 0
0 0 0 0 0 0 0 k13 0 0 0
0 k3 0 0 0 0 0 0 0 0 0
1
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCA
.
We observe that the Jacobian suffered very little changes if we compare it with
the original model from Stortelder and Hemker. In this case zero is an eigenvalue
of the matrix with algebraic and geometric multiplicities equal to 7 and that there
are conserved quantities present. And, any equilibrium point of (7.1.3) and the
singularity is nonisolated.
With the first integrals given in Proposition 7.1.2 and Proposition 7.1.4 we are
able to reduce the order of the system to 6. The set of equilibrium points of the
reduced system built the triangle
P =


0
0
0
c1
0
0


+ µ3


0
0
1
0
0
0


+ µ6


0
0
0
0
0
1


, µ3, µ6 ∈ R
+
0 , (7.1.6)
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with 0 ≤ µ3 ≤ [V ](0) and 0 ≤ µ6 ≤ [X ](0).
Zero is an eigenvalue with algebraic and geometric multiplicities equal to two. The
corresponding eigenvectors are the direction vectors of the hyperplane containing
the equilibrium points. The Jacobian at the equilibrium of the reduced system has
2 zero columns and the last line is a linear combination of the first, second and
sixth lines and it has the form
J∗r :=


|
Jr | 05×1
− − − | − −−−
0 k3 0 | 0

 ,
where Jr is the matrix (4.2.3).
In Theorem 4.1.6 we proved that the nonzero eigenvalues of Jr have negative real
part. Since any solution starting in N is stationary and the system converges to a
nonisolated stationary point, a similar argument allows us to conclude stability of
the equilibrium point of (7.1.3). The coordinates corresponding to the eigenvalues
equal zero are therefore constants that depend on the initial value problem and
the remaining ones are equal zero. 
Remark 7.1.7. Notice that the stability of the linear system y˙ = J∗r y can be
concluded from the stability of the matrix Jr.
Let λ1, λ2, λ3 and λ4 be the nonzero eigenvalues of Jr. In Theorem 4.1.6 we proved
that Reλi < 0, i = 1, . . . , 4. Thus, the general solution of the linear system
y˙ = J∗r y
can be written as
y(t) = α1v1e
λ1t + α2v2e
λ2t + α3v3e
λ3t + α4v4e
λ4t + α5v5 + α6v6,
with vi, i = 1, . . . , 4 the corresponding eigenvectors to λi and v5 = (0, 0, 1, 0, 0, 0)
T
and v6 = (0, 0, 0, 0, 0, 1)
T .
For t→∞ we have y(t)→ α5v5 + α6v6, with α5 and α6 uniquely determined by
the initial values. It holds,
|y(t,y0) − y(t, y˜0)| = |α1v1e
λ1t + α2v2e
λ2t + α3v3e
λ3t + α4v4e
λ4t − α˜1v1e
λ1t −
α˜2v2e
λ2t − α˜3v3e
λ3t − α˜4v4e
λ4t + (α5 − α˜5)v5 + (α6 − α˜6)v6|.
Since (α1 − α˜1)v1e
λ1t + (α2 − α˜2)v2e
λ2t + (α3 − α˜3)v3e
λ3t + (α4 − α˜4)v4e
λ4t is
o(1), as t→∞ we have
|y(t,y0)− y(t, y˜0)| ≤ Kδ, with δ → 0 as y˜1 → y0.
And the assertion follows by definition of stability.
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Model reduction
From the first integrals given in Proposition 7.1.5 we eliminate the variables x4, x6
and x7 :
x6 = −x5+c1; x4 = −x3−x6+c2 and x7 = −x1−x2−x6−x11−x8−x9−x10+c3,
where c1 = x5(0); c2 = x3(0) and c3 = x1(0) + x7(0).
Hence, we omit the 4th, 6th and 7th equations.
By Proposition 7.1.4
x9 =
k12
k6
(c− k7 lnx3 − x3), where c = k7 lnx3(0) + x3(0) and x10 =
k3
k12
x9.
Altogether, the order of the system can be reduced to 6 after performing the
following coordinate transformation:
y1 := x1; y2 := x2; y3 := x3; y4 := x5; y5 := x8; y6 := x11
and each occurrence of x4, x6, x7, x9 and x10 is substituted respectively by:
x4 = y4 − y3 + c
′
1 with c
′
1 = −x5(0) + x3(0) < 0;
x6 = −y4 + c1 with c1 = x5(0);
x7 = −y1 − y2 + y4 − y5 − (c− k7 ln y3 − y3)
(
k12 + k13
k6
)
− y6 + c
′
3 with
c′3 = −x5(0) + x1(0) + x7(0);
x9 =
k12
k6
(c− k7 ln y3 − y3), where c = k7 lnx3(0) + x3(0) and x10 =
k3
k12
x9.
The reduced system comprises the following 6 differential equations.
dy1
dt
= −
k1y1RV V
k2 + y1
dy2
dt
=
k1y1RV V
k2 + y1
− k3y2 − k4(y4 − y3 + c
′
1)y2y4 + k5(−y4 + c1) + k14y5y1
dy3
dt
= −
k6y3y5
k7 + y3
dy4
dt
= −k4(y4 − y3 + c
′
1)y2y4 + k5(−y4 + c1)
dy5
dt
= r1 + r2 − k12y5 − k13y5 − k14y5y1
dy6
dt
= k3y2,
(7.1.7)
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where
r1 =
k8(−y1 − y2 + y4 − y5 − (c− k7 ln y3 − y3)
(
k12+k13
k6
)
− y6 + c
′
3)(−y4 + c1)
k9 + (−y1 − y2 + y4 − y5 − (c− k7 ln y3 − y3)
(
k12+k13
k6
)
− y6 + c′3)
;
r2 =
k10(−y1 − y2 + y4 − y5 − (c− k7 ln y3 − y3)
(
k12+k13
k6
)
− y6 + c
′
3)y2
k11 + (−y1 − y2 + y4 − y5 − (c− k7 ln y3 − y3)
(
k12+k13
k6
)
− y6 + c′3)
.
Notice furthermore that although the last equation of the system (7.1.7) is a simple
integration of y2(t), it cannot be omitted.
7.2 From the common to the extrinsic pathway
As we have seen in Section 6.1.2 changing the value of complex TF.V IIa concen-
tration influences the lag length. This is not the case when we consider different
values of RV V, though.
Our approach is now to substitute RV V used in the truncated clotting mechanism
by introducing the remaining plasmatic factors and chemical reactions occurring
in the extrinsic pathway leading to the formation of thrombin, including the action
of inhibitors and having the complex TF.V IIa as initiator. Since Sortelder’s model
comprises the action of inhibitors, we also account for the action of TFPI, which
combines with factor Xa to form a strong inhibitor of the complex TF.V IIa. We
recall that this complex also activates factor IX that together with factor V IIIa
is again a strong activator of factor X. This reaction occurs in the presence of
phospholipids and the complex will be designated by IT (intrinsic tenase). Factor
V IIIa arises from plasmatic factor V III previously activated by of thrombin. The
contribution of ATIII is modelled as a first order reaction and besides factor Xa
it will inhibit factor IXa and TF : V IIa as well.
The mechanism of inhibition by TFPI has been the subject of numerous inves-
tigations. According to [HJEM02], the most satisfactory explanation for TFPI
behavior is provided by Baugh et. al. [BBK98]. For another approach see [PZA02].
The mechanism of action of TFPI by Baugh et. al. [BBK98] comprises two steps.
In a first step, factor Xa is inhibited the reaction between TFPI and Xa. The
XaTFPI complex formed in this initial step reacts efficiently with TF.V IIa in a
second step to yield an inhibited complex Xa.TFPI.TF.V IIa.
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Schematically, we have:
X + TF.V IIa X.TF.V IIa TF.V IIa + Xa
+
+
TFPI
Xa.TFPI
Xa.TFPI.TFV IIa
TFV IIa
k1
k−1
k2
k3k−3
k4k−4
Altogether we propose the following reaction scheme:
X + TF.V IIa X.TF.V IIa TF.V IIa +Xa
k1
k−1
kcatX
IX + TF.V IIa IX.TF.V IIa TF.V IIa + IXa
k2
k−2
kcatIX
II +Xa II.Xa IIa +Xa
c1
c−1
kcat2
V III + IIa V III.IIa IIa + V IIIa
k4
k−4
kcatV III
V IIIa + PL+ IXa IT
k5
k−5
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X + IT X.IT IT +Xa
k6
k−6
kcat10
V + IIa V.IIa Va + IIa
c2
c−2
kcatV
Xa + PL+ Va PT
kPT
kPL
II + PT II.PT IIa + PT
c3
c−3
kcatII
Xa + TFPI XaTFPI
k7
k−7
TF.V IIa +XaTFPI TF.V IIa.XaTFPI
k8
k−8
Xa XaATIII
kiXa
IIa IIaATIII
kiIIaATIII
IIa IIaα2M
kiIIaα2M
IXa IXaATIII
kiIXaATIII
TF.V IIa TF.V IIaATIII
kiTF.V IIaATIII
Figure 7.4: Reaction scheme corresponding for the extrinsic pathway with
TFPI, ATIII and α2M as inhibitors.
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We model the catalytic reactions by using the Michaelis and Menten equation and
the remaining ones by using the law of mass action. Thus, we obtain the following
system of differential equations comprising 22 equations:
d[X ]
dt
= −
kcatX [X ][TFV IIa]
kmX + [X ]
−
kcat10[X ][IT ]
km10 + [X ]
d[Xa]
dt
=
kcatX [X ][TFV IIa]
kmX + [X ]
+
kcat10[X ][IT ]
km10[Xa] + [X ]
− kiXaATIII [Xa]
−kPT [Xa][PL][Va] +kPL[PT ]−k7[Xa][TFPI]+ k−7[XaTFPI]
d[IX ]
dt
= −
kcatIX [IX ][TFV IIa]
kmIX + [IX ]
d[IXa]
dt
=
kcatIX [IX ][TFV IIa]
kmIX + [IX ]
− k5[V IIIa][PL][IXa]
k−5[IT ]− kiIXaATIII [IXa]
d[II]
dt
= −
kcatII [II][PT ]
kmII + [II]
−
kcat2[Xa][II]
km2 + [II]
d[IIa]
dt
=
kcatII [II][PT ]
kmII + [II]
+
kcat2[Xa][II]
km2 + [II]
− kiIIaα2M [IIa]
−kiIIaATIII [IIa]
d[V III]
dt
= −
kcatV III [V III][IIa]
kmV III + [V III]
d[V IIIa]
dt
=
kcatV III [V III][IIa]
kmV III + [V III]
− k5[V IIIa][PL][IXa] + k−5[IT ]
d[IT ]
dt
= k5[V IIIa][PL][IXa]− k−5[IT ]
d[V ]
dt
= −
kcatV [V ][IIa]
kmV + [V ]
d[Va]
dt
=
kcatV [V ][IIa]
kmV + [V ]
− kPT [Xa][PL][Va] + kPL[PT ]
d[PL]
dt
= −kPT [Xa][PL][Va]+kPL[PT ]−k5[V IIIa][PL][IXa]+ k−5[IT ]
d[PT ]
dt
= kPT [Xa][PL][Va]− kPL[PT ]
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d[TFPI]
dt
= −k7[Xa][TFPI] + k−7[XaTFPI]
d[XaTFPI]
dt
= k7[Xa][TFPI]− k−7[XaTFPI]
d[TFV IIa]
dt
= −k8[TFV IIa][XaTFPI] + k−8[TFV IIaXaTFPI]
−kiTFV IIaATIII [TFV IIa]
d[TFV IIaXaTFPI]
dt
= k8[TFV IIa][XaTFPI]− k−8[TFV IIaXaTFPI]
d[XaATIII]
dt
= kiXaATIII [Xa]
d[IIaATIII]
dt
= kiIIaATIII [IIa]
d[IIaα2M ]
dt
= kiIIaα2M [IIa]
d[IXaATIII]
dt
= kiIXaATIII [IXa]
d[TFV IIaATIII]
dt
= kiTFV IIaATIII [TFV IIa]
(7.2.1)
7.2.1 Qualitative analysis
Positivity
Let us rewrite the system (7.2.1) of ordinary differential equations in vector form:
x = f(x),
where the components of x are given by x1 = [X ], x2 = [Xa], x3 = [IX ], x4 =
[IXa], x5 = [II], x6 = [IIa], x7 = [V III], x8 = [V IIIa], x9 = [IT ], x10 =
[V ], x11 = [Va], x12 = [PL], x13 = [PT ], x14 = [TFPI], x15 = [XaTFPI], x16 =
[TFV IIa], x17 = [TFV IIaXaTFPI], x18 = [XaATIII], x19 = [IIaATIII],
x20 = [IIaα2M ], x21 = [IXaATIII] and x22 = [TFV IIa].
The system (7.2.1) can now be written as
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dx1
dt
= −
kcatXx1x16
kmX + x1
−
kcat10x1x9
km10 + x1
dx2
dt
=
kcatXx1x16
kmX + x1
+
kcat10x1x9
km10 + x1
− kiXaATIIIx2
−kPTx2x12x11 + kPLx13 − k7x2x14 + k−7x15
dx3
dt
= −
kcatIXx3x16
kmIX + x3
dx4
dt
=
kcatIXx3x16
kmIX + x3
− k5x8x12x4 + k−5x9 − kiIXaATIIIx4
dx5
dt
= −
kcatIIx5x13
kmII + x5
−
kcat2x5x2
km2 + x5
dx6
dt
=
kcatIIx5x13
kmII + x5
+
kcat2x5x2
km2 + x5
− kiIIaα2Mx6 − kiIIaATIIIx6
dx7
dt
= −
kcatV IIIx7x6
kmV III + x7
dx8
dt
=
kcatV IIIx7x6
kmV III + x7
− k5x8x12x4 + k−5x9
dx9
dt
= k5x8x12x4 − k−5x9
dx10
dt
= −
kcatV x10x6
kmV + x10
dx11
dt
=
kcatV x10x6
kmV + x10
− kPTx2x12x11 + kPLx13
dx12
dt
= −kPTx2x12x11 + kPLx13 − k5x8x12x4 + k−5x9
dx13
dt
= kPTx2x12x11 − kPLx13
dx14
dt
= −k7x2x14 + k−7x15
dx15
dt
= k7x2x14 − k−7x15
dx16
dt
= −k8x16x15 + k−8x17 − kiTFV IIaATIIIx16
dx17
dt
= k8x16x15 − k−8x17
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dx18
dt
= kiXaATIIIx2
dx19
dt
= kiIIaATIIIx6
dx20
dt
= kiIIaα2Mx6
dx21
dt
= kiIXaATIIIx4
dx22
dt
= kiTFV IIaATIIIx16.
(7.2.2)
Let furthermore
P = {x ∈ R22 : x1 > 0, . . . , x22 > 0}
be the positive orthant of R22.
Proposition 7.2.1. P and P are positively invariant for the system (7.2.2).
Proof. The vector x represents a vector of concentrations, and this means that
xi ≥ 0, i = 1, . . . , 22. Then, the system is defined in a relative open subset of P
with f(x) = (f1(x), . . . , f22(x))
T , where the function f is C∞ and the components
fi, i = 1, . . . , 22 are defined by the right-hand side of (7.2.2).
For x ∈ ∂P , define Cx = P . Setting furthermore xk = 0 in fk, k = 1, . . . , 22 yields
fi(x1, . . . , xk−1, 0, xk+1, . . . , x22) ≥ 0 for all xj ≥ 0, j 6= k and i = 1, . . . , 22.
Therefore, f(x) ∈ P, for all x ∈ ∂P . Hence, P and P are positively invariant for
the system (7.2.2). 
As a consequence of the last proposition, any orbit starting with positive initial
values will remain positive for all times.
First integrals and convergence to a stationary point
Since 

x˙1 + x˙2 + x˙13 + x˙15 + x˙18 = 0
x˙3 + x˙4 + x˙9 + x˙21 = 0
x˙5 + x˙6 + x˙19 + x˙20 = 0
x˙7 + x˙8 + x˙9 = 0
x˙10 + x˙11 + x˙13 = 0
x˙9 + x˙12 + x˙13 = 0
x˙14 + x˙15 = 0
x˙16 + x˙17 + x˙22 = 0,
(7.2.3)
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we conclude that there are at least eight conserved quantities in the system (7.2.2).
In fact, we have the following proposition:
Proposition 7.2.2. The scalar valued functions ϕ1(x) = x1 + x2 + x13 + x15 +
x18, ϕ2(x) = x3 + x4 + x9 + x21, ϕ3(x) = x5 + x6 + x19 + x20, ϕ4(x) = x7 +
x8 + x9, ϕ5(x) = x10 + x11 + x13, ϕ6(x) = x9 + x12 + x13, ϕ7(x) = x14 + x15 and
ϕ8(x) = x16 + x17 + x22 defined on R
22 are first integrals of the system (7.2.2).
Furthermore, the following proposition holds:
Proposition 7.2.3. The scalar valued functions defined on R22 by
ψ1(x) =
kcatIX
kiTFV IIaATIII
x22 + kmIX lnx3 + x3;
ψ2(x) =
kcatV III
kiIIaα2M
x20 + kmV III lnx7 + x7; and
ψ3(x) =
kcatV
kiIIaATIII
x20 + kmV lnx10 + x10;
are first integrals of the system (7.2.2).
Proof. The proof follows immediately by applying the definition of Lie derivative.
So, we show that Lf (ψi) = 0, i = 1, 2, 3.
Lf (ψ1)(x) = Dx(ψ1) = (0, 0,
kmIX
x3
+ 1, 0, . . . , 0, kcatIX
kiTF V IIaAT III
, 0, 0)
0
B@
f1(x)
...
f22(x)
1
CA
=
„
kmIX
x3
+ 1
«„
−
kcatIXx3x16
kmIX + x3
«
+
kcatIX
kiTF V IIaATIII
kiTF V IIaATIIIx16
= −kcatIXx16 + kcatIXx16 = 0;
Analogously, Lf (ψ2) = Lf (ψ3) = 0. 
Corollary 7.2.4. Given any solution of (7.2.2) with nonnegative initial values, all
the components xi(t), i = 1, . . . , 22 are bounded.
Proof. By directly applying the last proposition and Remark A.1.5 we conclude
that the solutions of the system (7.2.2) remain in the level set of ϕi, i = 1, . . . , 8
in which they start. Hence, ϕj(xi(t)), j = 1, . . . , 8 are constant functions of t for
all solutions and therefore bounded. Thus, all the components xi(t), i = 1, . . . , 22
are bounded. 
The proof of the next proposition is in all similar to the proof of Proposition 4.3.5
and therefore there is no need to repeat it here. So we state without proof that:
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Proposition 7.2.5. Let ϕ9(x) = x1, ϕ10(x) = x3, ϕ11(x) = x4, ϕ12 = −x18, ϕ13(x) =
−x19 and ϕ14(x) = −x22 be scalar functions defined on R
22. Then Lf (ϕi)(x) ≤
0, i = 9, . . . , 14.
Proposition 7.2.6. The positive limit set ω(y) of (7.2.2) is contained in
N := {x ∈ P : x1 + x2 + x13 + x15 + x18 = x1(0), x3 + x4 + x9 + x21 = x3(0),
x5 + x6 + x19 + x20 = x5(0), x7 + x8 + x9 = x7(0), x10 + x11 + x13 =
x10(0), x9 + x12 + x13 = x12(0), x14 + x15 = x14(0), x16 = 0
x16 + x17 + x22 = x16(0) + x22(0), x1 = 0, x2 = 0, x4 = 0, x6 = 0}.
Furthermore, any solution in N is stationary.
Proof. The two previous results together with Theorem A.3.11 imply that the
compact sets Mα := {x ∈ P : ϕj(x) ≤ α, j = 1, . . . , 14} are positively invariant
for all α ∈ [0, βj). Theorem A.3.15 guaranties that the solution of the initial value
problem exists on [0,∞). Moreover, this solution approaches its positive limit set
ω(y), as t → ∞. So, ω(y) is nonempty, compact and connected. By Theorem
A.3.16 ω(y) is also invariant.
Hence, by applying LaSalle’s principle stated in Theorem A.4.1 we conclude that
ω(y) ⊂ N.
Let furthermore z(t) = (z1(t), . . . , z22(t))
T be a solution in N. We prove that z(t)
is stationary. It holds, z(t) = (0, 0, z3(t), 0, z5(t), 0, z7(t), z8(t), z9(t), z10(t), z11(t),
z12(t), z13(t), z14(t), z15(t), z16(t), z17(t), z18(t), z19(t), z20(t), z21(t), z22(t))
T .
Hence,
z˙(t) = (0, 0, z˙3(t), 0, z˙5(t), 0, z˙7(t), z˙8(t), z˙9(t), z˙10(t), z˙11(t), z˙12(t), z˙13(t), z˙14(t),
z˙15(t), z˙16(t), z˙17(t), z˙18(t), z˙19(t), z˙20(t), z˙21(t), z˙22(t))
T .
Thus, together with (7.2.2) we have that z2(t) = 0 implies z˙18 = 0; z4(t) = 0
implies z˙21 = 0; and z6(t) = 0 implies z˙7 = 0, z˙10 = 0, z˙19 = 0, z˙22 = 0.
On the other hand, z16 = 0 implies z˙16 = 0, i.e k−8z17 = 0 or z17 = 0, because
k−8 6= 0. That is z˙17 = 0.
Similarly, z4 = 0 implies z˙4 = 0, i.e k−5z9 = 0 or z9 = 0, because k−5 6= 0. That
is, z˙9 = 0. Hence, z˙8 = 0, too.
Finally z2 = 0 implies z˙2 = kPLz13 + k−7z15 = 0. That is, z13 = z15 = 0, because
kPL, k−7 > 0. Therewith z˙13 = z˙15 = 0. Thus, z˙5 = z˙6 = z˙11 = z˙12 = z˙14 = 0.
Altogether,
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z˙(t) = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)T .
That is, z(t) is constant and the solution is stationary. 
Remark 7.2.7. The set of equilibrium points can be obtained once again by set-
ting the right-hand side of the system (7.2.2) to zero and solving for x. Together
with the conditions given in N of Proposition 7.2.6, it turned out that the set of
equilibria is a manifold of dimension 4 and it is given by
E := {x ∈ R22 : x1 = 0;x2 = 0;x4 = 0;x6 = 0;x9 = 0;x12 = x12(0);x13 =
0;x14 = x14(0);x15 = 0;x16 = 0;x17 = 0;x18 = x1(0);x21 = x3(0);x22 = x16(0) +
x22(0);x3+x21 = x3(0);x5+x19+x21 = x5(0);x7+x8 = x7(0);x10+x11 = x10(0)}.
Model reduction
From the first integrals given in Proposition 7.2.2 we eliminate the variables
x15, x9, x5, x7, x10, x13, x14 and x17 :
x15 = −x1 − x2 − x13 − x18 + c1; x9 = −x3 − x4 − x21 + c2; x5 = −x6 − x19 −
x20 + c3; x6 = −x8−x9+ c4; x10 = −x11−x13 + c5; x13 = −x9−x12 + c6; x14 =
−x15 + c7; and x17 = −x16 − x22 + c8,
where c1 = x1(0); c2 = x3(0); c3 = x5(0); c4 = x7(0); c5 = x10(0); c6 = x12(0); c7 =
x14(0) and c8 = x16(0) + x22(0).
Hence, we omit equations 15, 9, 5, 7, 10, 13, 14, 17.
By Proposition 7.2.3 we have
x22 =
kiTFV IIaATIII
kcatIX
(c9 − kmIX lnx3 − x3),
x20 =
kiIIaα2M
kcatV III
(c10 − kmV III lnx7 − x7) and
x19 =
kiIIaATIII
kcatV
(c11 − kmV lnx10 − x10)
where c9 = kmIX lnx3(0) + x3(0) +
kcatIX
kiTFV IIaATIII
x22(0),
c10 = kmV III lnx7(0) + x7(0) and c11 = kmV lnx10(0) + x10(0).
Then the order of the system can be reduced to 11 after performing the following
coordinate transformation:
y1 := x1; y2 := x2; y3 := x3; y4 := x4; y5 := x6; y6 := x8; y7 := x11; y8 := x12
y9 := x16; y10 := x18; y11 := x21.
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We obtain the following system of 11 differential equations.
dy1
dt
= −
kcatXy1y9
kmX + y1
−
kcat10y1r2
km10 + y1
dy2
dt
=
kcatXy1y9
kmX + y1
+
kcat10y1r2
km10y2 + y1
− kiXaATIIIy2
−kPT y2y8y7 + kPLr3 − k7y2r4 + k−7r1
dy3
dt
= −
kcatIXy3y9
kmIX + y3
dy4
dt
=
kcatIXy3y9
kmIX + y3
− k5y6y8y4 + k−5r2 − kiIXaATIIIy4
dy5
dt
=
kcatIIr10r3
kmII + r10
+
kcat2r10y2
km2 + r10
− kiIIaα2My5 − kiIIaATIIIy5
dy6
dt
=
kcatV IIIr5y5
kmV III + r5
− k5y6y8y4 + k−5r2
dy7
dt
=
kcatV r6y5
kmV + r6
− kPT y2y8y7 + kPLr3
dy8
dt
= −kPT y2y8y7 + kPLr3 − k5y6y8y4 + k−5r2
dy9
dt
= −k8y9r1 + k−8r11 − kiTFV IIaATIIIy9
dy10
dt
= kiXaATIIIy2
dy11
dt
= kiIXaATIIIy4
(7.2.4)
with,
r1 = −y1 − y2 − y3 − y4 − y11 + y8 − y10 + c2 − c6 + c1;
r2 = −y3 − y4 − y11 + c2; r3 = y3 + y4 − y8 − c2 + c6;
r4 = y1 + y2 + y3 + y4 + y11 − y8 + y10 − c2 + c6 − c1 + c7;
r5 = −y6 + y3 + y4 + y11 − c2 + c4;
r6 = −y7−y3−y4−y11+y8+c2−c6+c5; r7 =
kiTFV IIaATIII
kcatIX
(c9−kmIX ln y3−y3);
r8 =
kiIIaα2M
kcatV III
(c10 − kmV III ln r5 − r5); r9 =
kiIIaATIII
kcatV
(c11 − kmV ln r6 − r6);
r10 = −y5 − r9 − r20 + c3; r11 = −y9 − r7 + c8.
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Although the number of equations is reduced, the complexity of the right-hand side
of the dynamical system has increased. It is however possible that the complexity
diminishes if some values of the constants are known. On the other hand, there are
constants that are dimensionless and others that are not. Therefore, the next step
before handling questions of stability would be to make a dimension analysis. A
work to be accomplished in a future investigation. The same can be said to what
the numerical solution is concerned.
Chapter 8
Summary and Concluding
Remarks
The first chapter is a brief description of the blood coagulation system. Besides
making an excursion through the nomenclature and the principal properties of
this system we were confronted with the pertinence of some questions that are in
nowadays object of discussion among the scientific community investigating the
process of thrombin formation. As a matter of fact, we are in the presence of a
network of chemical reactions involving a series of positive and negative feedback
loops and Chapter 1 gave an insight into what is known about this complex system
and the problems arising while modelling such a system mathematically.
The second chapter is an excursion on what is known about the mathematical
modelling of biochemical networks. There we presented some of the formalism
developed by Martin Feinberg and Rutherford Aris regarding structural aspects
of such networks. This allowed easy reference to some of the best known concepts
and theories in this field, like stoichiometry or the defect of a network, that are not
standard for mathematicians. Although this formalism does not include explicitly
mathematical descriptions of reactions where a substance is activated by another,
like in the blood coagulation system when an inactive proenzyme is converted
into its active form, this chapter was useful, in particular, to understand what
determines the structure of a chemical network.
In the third chapter we described two of the most cited mathematical models
for modelling a part of the blood coagulation system. These models are due to
Stortelder, Hemker and Hemker [SHH97] and to Jones and Mann [JoMa94]. The
model from Stortelder and Hemker models the so called common pathway and the
one from Jones and Mann the so called extrinsic pathway. The models comprise
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systems of nonlinear differential equations, where the reaction constants are taken
as parameters and the physiological concentration of the different factors involved
in the blood coagulation process are taken as initial values. To the description done
in this chapter it belongs the presentation of the numerical solution and the anal-
ysis of the stoichiometry. From the numerical analysis of the system by Stortelder
we could identify some of the parameters that influence both the concentration of
thrombin at the equilibrium and the total amount of thrombin formed. Since the
reaction scheme of Stortelder and Hemker does not fit the formalism presented in
the second chapter, the stoichiometric analysis was only performed for the model
due to Jones and Mann. Moreover, we interpreted the reaction scheme as a graph
and we observed the existence of loops and determined the number of connected
components. Since the network has deficiency 4 and is not weakly reversible, we
could not conclude or exclude, with the formalism presented in chapter two, the
existence of multiple positive equilibria in each stoichiometric class. Due to incon-
sistencies to the law of mass action, we traced back the equations corresponding
to reaction scheme of Jones and Mann and obtained a new set of equations.
The fourth chapter is devoted to the analysis of the dynamics of both systems by
doing a qualitative analysis using results of the local theory of differential equations
and nonlinear dynamical systems. For the readears that are not familiar with the
main results of the qualitative theory, we present a survey of known results in
appendix. We concluded that the positive orthant and its closure are positively
invariant for Stortelder’s system, that the solutions are bounded and that every
solution starting in the set containing the positive ω− limit set is stationary.
Although been relatively compact, we were also able to reduce the dimension of the
system from 9 to 5 after identifying three linear first integrals and one nonlinear
first integral. It turned out that the equilibrium points of the reduced system
belonged to a segment of line and that the Jacobian at any equilibrium point had
one eigenvalue equal to zero and that the remaining ones have negative real parts.
The stability of this point was demonstrated therefore with the help of a result from
Bibikov. To finalize, we made a numerical simulation and observed that the course
of thrombin concentration with time is very well described by its linearization at
the equilibrium point toward which the system converges. The qualitative analysis
of the system proposed by Jones and Mann should have followed the same pattern
as before, however we prove that the system does not remain positive for all
times for a given set of positive initial values and the qualitative analysis was
performed for the corrected version presented in the third chapter. This model
comprises 18 equations and the positive orthant is positively invariant and the
solution bounded. In contrast with the model from Stortelder and Hemker, the
sum of all the components is again a first integral. However, with the results at
hand we were not able to prove that any solution starting in the set containing
the positive ω− limit set is stationary. There were some conditions missing and
we could deduce them after calculating some of the coordinates of the equilibrium
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point explicitly. Using 6 linear independent first integrals we were able to reduce
the dimension of the system to 12. The equilibrium point was determined explicitly
and asymptotic stability of the reduced model followed.
Since the application of a drug can be of interest to reestablish hemostatic equi-
librium, it is very important to address the question of the controllability of the
system. This was done in the fifth chapter. There we started by analyzing the
controllability of the linearized system from Stortelder and Hemker. It turned out
that the linearized system was not completely controllable, however we identified
a controllable subspace of dimension 4 and give a numerical example illustrating
the hypothetical inhibition of anti-thrombin. The controllability of the non-linear
system followed by the identification of a flat output. For the readears that are not
familiar with these mathematical concepts, we made a summary of the principal
definitions and results and it can be found in appendix.
In chapter three we derived the set of differential equations corresponding to the
reaction scheme published in the paper [JoMa94] following the same strategy as
the authors by using the law of mass action. However, one should keep in mind
that we are in the presence of enzyme catalyzed reactions and that the Michaelis
and Menten approach may be more appropriate for the modelling of such kind of
networks. So, in chapter six, we rewrite the system by using this approach every
time we are in the presence of a catalysis. While deriving the set of differential
equations one notices that there is a huge number of candidate models and from
these we selected the one that better approximated the curve obtained by nu-
merical integration of the system modelled using the law of mass action and a
qualitative analysis was done yielding the same qualitative information as before.
Testing every empirical result would be very exhaustive, however one should at
least verify whether the system is responsive to changes in concentration of some
of the factors involved. In our case, we checked the effect of changing different
concentrations of the process input and compared the course of thrombin con-
centration with time in the presence and absence of hemophilia. This model for
the extrinsic pathway served furthermore as a basis for building a model for the
intrinsic pathway. Although there is some controversy regarding this pathway, its
contribution for thrombin formation and the occurrence or not of a determined
reaction, one should keep in mind that the presence of foreign substances, like
artificial valves, in the organism may activate the intrinsic cascade and damage
vital organs. So, while there is not a consensus among the scientific community
investigating the blood coagulation system regarding this, it makes sense to intro-
duce new mathematical approaches to model a part of this mechanism in order to
gain more insights. These should be validated with experimental data of course.
Unfortunately, by the time this thesis has been written, no experimental data was
available and therefore no validation or refutation of our approach was possible.
Nevertheless, we proposed a possible mechanism of action and provided a numer-
ical solution that agreed with the theoretical knowledge in the field. Besides that,
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we did a qualitative analysis, identified conserved quantities and reduced the order
of the system and, at least for the set of constants available, asymptotic stability
followed as before. Anyway, a more realistic approach should include in both cases
the action of inhibitors.
Since physiologists may influence the system by adding thrombocytes to a sam-
ple of blood, we describe in chapter seven a possible mechanism of action for the
platelets based on the knowledge gained from the previous analysis extending the
model from Stortelder and Hemker as a first approach to modelling platelet ac-
tion. Qualitative analysis and numerical simulation were also done in this chapter,
following the same pattern as before. The lag present in the course of throm-
bin concentration with time is imperceptible in the numerical results. Without
excluding the possibility that this may be the case when a purified enzyme like
RV V is used to trigger the system, we finished this chapter by proposing a new
scheme for the extrinsic pathway as an extension of Stortelder’s model by replac-
ing the purified enzyme RV V by the reactions that are thought to occur in the
extrinsic pathway, including also inhibitory reactions. No numerical solution was
presented because we could not identify from experimental data the value of the
dimensionless reaction constants
At this point it is important to notice that the models presented in this thesis
cannot be compared without some previous adaptations that could be realized in
future investigations. In fact, besides that they model different parts of the blood
coagulation system, they are significantly different. For instance, since the reac-
tion schemes based on the original reaction scheme of Mann and Jones do not
include the action of inhibitors and Stortelder’s model does, one should first ac-
count for inhibitory activity before comparing them. Moreover, this model should
use dimensionless variables, because the constants present in Stortelder’s model
are also dimensionsless. However, Stortelder’s model should be extended first and
the value of dimensionsless variables must be gained and this cannot be done
without experimental data.
All the numerical solutions are calculated with Scilab 3.0 and for symbolic calcu-
lations we used Maple 9.
We hope that this work will help people working in the mathematical modelling
of biological or physiological systems that are highly nonlinear to be aware of the
difficulties inherent to such a task and to learn that apparently simple questions
regarding mathematical aspects like stability or controllability of more general
systems with several unknown parameters have to be handled properly. Moreover,
we saw how classical mathematical theorems can be useful to gain more insights
into complex phenomena that arise from the current practice of investigation of
other disciplines.
Appendix A
General Methods of Qualitative
Theory
The main goal here is to present some definitions and results that elucidate the
understanding of the qualitative behavior of flows, induced by ordinary differential
equations or by systems of ordinary differential equations near critical points. This
problem is closely related to the long-time behavior of solutions or, in other words,
to the so-called stability theory. Two of the central concepts are the stability of
equilibrium points in the sense of Lyapunov and a stability criteria due to J.
P. LaSalle. Although these concepts are standard for mathematicians, they are
included here as a guideline for other scientists to whom these concepts are not so
standard.
A.1 Basic definitions and criteria
In this work, we deal with so called autonomous differential equations. These
equations have the right-hand side not depending upon the time t and therefore
they have the form
x˙ = f(x). (A.1.1)
We assume that the function f is defined on U ⊆ Rn, nonempty, open and con-
nected, and that f is locally Lipschitz (f is k times continuous differentiable or of
class Ck, where k ≥ 1).
The fundamental existence-uniqueness theorem for a nonlinear autonomous system
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of ordinary differential equations asserts that the initial value problem
x˙ = f(x),x(t0) = y with t0 ∈ R,y ∈ U , has exactly one solution on an open
interval, which is called the maximal interval of existence and denoted by I, and
t0 ∈ I. A proof of this result can be found in any standard literature for differential
equations like [Ama90], [Arn80] or [Per96].
Let us denote the solution of the initial value problem x˙ = f(x),x(0) = y, with
y ∈ U , by S(t,y) and the maximal interval of existence of this solution by Iy.
(i) S(t,y) = y for all t if and only if f(y) = 0. Points with this property are
called stationary points, or equilibrium points, of the equation.
(ii) S is also called general solution or local flow of x˙ = f(x).
In general, we need to know properties of solutions even if they are not given
explicitly. And, one of the first tasks to do is therefore to obtain information about
the maximal interval of existence. Since this interval will be generally different from
(−∞,+∞), we need criteria that guarantee that the maximal interval of existence
extends to infinity.
Proposition A.1.1. Consider the autonomous equation x˙ = f(x) and y ∈ U . If
K ⊆ U is compact and if the positive semitrajectory S+(y) = {S(t,y) : t ∈
Iy and t ≥ 0} is contained in K then S(t,y) exists for t ∈ [0,∞). Likewise, if the
negative semitrajectory S−(y) = {S(t,y) : t ∈ Iy and t ≤ 0} is contained in K
then S(t,y) exists for t ∈ (−∞, 0].
Instead of simply using curves to describe a vector field one may also use deriva-
tives of functions. This allows us to investigate how a given scalar-valued function
changes along solutions of a differential equation. For that matter, two basic con-
cepts are those of Lie derivative and of first integral1.
Theorem A.1.2. Let x˙ = f(x) be given on U , U∗ ⊆ U be a nonempty open set and
ϕ : U∗ → R a C1− function. Then the function Lf (ϕ) : U
∗ → R, (Lf (ϕ)(x)) :=
Dx(ϕ)f(x) is called the Lie derivative of ϕ with respect to f . If z(t) solves x˙ = f(x)
then
ϕ˙(x) =
d
dt
(ϕ(z(t))) = (Dzϕ)z˙(t) = (Dzϕ)f(z(t)) = Lf (ϕ)(z(t)).
Remark A.1.3. If ϕ˙(x) is negative in U then ϕ(x) decreases along the solution
z(t0) through x0 ∈ U at t = 0.
Definition A.1.4. Let x˙ = f(x) be given on U , U∗ ⊆ U be a nonempty open set
and ϕ : U∗ → R a C1− function. Then, we call ϕ a first integral of x˙ = f(x) if ϕ
is not constant and Lf (ϕ) = 0.
1Fist integrals are conserved quantities. Thus, any autonomous system having a non trivial
first integral is called conservative system.
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Remark A.1.5. If ϕ is a first integral of x˙ = f(x) then the solutions of x˙ = f(x)
remain in the level set of ϕ in which they start. This means that ϕ(z(t)) is a
constant function of t for all solutions.
For further properties of Lie derivatives and of first integrals we refer to [Arn80],
p. 77-83.
A.2 Lyapunov’s stability theory
Let us start by formally defining stability after [Son90]:
Definition A.2.1. Let y ∈ U such that the solution z(t) = S(t,y) of the system
(A.1.1) for t ∈ [0,∞) exists. This solution is called stable if for all ε > 0 there
exits δ > 0 such that for all y∗ ∈ U with |y − y∗| < δ the solution S(t,y∗) in
[0,∞) exists and |S(t,y∗)− z(t)| < ε for all t > 0. If the solution is not stable it is
called unstable. Further, the solution z(t) is asymptotically stable if z(t) is stable
and besides that if ρ exists such that
lim
t→∞
|S(t,y∗)− z(t)| = 0
for all y∗ ∈ U with |y∗ − y| < ρ.
Remark A.2.2. The equilibrium point y∗ is stable if the trajectories do not depart
to far from y∗ whenever the initial state is chosen close enough to y∗. Asymptotic
stability of y∗ requires stability and implies that the solution S(t,y∗) always ap-
proaches the equilibrium point y∗ provided that the initial deviation is within a
certain region around y∗.
Lyapunov’s stability theory is one of the methods at hand that help to establish
stability.
The so called first method of Lyapunov, or Lyapunov’s indirect method, presup-
poses a known stationary solution and uses the linearization of the system at
stationary points. Since the linearization is made locally, this method can only be
used to prove local stability.
The stability on nonhyperbolic equilibrium points (see Remark A.2.4) may be
decided by using Lyapunov’s second method, also called Lyapunov’s direct method,
that does not require the knowledge of the solutions themselves [LaSa61]. This
method makes use of a function, known as the Lyapunov function.
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A.2.1 Linearization principle for stability
Following [Per96], let x∗ be an equilibrium point of the system (A.1.1). Lineariza-
tion of the function f(x) near x∗ means to approximate f(x) by its first order
Taylor polynomial:
f(x) = f(x∗) +Df (x
∗)(x− x∗) + o(x) = Df (x
∗)(x − x∗) + o(x),
since f(x∗) = 0.
Moreover, Df (x
∗) denotes the Jacobian matrix at the equilibrium point and o(.)
denotes the Landau symbol, i. e. f(x) = o(g(x)) ⇔ |f(x)| / |g(x)| → 0 as x →
0. Thus, for nearly solutions it is expected that the deviation from equilibrium
y(t) = x(t) − x∗ will be governed by the linearized system
y˙ = Ay, where A = Df (x
∗).
Theorem A.2.3. Let x∗ be an equilibrium point of the system (A.1.1). If all the
eigenvalues of the Jacobian Df (x
∗) have negative real part then x∗ is asymptotically
stable. If Df (x
∗) has at least an eigenvalue with positive real part then x∗ is an
unstable equilibrium point.
Remark A.2.4. An equilibrium point x∗ is called hyperbolic if none of the eigen-
values of the matrix Df (x
∗) have zero real part. Problems occur when one or more
of the eigenvalues is either zero or purely imaginary while the remaining ones are
negative. In other words, if we are in the presence of a nonhyperbolic equilibrium
point. In this cases, Theorem A.2.3 is inconclusive and more detailed information
is needed to make assertions about the nature of the equilibrium. This happens
to be the case when dealing with conservative systems.
A.2.2 Lyapunov functions
To study the stability of a nonhyperbolic equilibrium point we may use furthermore
the following theorem:
Theorem A.2.5 (Stability theorem). Let U be an open subset of Rn containing x0.
Suppose that f is defined in U and is of class C1 and that f(x0) = 0. Suppose
further that there exists a function ϕ on U and of class C1 satisfying ϕ(x0) = 0
and ϕ(x) > 0 if x 6= x0. Then
(i) if Lf (ϕ)(x) ≤ 0, for all x ∈ U then x0 is stable;
(ii) if Lf (ϕ)(x) < 0, for all x ∈ U \ {x0} then x0 is asymptotically stable;
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A proof of this theorem can be found in [Per96].
Definition A.2.6. A function ϕ : Rn → R satisfying the hypotheses of Theorem
A.2.5 is called Lyapunov function.
A Lyapunov function is continuously defined on the state space, bounded from
below, and non-increasing along trajectories. Such a function is constant over the
limit set of each trajectory; that is, its derivative with respect to time vanishes on
every limit set.
Remark A.2.7. A strict or strong Lyapunov function - that is, a strictly decreas-
ing function over nonstationary trajectories - causes every trajectory to approach
asymptotically a set of equilibria. The system is convergent if each limit set con-
tains a single equilibrium point. Thus, Theorem A.2.5 gives a criterion that can
be applied if we know an appropriate Lyapunov function ϕ. However, there is no
general method of finding Lyapunov functions, from general non-linear equations.
In the sequel we treat briefly the particular case in which the Jacobian of the
right-hand side of a differential autonomous nonlinear system at the equilibrium
has only one zero eigenvalue and the remaining eigenvalues have negative real part.
For more details we refer to [Bib79] or to [LaSa61].
A.2.3 Critical case of one zero eigenvalue
Suppose that the basic system is
x˙ = Px+ q(x), (A.2.1)
where P is a constant matrix of the linear terms and q(x) is a vector whose
components q1, q2, . . . are convergent power series in those components xi, i =
1, . . . , n of x which beginn with terms of degree at least 2.
If the matrix P has eigenvalues with zero real parts and has no eigenvalue with
positive real part. Then, we are confronted with a case, which Lyapunov called
critical.
In particular, one of the cases Lyapunov discussed extensively is the case of one
characteristical real root equal to zero and this is also the case we are interested
in.
So, let us suppose that the system (A.2.1) has one zero eigenvalue with the others
having negative real parts.
Following Bibikov [Bib79] (page 75) there is a non singular transformation that
reduces the system (A.2.1) to a system of the form
y˙ = F (y, z)
z˙ = Qz+ F˜ (y, z), where
(A.2.2)
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y = x1; F (y, z) and F˜ (y, z) are formal power series (the symbol ∼ means the
expansion of the corresponding power series may contain terms linear in y). z
is a (n − 1)−dimensional vector and Q is a constant matrix whose characteristic
roots κ2, . . . , κn are the same as those of P which are not zero, and therefore have
negative real parts.
Theorem 3.2 of [Bib79] (page 18) gives sufficient conditions for the formal transfor-
mation of (A.2.2) into its normal form on invariant surface (NFIS) to converge.
The NFIS has the form
y˙′ = Y (y′)
z˙′ = Qz′ + Z ′(y, z′).
(A.2.3)
If Y (y′) = 0 then we are in the transcendental case and for the solution of stability
problems one has to take into account all the terms of the expansion of the right-
hand part of (A.2.1). Here, we typically have a non-isolated singularity.
If Y (y′) = gy′N + . . . , g 6= 0 then we are in the algebraic case and the stability of
the origin depends on a finite number of terms in the expansion of the right-hand
side of (A.2.1).
Theorem 12.2 of [Bib79], page 79, says that in the transcendental case the zero
solution of the system (A.2.1) is stable.
Theorem 12.1 of [Bib79], page 77, gives a solution for the stability problem de-
pendent on the sign of g.
Altogether, the solutions of the stability problem in the critical case of one zero
eigenvalue is reduced to either calculate the sign of g, or to proving that the case
is transcendental.
Because it is important to handle the stability problem in some of the systems
considered in this thesis, we summarize in the following theorem (S. Walcher,
private statement) the information regarding the transcendental case:
Theorem A.2.8. Let x∗ = (x∗1, . . . , x
∗
n) be a stationary point of
x˙ = f(x),
where f is an analytic function in U ⊂ Rn. Furthermore, Df (x
∗) has a simple
eigenvalue λ1 = 0 and n−1 eigenvalues λ2, . . . , λn, with negative real parts. If the
stationary point is not isolated, then the transformation into NFIS converges in
x2 − x
∗
2 = x3 − x
∗
3 = . . . = xn − x
∗
n = 0. The NFIS has the representation
x˙1 =
d
dt
(x1 − x
∗
1) = 0
x˙2 =
d
dt
(x2 − x
∗
2) = λ2(x2 − x
∗
2) + . . .
...
x˙n =
d
dt
(xn − x
∗
n) = λn(xn − x
∗
n) + . . .
(A.2.4)
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Moreover, it holds that x∗ is stable but not asymptotically stable. The equilibrium
point has coordinates x1 = c and x2 = . . . = xn = 0.
A.3 Invariance. Limit sets
In general, we are interested in studying the asymptotic behavior of solutions. But,
sometimes it happens that a system is asymptotically stable in theory, but actually
unstable in practice. This means that, in order to have ”true” asymptotic stability,
one should be sure that when the perturbations are not too large the system tends
to return to equilibrium [LaSa61], particularly if the system is nonlinear. Concepts
like limit set and invariance constitute an attempt to understand properties and
long-time behavior of solutions .
In the sequel we introduce these concepts and some properties.
A.3.1 Invariance
Using the same notation as in [Wal01], we have:
Definition A.3.1. Let x˙ = f(x) be given on U , and let Y be a subset of U .
(i) If S(t,y) ∈ Y for all t ∈ Iy whenever y ∈ Y then Y is called an invariant set
of x˙ = f(x).
(ii) The set Y is called positively invariant with respect to x˙ = f(x) if for all
y ∈ Y the positive semitrajectory S+(y) is contained in Y.
(iii) The set Y is called negatively invariant with respect to x˙ = f(x) if for all
y ∈ Y the negative semitrajectory S−(y) is contained in Y.
A proof of the following result can also be found in [Wal01].
Proposition A.3.2. Let x˙ = f(x) be given on U , and let K ⊆ U be compact and
homeomorphic to a convex set such that, for all y ∈ K the positive semitrajectory
S+(y) is contained in K. Then K contains a stationary point of the differential
equation. Moreover, K is positively invariant.
Remark A.3.3. (i) Invariant subsets are unions of trajectories S(y) = {S(t,y) :
t ∈ Iy} and vice-versa.
(ii) Let x˙ = f(x) be given on U and consider Y ⊆ U invariant. Then, the closure
Y , the interior int(Y ) and the boundary ∂Y are also invariant.
(iii) Any subset of S(y) containing only stationary points of the differential equa-
tion is invariant.
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We now present some criteria for invariance without actual knowledge of solutions
in order to develop some strategies to determine invariant sets with respect to the
flow induced by f . The proofs can be found in [Ama90] (pages 215–219).
Theorem A.3.4. Let M ⊆ U be closed. Then M is positively invariant if and only
if for every x ∈M, the subtangent condition
lim
t→0+
inf
dist(x+ tf(x),M)
t
= 0 (A.3.1)
is satisfied.
Remark A.3.5. Condition (A.3.1) is obviously satisfied for x ∈ int(M). It is there-
fore only a condition for f on the boundary ofM . Notice furthermore that int(M)
can be empty and as a consequence ∂M =M is possible.
This result can be put in other terms:
Theorem A.3.6. Let x˙ = f(x) be given on U and ϕ : U → R be a C1−mapping
such that ∇ϕ(x) 6= 0 for all x ∈ ϕ−1(0), i. e., assume that 0 is a regular value of
ϕ. Then, M := ϕ−1(−∞, 0] is positively invariant if and only if
〈∇ϕ(x), f(x)〉 ≤ 0, for all x ∈ ∂M = ϕ−1(0). (A.3.2)
Remark A.3.7. Here it is stated that if M is a manifold with boundary and if
dim(M) = n, then condition (A.3.1) is equivalent to requiring that the vector field
f ”points inward” or ”lies below the tangent plane” along ∂M. This also explains
the name subtangent condition.
Corollary A.3.8. Let x˙ = f(x) be given on U ⊆ Rn and let ϕ1, . . . , ϕk be C
1−
mappings from U to R. Moreover, assume that 0 is a regular value of each ϕj , j =
1, . . . , k, and let
M :=
k⋂
j=1
ϕ−1j (−∞, 0].
If
〈∇ϕj(x), f(x)〉 ≤ 0, for all x ∈ ϕ
−1
j (0), j = 1, . . . , k, (A.3.3)
then M is positively invariant. If
〈∇ϕj(x), f(x)〉 = 0, for all x ∈ ϕ
−1
j (0), j = 1, . . . , k, (A.3.4)
then M and all the hypersurfaces ϕ−1j (0), j = 1, . . . , k, are invariant.
Remark A.3.9. If 0 is a regular value of the C1-mapping ϕ : U → R, then we
know that ϕ−1(0) is a hypersurface in Rn, which bounds the n−dimensional
C1−manifold ϕ−1(−∞, 0]. Moreover, ∇ϕ(x) is a vector in the direction of the
outward unit normal at x ∈ ϕ−1(0). Hence, Corollary A.3.8 states in particular
that M is invariant if at every x, f is a tangent vector on every hypersurface
ϕ−1(0) through that point.
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The following criterion holds for convex sets and is a special case of Theorem
A.3.4.
Proposition A.3.10. Let x˙ = f(x) be given on U and let V be convex with nonempty
interior. Furthermore, for x ∈ ∂V define
Cx := {Z ∈ R
n : x+ sZ ∈ int(V ) for sufficiently small s > 0}.
If f(x) ∈ Cx for all x ∈ ∂V then V is positively invariant.
The following theorem is also proved in [Ama90] and shows that Lyapunov func-
tions can be used to determine positively invariant sets:
Theorem A.3.11. Let −∞ ≤ γ < β and assume that ϕ : U → R is a Lyapunov
function on
{x ∈ U| γ < ϕ(x) < β}.
Then
Mα := {x ∈ U| ϕ(x) ≤ α}
is positively invariant for each α ∈ [γ, β).
Remark A.3.12. Theorem A.3.6 and Theorem A.3.11 are closely related. How-
ever, while Theorem A.3.6 involves a condition that must be satisfied only on the
boundary ofMα, Theorem A.3.11 requires ϕ to be a Lyapunov function in a whole
neighborhood of ∂M.
A.3.2 Limit sets
The following definition and the proofs of the subsequent theorems can be found
in [Wal01].
Definition A.3.13. Let x˙ = f(x) be given on U and let y ∈ U be such that S(t,y)
exists for 0 ≤ t < ∞, respectively for −∞ < t ≤ 0. Then Z ∈ U is called an
ω− limit point, respectively an α− limit point, of y if there is a sequence (tk)k∈N
of positive numbers with tk → ∞ as k → ∞, respectively if there is a sequence
(tk)k∈N of negative numbers with tk → −∞ as k→∞, such that
lim
k→∞
S(tk,y) = Z.
The collection of all ω−limit points, respectively of all α−limit points, is called
ω−limit set, respectively α−limit set, and is denoted by w(y), respectively by
α(y).
Remark A.3.14. (i) Intuitively if z(t) is a solution of the initial value problem
x˙ = f(x), f(x0) = 0 its ω−limit set is whatever the curve z(t) tends to with
infinite time [LaSa61].
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(ii) Limit sets are properties of solution orbits rather than individual points.
(iii) Limit sets may be empty.
Theorem A.3.15. For x˙ = f(x) given on U , let y ∈ U and K be a compact set such
that S(t,y) ∈ K, i. e., the solution is bounded, for all sufficiently large t. Then,
S(t,y) exists for all positive real t, and ω(y) is nonempty, compact and connected.
Theorem A.3.16. Let x˙ = f(x) be given on U ⊆ Rn, and y ∈ U such that S(t,y)
exists for all t ∈ [0,∞). Then w(y) is an invariant set.
A.4 LaSalle’s invariance principle
We are now in a position to state the following theorem, which gives a useful
tool to determine limit sets for certain classes of functions. This proposition is
known as LaSalle invariance principle. A proof can be found either in [Ama90] or
in [LaSa61] or in [KnoKa74].
Theorem A.4.1 (LaSalle). Let M ⊆ U be closed and assume that ϕ : M → R is
a C1 Lyapunov function on M ⊆ U . If y ∈ M is such that S+(y) ∈ M for all
t ∈ [0,∞), there exists some α ∈ R such that ω(y) ⊆ ϕ−1(α). In particular,
ω(y) ⊆ N := {x ∈M : Lf (ϕ)(x) = 0}.
Remark A.4.2. (i) If we impose that Lf (ϕ)(x) < 0 for all x 6= 0 in M, then the
equilibrium point is stable and all positive semitrajectories converge to the
equilibrium point as t→∞ [LaSa61].
(ii) LaSalle’s principle can be used if the system has an equilibrium set rather
than an isolated equilibrium point and it does not require the function ϕ(x)
to be positive definite.
Besides equilibrium points and periodic orbits, a dynamical system can have
strange attractors as limit sets. However, not every limit set of a trajectory of
(A.1.1) is an attracting set of (A.1.1) [Per96].
Appendix B
Results from Control Theory
We start with a general definition for a controlled dynamical system and state
in the sequel important properties such as controllability, stabilizability, observ-
ability and detectability. For the proofs of the results refer to [Zab92] , [Son90],
[Bar75], [KnKw80] and [NivdSc90]. The last section concerns flat systems and
their application to motion planning. For literature on flat systems see [Rot97]
and [FLMR95].
B.1 Basic definitions and criteria
Definition B.1.1 (Control System). We say that
Σ = (T , X, U,U , Y, s, o)
is a control system if
(i) T is a nonempty subset of R,
(ii) X,Y and U are nonempty topological spaces,
(iii) U is a nonempty subset of {u|u : T → U},
(iv) s is a mapping defined on a subset Ds of the set
D = {(t0, t1,x,u)|t0, t1 ∈ T , t0 ≤ t1,x ∈ X,u ∈ U}
into X with the following properties:
(a) For all t0 ∈ T and x ∈ X there exists t1 ∈ T with t1 > t0 and u ∈ U
such that (t0, t1,x,u) ∈ Ds.
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(b) (t0, t0,x,u) ∈ Ds and it is s(t0, t0,x,u) = x, for all t0 ∈ T ,x ∈ X and
u ∈ U .
(c) For all t0, t1 ∈ T with t0 < t1 and u,u
∗ ∈ U with u(t) = u∗(t), for all
t ∈ [t0, t1] ∩ T and for each x ∈ X such that (t0, t1,x,u) ∈ Ds,
(t0, t1,x,u
∗) ∈ Ds and s(t0, t1,x,u) = s(t0, t1,x,u
∗) hold .
(d) For all t0, t1 ∈ T with t0 < t1 and for all x0 ∈ X,u ∈ U with
(t0, t1,x0,u) ∈ Ds,
(t0, t,x0,u) ∈ Ds and (t, t1,x,u) ∈ Ds
hold for each t ∈ [t0, t1] ∩ T with x = s(t0, t,x0,u).
(e) For all t0, t1, t2 ∈ T with t0 ≤ t1 ≤ t2 and for all x ∈ X,u ∈ U such
that (t0, t2,x,u) ∈ Ds,
s(t1, t2,x1,u) = s(t0, t2,x,u) with x1 = (t0, t1,x,u) holds.
(v) o is a mapping from T ×X × U into Y.
Remark B.1.2. In the former definition, X is called the state space, Y the output
space and U is the control variable space; T denotes the time-domain or time
horizon, s the system transfer matrix and o the output mapping.
In this thesis we deal with the so called finite dimension differential control sys-
tems.
Definition B.1.3. Let D∗ ⊂ T ×X × U and let f : D∗ → X with:
(i) f(t,x,u) is piecewise continuous in u, t for all x ∈ X.
(ii) f(t,x,u) is Lipschitz-continuous in x ∈ X for (t,u) ∈ (T × U) ∩D∗x.
σ = (T , X, Y, U,U , f ,o) is a finite dimensional differential control system if
(i) T is a real interval;
(ii) X,Y, U are finite dimensional Euclidean spaces;
(iii) U is a set of piecewise continuous functions on T .
(iv) f : D∗ ⊂ T ×X × U → X fulfilling the conditions mentioned above.
(v) o : T ×X × U → Y is the output map function.
From this class of system, continuous time linear differential control systems de-
serve our special attention.
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Definition B.1.4. If
f(t,x,u) = A(t)x +B(t)u, o(t,x,u) = C(t)x+D(t)u
then σ is a linear differential control system with A ∈ R(n,n), B ∈ R(n,m), C ∈
R
(k,n) and D(t) ∈ R(k,m). Furthermore, x(t) ∈ Rn and u(t) ∈ Rm.
B.1.1 Controllability and observability
Controllability and observability can be checked in a purely algebraic way. Control-
lability essentially means that it should be always possible to reach an arbitrary
state from another arbitrary state in a finite time. Closely related to the idea
of controllability is that of observability, which in general terms means that it is
possible to determine the state of a system by solely measuring the output. This
section is a survey of the results on controllability and observability that can be
found for instance in [Son90], [Bar75] and in [KnKw80].
Let us formalize first the definition of controllability.
Definition B.1.5. Let Σ be a control system. Then,
(i) The pair (t1,x1) ∈ T ×X can be steered to some point (t2,x2) ∈ T ×X, t2 >
t1, if there exists a control function u ∈ U such that (t1, t2,x1,u) ∈ Ds and
s(t1, t2,x1,u) = x2.
(ii) x1 ∈ X can be steered to x2 in time T > 0 if for any t ∈ T with t+ T ∈ T ,
(t,x1) can be steered to (t+T,x2). Symbolically, we write (t,x1) (t+T,x2).
(iii) x1 ∈ X can be steered to x2 if for any t1 ∈ T there exists t2 ∈ T with
t2 > t1 such that (t1,x1) (t2,x2). Moreover, the state (t2,x2) is said to be
reachable.
In practice, we have a more common definition:
Definition B.1.6. Let Σ be a control system. Then,
(i) Σ is (completely) controllable on the interval [t0, t1] if for all state points
x1,x2 ∈ X it holds (t0,x1) (t1,x2).
(ii) Σ is (completely) controllable in time interval T if for all state points x1,x2 ∈
X and for all t ∈ T it holds (t,x1) (t+ T,x2).
(iii) Σ is (completely) controllable if x1  x2, for all x1,x2 ∈ X.
The following theorem, due to Hautus and Kalman, gives necessary and sufficient
conditions for controllability of time invariant systems.
200 Appendix B. Results from Control Theory
Theorem B.1.7. Consider the time invariant system
x˙ = Ax+Bu.
The following conditions are equivalent
(i) The pair [A,B] is completely controllable
(ii) For each eigenvector ν of AT holds νTB 6= 0.
(iii) The Kalman controllability matrix
U = [B,AB,A2B, . . . , An−1B]
has maximal rank n.
Corollary B.1.8. If rankB = p < n, then the condition in Theorem B.1.7 reduces
to
rank[B,AB,A2B, . . . , An−pB] = n.
If a system is not completely controllable, it can be shown that it is possible to
transfer it from an initial state x0 to a final state xf provided that both belong to
the column space of the controllability matrix. The proof of the following result,
often called the Kalman controllability decomposition, can be found in [Son90]. Let
GL(n) denote the group of all invertible n× n matrices over a field K.
Lemma B.1.9. Assume that the pair [A,B] is not controllable. Let r < n be the
dimension of the controllable subspace R[A,B]. Then, there exists T ∈ GL(n) such
that the matrices A˜ := T−1AT and B˜ := T−1B have the block structure
A˜ =
(
A1 A2
0 A3
)
B˜ =
(
B1
0
)
,
where A1 is r × r and B1 is r×m. Furthermore, the pair [A1, B1] is controllable.
Definition B.1.10. The control system Σ is completely observable if for any t0 and
any initial state x(t0) = x0 there is a finite time t1 > t0 such that the knowledge
of u(t) and y(t) for t0 ≤ t ≤ t1 suffices to determine x0.
In fact, the concept of observability tells something about the dynamical relation-
ships between the components of x(t) in the sense that deviations in the state at
the time t0 are reflected on deviations in the output y(t), where t belongs to an
interval.
The following theorem gives a necessary and sufficient condition for observability.
Theorem B.1.11. The system Σ is completely observable if and only if for any t1
there exists t0 < t1 such that the observability matrix
V (t0, t1) =
∫ t1
t0
Φ(t, t1)
TC(t)TC(t)Φ(t, t1) dt
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is positive definite. Φ(t, τ) is the state transition matrix of the homogeneous dif-
ferential equation x˙ = A(t)x.
A proof of this result can be find in both [Bar75] and [KnKw80]. For time-invariant
systems we have the following theorem corresponding to the controllability crite-
rion of Theorem B.1.7.
Theorem B.1.12. The time invariant system
x˙(t) = Ax(t) +Bu(t), y˙ = Cx (B.1.1)
is observable if and only if one of the following conditions hold:
(i) The rank of the observability matrix
V := (CT , ATCT , (A2)TCT , . . . , (An−1)TCT ) (B.1.2)
is equal to n.
(ii) If p is an eigenvector of the matrix A then Cp 6= 0.
For time invariant systems it holds furthermore:
Theorem B.1.13. If the system σ is time-invariant then if the observability matrix
(B.1.2) has rank n1 < n there exists a system algebraically equivalent to S obtained
by a transformation x → Px, y → Qy such that A and C have respectively the
following block structure
A =
(
A11 0
A21 A22
)
C =
(
C11
0
)
,
and the system
x˙1 = A11x1, y1 = C11x1
is completely observable. Furthermore, dimx1 = n1.
Remark B.1.14. The vector with the remaining states x2 of dimension n − n1
is said to be unobservable and the state space has been divided into two parts
regarding observability. This aspect is used to define detectability.
Notice furthermore that controllability and observability are dual properties in
the sense that the pair [A,B] is controllable if and only if the pair [BT , AT ] is
observable and the pair [C,A] is observable if and only if [AT , CT ] is controllable.
As a final remark, notice that a linear time-invariant system can be split up into
four mutually exclusive parts, respectively (1) completely controllable but unob-
servable; (2) completely controllable and completely observable; (3) uncontrollable
and unobservable and (4) completely observable but not controllable.
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B.1.2 Stabilizability and detectability
The general definition of stabilizability and detectability can also be found in
books like [Zab92], [Son90], [Bar75], [KnKw80]. Here we give special attention to
the time invariant case and introduce the following definitions:
Definition B.1.15. The ordered pair [A,B] is called stabilizable if there exists F ∈
R
(m,n) such that A+BF is asymptotically stable.
Definition B.1.16. The ordered pair [A,B] is called detectable if there exists K ∈
R
(m,k) such that A+BK is asymptotically stable.
It is clear by definition that these are dual properties, since [A,B] is stabilizable
if and only if the pair [BT , AT ] is detectable and the pair [A,C] is detectable if
and only if [AT , CT ] is stabilizable.
Remark B.1.17. (i) The system is stabilizable if and only if the non-controllable
subspace is stable.
(ii) The system is called detectable if its unobservable subspace is contained in
its stable subspace.
If a system is not completely observable then it is impossible to uniquely determine
the state of the system from the output. However, if the system is detectable then it
can at least be asymptotically reconstructed from the past behavior of the output.
B.2 Second order Taylor expansions
There are several approaches to find the second-order approximation to a dynam-
ical system. In this work we make use of the Magnus and Neudecker [MaNeu99]
definition of the Hessian matrix, since it can be easily implemented in a software
for symbolic calculations like MAPLE, MUPAD or MATLAB.
Then, as stated in [MaNeu99], the second order Taylor expansion of a twice dif-
ferentiable function f : Rn → Rm around x0 is given by
f(x) ≈ f(x0) +Df(x− x0) +
1
2
(Im ⊗ (x − x0)
T )Hf(x0)(x− x0),
where ⊗ denotes the Kronecker Product and
Hf(x0) =
∂2f(x0)
∂x∂xT
= D vec((Df(x0))
T )
is the Hessian matrix.
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Observing moreover that
Df(x) =


Df1(x)
Df2(x)
...
Dfm(x)


and that
Hf(x) =


Hf1(x)
Hf2(x)
...
Hfm(x)

 ,
we conclude that the Hessian Hf(x) is of dimension mn × n and consists of m
vertically concatenated symmetric n× n matrices.
Remark B.2.1. Given an equilibrium of a function, one computes the eigenvalues
of the Hessian matrix and determines the type of equilibrium by computing the
index 1 of that equilibrium. If the Hessian matrix is positive definite, the equilib-
rium point is a minimum, and if the Hessian is negative definite it is a maximum.
If the Hessian matrix has eigenvalues zero or has positive and negative eigenvalues
then the equilibrium point is a saddle point.
B.3 About flat systems
In this section, we introduce briefly the fundamental concepts of flatness based on
differential geometric and algebraic methods in view of the practical application
within the scope of the present work. For these and for other aspects of the analysis
of flatness please refer to [MMR97], [Rot97] and [FLMR95], where the theory is
formalized and illustrated with some examples.
In many modern systems, one typical use of control theory is to invert the dynamics
of a system to compute the inputs required in order to perform a specific task.
The inversion problem may consist in determining appropriate inputs to steer a
control system from a state to another or may involve finding inputs to follow a
desired trajectory for some or all state variables of the system.
Since the use of linear structures alone is oft not sufficient to solve the control
problems that are arising in applications, control theorists look for other type of
1Number of negative eigenvalues
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structures that in addition to simple linear ones help to understand the complexity
of the system. To this class of system belong the so called flat systems, for which
the structure of the trajectories of the nonlinear dynamics can be completely
characterized.
Roughly speaking, the system is said to be flat if it is possible to find a set of vari-
ables, called the flat outputs, such that the system is algebraic over the differential
field generated by the set of flat outputs. In other words, the system is flat if the
state and input variables can be directly expressed in terms of the flat outputs
(equal in number to the number of inputs) and finite number of its derivatives
without integrating any differential equation.
One of the properties of flat systems is that they can be feedback linearized using
dynamic feedback. However, because it is a property inherent to the system, flat-
ness does not imply that the principal intention is to transform the system to a
single linear system via a dynamic feedback and appropriate change of coordinates.
In fact, flatness is a geometric property independent of coordinate choice and is
an indicator that the nonlinear structure of the system is well characterized and
one can exploit that structure designing control algorithms for motion planning,
desired trajectory generation and stabilization.
Moreover, the flat output has usually a physical meaning and they might be re-
garded as providing another nonlinear extension of Kalman’s controllability con-
dition.
Formally speaking, let us consider the non-linear dynamical system defined by
x˙ = f(x,u),x(0) = x0 ∈Mn,u ∈ R
m, rank
∂f(x,u)
∂u
= m, (B.3.1)
where x is the n−dimension state variable defined in a manifold of dimension
n, isomorphic to Rn in a neighborhood of the origin (for the purpose of this
work, actually no distinction will be made between Mn and R
n), and u is the
m−dimension input.
Following the definition given in [Rot97], we have:
Definition B.3.1. A non-linear dynamical system (B.3.1) is called (differential2)
flat if there is a fictive output y = (y1, . . . , ym) with m = dimu satisfying the
following conditions:
(i) The variables yi, i = 1, . . . ,m can be expressed as a function of the state
variables xj , j = 1, . . . , n and ui, i = 1, . . . ,m, and a finite number of time
2The word differential is used to emphasize that all states of the system can be obtained by
differentiating y
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derivatives u
(k)
i , k = 1, . . . , αi. That is,
y = ϕ(x, u1, . . . , u
(α1)
1 , . . . , um, . . . , u
(αm)
m )
= ϕ(x,u, u˙, . . . ,u(α)).
(ii) The variables xi, i = 1, . . . , n, respectively uj, j = 1, . . . ,m can be expressed
as a function of yi, i = 1, . . . ,m and a finite number of their time-derivatives
y
(k)
i , k = 1, . . . , βi + 1, i. e.
x = ψ1(y1, . . . , y
(β1)
1 , . . . , ym, . . . , y
(βm)
m )
= ψ1(y, y˙, . . . ,y
(β));
u = ψ2(y1, . . . , y
(β1+1)
1 , . . . , ym, . . . , y
(βm+1)
m )
= ψ2(y, y˙, . . . ,y
(β+1)).
(B.3.2)
(iii) The components of y are differential independent, i. e., they do not satisfy a
differential equation of the form:
ϕ(y, y˙, . . . ,y(γ)) = 0.
If these conditions are at least locally satisfied, then the fictive output y is
flat and the system is also called flat.
Remark B.3.2. If condition (ii) holds then condition (iii) is equivalent to
dimy = dimu.
Like this, we may speak about a finite parametrization of the system by a flat
output. This parametrization facilitates the determination and the analysis of
stationary points (xs,ys) of the system B.3.1. For that, we only need to consider
equations (B.3.2) evaluated at y = ys and y
(k) = 0, k ≥ 1 to obtain:
xs = ψ1(ys, 0, . . . , 0) = ψ¯1(ys)
us = ψ2(ys, 0, . . . , 0) = ψ¯2(ys).
(B.3.3)
Notice that an explicit representation of the relation x(us) is not always possible.
By using the equations (B.3.3), we can for instance calculate the equilibrium point
as a function of ys.
Remark B.3.3. (i) A flat output is not uniquely determined;
(ii) A system without controls cannot be flat;
(iii) The distance to flatness is measured a non-negative integer called the defect.
Thus, a system is flat if and only if its defect is zero.
The defect of a linear system is equal to the dimension of its torsion submodule, i.
e., to the dimension of its Kalman uncontrollable subspace. The following theorem
holds:
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Theorem B.3.4. A linear system is flat if and only if it is controllable.
If a system is not flat, the general solution cannot be expressed without the inte-
gration of at least one of the differential equations. Though we can obtain more
information about the system by checking for flatness. Namely, which are the com-
ponents that are responsible for the non-flatness and how they can be approached
and have some hints for the adequate choice of the inputs.
Noteworthy is that there is no general computable test for checking whether a
system is flat. One of the main difficulties is moreover that a candidate flat output
may a priori depend on derivatives of the control function of arbitrary order, since
it remains up to now an open problem whether the order of the derivatives admits
an upper bound.
Appendix C
Technical Remarks
C.1 Solving systems of stiff differential equations using
SciLab
Roughly speaking, a stiff problem is one in which the stability is associated with
big eigenvalues (with negative real parts) of the Jacobian matrix of the function
on the right-hand-side of the ODE. This implies that the Jacobian has a big norm,
which in its turn is associated to a big Lipschitz constant. As a consequence, the
process described by the ODE contains components operating on different time
scales. This kind of problem should be solved by implicit methods of integration,
in which the step size is chosen to be very small for assuring stability giving the
desired accuracy. A survey on numerical methods suitable to approach the solution
of stiff systems is given in [Hemk72].
In this thesis, the numerical solution of the different systems was obtained using
SCILAB- 3.0.
SCILAB is a numerical programming and graphics environment available for free
from the French Government’s ”Institut Nationale de Recherche en Informatique et
en Automatique - INRIA”. It is similar in operation to MATLAB, GNU OCTAVE,
or other existing numerical/graphic environments and it can be run using a variety
of operating systems including UNIX, WINDOWS, Linux, etc.
SCILAB is available for free from the SCILAB web page: http://scilabsoft.inria.fr
together with several documentation files in several formats that help to get started
with the program.
Developed for system control and signal processing applications, SCILAB con-
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tains high quality solvers for ODEs [Sall04]. In the simplest use of SCILAB to
solve ODEs, one only needs to give the initial value problem and the interval of
integration. If the user does not specify something else, the solver chooses between
stiff and non stiff methods. However, if the system is stiff, it is recommended the
user to provide the Jacobian of the function on the right-hand side because of ac-
curacy reasons. Otherwise, it will be computed internally by the finite differences
method. Furthermore, stability of the system is also required and this is achieved
if the Jacobian matrix of the function defined by the right-hand side of the system
is stable at the equilibrium point.
C.2 The modules TriSer and Tsolve
The functions available in these modules allow one to decompose efficiently any
polynomial system into fine triangular systems and into irreducible triangular sys-
tems, to decompose any algebraic variety into unmixed or irreducible subvarieties,
and to solve any system of polynomial equations and inequalities [Wang04]. For
the decomposition of ordinary differential polynomial systems into irreducible dif-
ferential triangular systems one can use furthermore the module dTriser.
Appendix D
Original Model from Stortelder
and Hemker
SciLab code:
; getf(”C : /DokumenteundEinstellungen/Sandra/Doutoramento
/SciLabHemker/Sys9/BCHemk.sci”);
x0 is the vector containing the initial values and it corresponds to the physiological
concentration in the blood given in µM/l.
x0=[0.2;0;0.03;0;0.05;0;1.4;0;0];
t0=0;
The interval of integration corresponding to 30 minutes is represented by
T=[0:0.01:30];
The solution is obtained by calling the routine ode. The argument BCHemkj indi-
cates that the jacobian was provided.
sol=ode(x0,t0,T,BCHemk,BCHemkj);
The amydolitic activity of thrombin is given by
AmAct=sol(8,:)+0.556*sol(9,:);
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The function, BCHemk is given by
function xdot=BCHemk(t,x)
RVV=0.03;
k1=2.391d2;
k2=2.365d1;
k3=4.531;
k4=1.229d2;
k5=8.014d2;
k6=7.844;
k7=1.497d2;
k8=4.387d1;
k9=6.225d1;
k10=1.240d1;
k11=6.148d-2;
k12=7.859d-1;
k13=1.762d-1;
//reactions on the right-hand side
r1=(k1*x(1)*RVV)/(k2+x(1));
r2=k3*x(2);
r3=k6*x(3)*x(8)/(k7+x(3));
r4=k4*x(4)*x(2)*x(5);
r5=k5*x(6);
r6=(k8*x(7)*x(6))/(k9+x(7));
r7=(k10*x(7)*x(2))/(k11+x(7));
r8=k13*x(8);
r9=k12*x(8);
//system of ODE’s
xdot=[-r1;..
r1-r2-r4+r5;..
-r3;..
r3-r4+r5;..
-r4+r5;..
r4-r5;..
-r6-r7;..
r6+r7-r8-r9;..
r8] //correction according to the reaction scheme instead of r9
endfunction
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Appendix E
Platelets Contribution - An
Extension of Stortelder’s Model
First approach to model the influence of platelets - adapted from [SHH97].
; getf(”C : /DokumenteundEinstellungen/Sandra/Doutoramento
/SciLabHemker/Sys9Mod/BCHemkThromb.sci”);
T=[0:0.01:30];
xt=[0.2;0;0.03;0;0.05;0;1.4;0;0;0;0];
t0=0;
solt=ode(xt,t0,T,BCHemkThromb,BCHemkThromb);
function xdot=BCHemkThromb(t,x)
RVV=0.03;
k1=2.391d2;
k2=2.365d1;
k3=4.531;
k4=1.229d2;
k5=8.014d2;
k6=7.844;
k7=1.497d2;
k8=4.387d1;
k9=6.225d1;
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k10=1.240d1;
k11=6.148d-2;
k12=7.159d-1; changing this value changes the equilibrium level of AmAct
k13=1.762d-1;
kT=5.53; constant for thrombocyte action
r1=(k1*x(1)*RVV)/(k2+x(1));
r2=k3*x(2);
r3=k6*x(3)*x(8)/(k7+x(3));
r4=k4*x(4)*x(2)*x(5);
r5=k5*x(6);
r6=(k8*x(7)*x(6))/(k9+x(7));
r7=(k10*x(7)*x(2))/(k11+x(7));
r8=k13*x(8);
r9=k12*x(8);
r10=kT*x(8)*x(1); first order reaction modeling the activation of factor X
by thrombin at the surface of activated platelets
xdot=[-r1;..
r1-r2-r4+r5+r10;..
-r3;..
r3-r4+r5;..
-r4+r5;..
r4-r5;..
-r6-r7;..
r6+r7-r8-r9-r10;..
r9;..
r8]
endfunction
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Appendix F
Corrected Model from Mann
and Jones
SciLab code:
; getf(”C : /DokumenteundEinstellungen/Sandra/Doutoramento/
SciLabMann/BCMannCorr.sci”);
x0 is the vector containing the initial values and it corresponds to the phisiological
concentration in the blood given in µM.
x0=[0.000005;0.09;0.2;0.032;0.0007;1.4;0;0;0;0;0;0;0;0;0;0;0;0];
t0=0;
The interval of integration, where the time of 16 minutes is given in seconds is
represented by
T=[0:0.1:960];
The solution is obtained by calling the routine ode. The argument BCMannCorrj
indicates that the jacobian was provided.
sol=ode(x0,t0,T,BCMannCorr,BCMannCorrj);
The amount of activated thrombin in blood is given by
a=sol(9,:)+1.2*sol(11,:);
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In the function, BCMannCorr the constants are reduced to the appropriate dimen-
sion.
function xdot=BCMannCorr(t,x)
k1=20;
k2=20;
k3=10;
k4=20;
k5=10;
k6=100;
k7=10;
k8=400;
k9=0.005;
k10=0.4;
k11=0.3;
k12=1.15;
k13=8.2;
k14=32;
k15=0.1;
k16=25;
k17=44;
k18=0.001;
k19=70;
k20=0.02;
xdot=[k11*x(12)-k6*x(1)*x(2)+k16*x(12)+k12*x(13)-k6*x(1)*x(3)+k17*x(13);..
k16*x(12)-k6*x(1)*x(2)-k15*x(2)*x(16);..
k17*x(13)-k6*x(1)*x(3)-k6*x(7)*x(3)+k18*x(14);..
-k1*x(4)*x(16)-k2*x(4)*x(9);..
-k3*x(5)*x(16)-k4*x(5)*x(9);..
k19*x(10)-k6*x(8)*x(6);..
k7*x(18)*x(15)-k9*x(7)-k6*x(7)*x(3)+k18*x(14)+k13*x(14);..
k8*x(16)*x(17)-k10*x(8)+k19*x(10)-k6*x(8)*x(6)+k14*x(10);..
k5*x(8)*x(11);..
k6*x(8)*x(6)-k19*x(10)-k14*x(10);..
k14*x(10)-k5*x(8)*x(11);..
k6*x(1)*x(2)-k16*x(12)-k11*x(12);..
k6*x(1)*x(3)-k17*x(13)-k12*x(13);..
k6*x(7)*x(3)-k18*x(14)-k13*x(14);..
k9*x(7)-k7*x(18)*x(15)+k11*x(12)+k15*x(2)*x(16);..
k10*x(8)-k8*x(16)*x(17)+k12*x(13)+k13*x(14);..
k10*x(8)-k8*x(16)*x(17)+k1*x(4)*x(16)+k2*x(4)*x(9);..
k9*x(7)-k7*x(18)*x(15)+k3*x(5)*x(16)+k4*x(5)*x(9)]
endfunction
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